No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, d1egyA_, 1.0000, 0.00, 1.000, 403, 403, CYTOCHROME P450ERYF WITH 9-AMINOPHENANTHRENE BOUND
2, d1oxaA_, 0.9972, 0.00, 1.000, 403, 403, CYTOCHROME P450 (DONOR:O2 OXIDOREDUCTASE)
3, d1eupA_, 0.9965, 0.39, 1.000, 403, 403, X-RAY CRYSTAL STRUCTURE OF CYTOCHROME P450ERYF WITH ANDROSTENDIONE BOUND
4, d1eh0A_, 0.9964, 0.44, 1.000, 403, 403,  
5, d1z8pA_, 0.9958, 0.44, 1.000, 403, 403, FERROUS DIOXYGEN COMPLEX OF THE A245S CYTOCHROME P450ERYF
6, d1jioA_, 0.9956, 0.47, 0.978, 403, 403, P450ERYF/6DEB
7, d1jipA_, 0.9954, 0.53, 0.980, 403, 403, P450ERYF(A245S)/KETOCONAZOLE
8, d1z8qA_, 0.9947, 0.50, 0.978, 403, 403, FERROUS DIOXYGEN COMPLEX OF THE A245T CYTOCHROME P450ERYF
9, d1jinA_, 0.9947, 0.53, 0.978, 403, 403, P450ERYF/KETOCONAZOLE
10, d1z8oA_, 0.9939, 0.54, 1.000, 403, 403, FERROUS DIOXYGEN COMPLEX OF THE WILD-TYPE CYTOCHROME P450ERYF
11, d4umzA_, 0.9131, 0.44, 0.983, 402, 402, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED SUBSTRATE MIMIC BEARING A 2-DIMETHYLAMINOMETHYLBENZOATE GROUP
12, d2wi9A_, 0.9117, 2.14, 0.469, 396, 390, SELECTIVE OXIDATION OF CARBOLIDE C-H BONDS BY ENGINEERED MACROLIDE P450 MONOOXYGENASE
13, d2whwA_, 0.9110, 2.08, 0.468, 396, 389, SELECTIVE OXIDATION OF CARBOLIDE C-H BONDS BY ENGINEERED MACROLIDE P450 MONOOXYGENASE
14, d4umzB_, 0.9105, 2.08, 0.468, 396, 389, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED SUBSTRATE MIMIC BEARING A 2-DIMETHYLAMINOMETHYLBENZOATE GROUP
15, d4bf4D_, 0.9104, 2.15, 0.470, 395, 389, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
16, d2vzmA_, 0.9100, 2.18, 0.468, 397, 389, CRYSTAL STRUCTURE OF THE NARBOMYCIN-BOUND PIKC D50N MUTANT
17, d4bf4O_, 0.9094, 2.06, 0.469, 395, 388, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
18, d4b7dB_, 0.9093, 2.09, 0.472, 397, 388, PIKC BOUND TO THE 10-DML ANALOG WITH THE 3-(NN-DIMETHYLAMINO) PROPANOATE ANCHORING GROUP
19, d4bf4M_, 0.9087, 2.07, 0.470, 393, 387, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
20, d4bf4A_, 0.9086, 2.12, 0.469, 397, 388, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
21, d3zpiB_, 0.9085, 2.14, 0.469, 396, 388, PIKC D50N MUTANT IN P21 SPACE GROUP
22, d4jbtB_, 0.9079, 2.15, 0.468, 396, 389, THE 2.2 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH ANDROSTENEDIONE
23, d4bf4B_, 0.9077, 2.54, 0.335, 407, 397, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
24, d4jbtA_, 0.9076, 2.15, 0.469, 397, 388, THE 2.2 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH ANDROSTENEDIONE
25, d4j6cB_, 0.9076, 2.55, 0.335, 407, 397, THE 1.9 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH PROGESTERONE
26, d4bf4N_, 0.9076, 2.55, 0.335, 406, 397, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
27, d4j6cA_, 0.9075, 2.14, 0.466, 397, 388, THE 1.9 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH PROGESTERONE
28, d4bf4G_, 0.9074, 2.55, 0.335, 407, 397, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
29, d3zk5B_, 0.9071, 2.55, 0.335, 407, 397, PIKC D50N MUTANT BOUND TO THE 10-DML ANALOG WITH THE 3-(NN-DIMETHYLAMINO)ETHANOATE ANCHORING GROUP
30, d2vzmB_, 0.9070, 2.16, 0.469, 396, 388, CRYSTAL STRUCTURE OF THE NARBOMYCIN-BOUND PIKC D50N MUTANT
31, d4bf4L_, 0.9069, 2.08, 0.470, 394, 387, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
32, d4bf4H_, 0.9069, 2.08, 0.470, 394, 387, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
33, d4bf4I_, 0.9068, 2.07, 0.470, 397, 387, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
34, d4j6dB_, 0.9067, 2.05, 0.470, 396, 387, THE 2.4 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH TESTOSTERONE
35, d2wi9B_, 0.9067, 2.18, 0.469, 396, 388, SELECTIVE OXIDATION OF CARBOLIDE C-H BONDS BY ENGINEERED MACROLIDE P450 MONOOXYGENASE
36, d2c7xA_, 0.9067, 2.52, 0.333, 406, 396, CRYSTAL STRUCTURE OF NARBOMYCIN-BOUND CYTOCHROME P450 PIKC (CYP107L1)
37, d4bf4P_, 0.9064, 2.15, 0.461, 394, 388, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
38, d4bf4J_, 0.9061, 2.25, 0.470, 396, 389, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
39, d4bf4F_, 0.9061, 2.08, 0.470, 396, 387, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
40, d4j6dA_, 0.9060, 2.08, 0.468, 397, 387, THE 2.4 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH TESTOSTERONE
41, d4bf4E_, 0.9056, 2.19, 0.469, 396, 388, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
42, d4bf4K_, 0.9054, 2.53, 0.336, 406, 396, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
43, d3zpiA_, 0.9053, 2.08, 0.473, 397, 387, PIKC D50N MUTANT IN P21 SPACE GROUP
44, d3zk5A_, 0.9051, 2.10, 0.473, 397, 387, PIKC D50N MUTANT BOUND TO THE 10-DML ANALOG WITH THE 3-(NN-DIMETHYLAMINO)ETHANOATE ANCHORING GROUP
45, d2c6hA_, 0.9051, 2.19, 0.466, 396, 388, CRYSTAL STRUCTURE OF YC-17-BOUND CYTOCHROME P450 PIKC (CYP107L1)
46, d2c6hB_, 0.9049, 2.19, 0.469, 397, 388, CRYSTAL STRUCTURE OF YC-17-BOUND CYTOCHROME P450 PIKC (CYP107L1)
47, d4b7dA_, 0.9048, 2.19, 0.469, 397, 388, PIKC BOUND TO THE 10-DML ANALOG WITH THE 3-(NN-DIMETHYLAMINO) PROPANOATE ANCHORING GROUP
48, d2whwB_, 0.9047, 2.08, 0.469, 393, 386, SELECTIVE OXIDATION OF CARBOLIDE C-H BONDS BY ENGINEERED MACROLIDE P450 MONOOXYGENASE
49, d4j6bB_, 0.9045, 2.13, 0.468, 394, 387, THE 2.2 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH PREGNENOLONE
50, d4j6bA_, 0.9044, 2.06, 0.472, 393, 386, THE 2.2 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH PREGNENOLONE
51, d4bf4C_, 0.9042, 2.07, 0.469, 393, 386, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
52, d4b7sB_, 0.9041, 2.53, 0.334, 405, 395, PIKC D50N MUTANT BOUND TO THE 10-DML ANALOG WITH THE 3-(NN- DIMETHYLAMINO)PROPANOATE ANCHORING GROUP
53, d4b7sA_, 0.9029, 2.53, 0.334, 405, 395, PIKC D50N MUTANT BOUND TO THE 10-DML ANALOG WITH THE 3-(NN- DIMETHYLAMINO)PROPANOATE ANCHORING GROUP
54, d2ca0A_, 0.9028, 2.12, 0.468, 396, 387, CRYSTAL STRUCTURE OF YC-17-BOUND CYTOCHROME P450 PIKC ( CYP107L1)
55, d2bvjA_, 0.9028, 2.09, 0.469, 393, 386, LIGAND-FREE STRUCTURE OF CYTOCHROME P450 PIKC (CYP107L1)
56, d2cd8B_, 0.9016, 2.13, 0.470, 397, 387, CRYSTAL STRUCTURE OF YC-17-BOUND CYTOCHROME P450 PIKC (CYP107L1)
57, d5gweC_, 0.9002, 2.11, 0.469, 393, 386, CYTOCHROME P450 CREJ
58, d2ca0B_, 0.8995, 2.04, 0.472, 394, 386, CRYSTAL STRUCTURE OF YC-17-BOUND CYTOCHROME P450 PIKC ( CYP107L1)
59, d4mm0B_, 0.8994, 2.16, 0.472, 392, 386, CRYSTAL STRUCTURE ANALYSIS OF THE PUTATIVE THIOETHER SYNTHASE SGVP INVOLVED IN THE TAILORING STEP OF GRISEOVIRIDIN
60, d5gweA_, 0.8992, 2.39, 0.292, 405, 390, CYTOCHROME P450 CREJ
61, d2cd8A_, 0.8982, 2.16, 0.469, 393, 386, CRYSTAL STRUCTURE OF YC-17-BOUND CYTOCHROME P450 PIKC (CYP107L1)
62, d4mm0A_, 0.8970, 2.21, 0.385, 394, 387, CRYSTAL STRUCTURE ANALYSIS OF THE PUTATIVE THIOETHER SYNTHASE SGVP INVOLVED IN THE TAILORING STEP OF GRISEOVIRIDIN
63, d5cjeA_, 0.8969, 2.21, 0.385, 394, 387, STRUCTURE OF CYP107L2
64, d3a50A_, 0.8969, 2.48, 0.294, 405, 391, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND VITAMIN D3
65, d3a51A_, 0.8967, 2.48, 0.294, 405, 391, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND 25-HYDROXYVITAMIN D3
66, d3abaA1, 0.8962, 2.19, 0.473, 391, 385, CRYSTAL STRUCTURE OF CYP105P1 IN COMPLEX WITH FILIPIN I
67, d5xjnA_, 0.8960, 2.26, 0.385, 392, 387, CYTOCHROME P450 CREJ IN COMPLEX WITH (4-ETHYLPHENYL) DIHYDROGEN PHOSPHATE
68, d4yzrA_, 0.8960, 2.16, 0.474, 390, 384, BACILLUS SUBTILIS 168 BACILLAENE POLYKETIDE SYNTHASE (PKS) CYTOCHROME P450 PKSS
69, d5gweD_, 0.8958, 2.54, 0.424, 402, 389, CYTOCHROME P450 CREJ
70, d3a4zA_, 0.8958, 2.54, 0.424, 402, 389, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION
71, d3a4zD_, 0.8944, 2.39, 0.370, 393, 389, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION
72, d3a51D_, 0.8943, 2.37, 0.294, 403, 388, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND 25-HYDROXYVITAMIN D3
73, d3a50D_, 0.8935, 2.01, 0.378, 388, 386, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND VITAMIN D3
74, d3a50C_, 0.8930, 2.01, 0.378, 388, 386, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND VITAMIN D3
75, d3a4zE_, 0.8930, 2.35, 0.294, 403, 388, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION
76, d3a4zC_, 0.8928, 2.48, 0.425, 402, 388, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION
77, d3cv9A1, 0.8926, 2.48, 0.425, 402, 388, CRYSTAL STRUCTURE OF VITAMIN D HYDROXYLASE CYTOCHROME P450 105A1 (R73A/R84A MUTANT) IN COMPLEX WITH 1ALPHA25- DIHYDROXYVITAMIN D3
78, d3a51C_, 0.8926, 2.57, 0.425, 401, 388, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND 25-HYDROXYVITAMIN D3
79, d2z3uA_, 0.8924, 2.57, 0.425, 402, 388, CRYSTAL STRUCTURE OF CHROMOPYRROLIC ACID BOUND CYTOCHROME P450 STAP (CYP245A1)
80, d5x7eA1, 0.8922, 2.49, 0.424, 401, 387, CRYSTAL STRUCTURE OF VITAMIN D HYDROXYLASE CYTOCHROME P450 105A1 (R84A MUTANT) IN COMPLEX WITH 125-DIHYDROXYVITAMIN D2
81, d3a51B_, 0.8921, 2.54, 0.423, 401, 388, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND 25-HYDROXYVITAMIN D3
82, d3a50B_, 0.8921, 2.49, 0.424, 401, 387, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND VITAMIN D3
83, d3a50E_, 0.8920, 2.55, 0.423, 401, 388, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND VITAMIN D3
84, d3a51E_, 0.8919, 2.44, 0.364, 399, 390, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND 25-HYDROXYVITAMIN D3
85, d3a4zB_, 0.8918, 2.55, 0.425, 401, 388, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION
86, d2zbyA1, 0.8908, 2.81, 0.323, 411, 399, CRYSTAL STRUCTURE OF VITAMIN D HYDROXYLASE CYTOCHROME P450 105A1 (R84A MUTANT)
87, d2zbzA1, 0.8905, 2.81, 0.323, 411, 399, CRYSTAL STRUCTURE OF VITAMIN D HYDROXYLASE CYTOCHROME P450 105A1 (R84A MUTANT) IN COMPLEX WITH 125-DIHYDROXYVITAMIN D3
88, d3a1lA_, 0.8904, 2.46, 0.359, 403, 390, CRYSTAL STRUCTURE OF 1111 -DICHLOROCHROMOPYRROLIC ACID BOUND CYTOCHROME P450 STAP (CYP245A1)
89, d5cweB_, 0.8894, 2.49, 0.424, 402, 387, STRUCTURE OF CYP107L2 FROM STREPTOMYCES AVERMITILIS WITH LAURIC ACID
90, d3cv8A1, 0.8893, 2.49, 0.424, 402, 387, CRYSTAL STRUCTURE OF VITAMIN D HYDROXYLASE CYTOCHROME P450 105A1 (R84F MUTANT)
91, d3vrmA_, 0.8892, 2.50, 0.424, 401, 387, STRUCTURE OF CYTOCHROME P450 VDH MUTANT T107A WITH BOUND VITAMIN D3
92, d5cweA_, 0.8883, 2.50, 0.424, 401, 387, STRUCTURE OF CYP107L2 FROM STREPTOMYCES AVERMITILIS WITH LAURIC ACID
93, d5gnmB_, 0.8880, 2.49, 0.424, 402, 387, CYTOCHROME P450 VDH (CYP107BR1) L348M MUTANT
94, d2wm4A_, 0.8874, 2.40, 0.365, 399, 389, X-RAY STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP124 IN COMPLEX WITH PHYTANIC ACID
95, d1gwiB_, 0.8873, 2.47, 0.364, 403, 390, THE 1.92 A STRUCTURE OF STREPTOMYCES COELICOLOR A3(2) CYP154C1: A NEW MONOOXYGENASE THAT FUNCTIONALIZES MACROLIDE RING SYSTEMS
96, d4ubsA_, 0.8866, 2.47, 0.364, 403, 390, THE CRYSTAL STRUCTURE OF CYTOCHROME P450 105D7 FROM STREPTOMYCES AVERMITILIS IN COMPLEX WITH DICLOFENAC
97, d2zbxA1, 0.8865, 2.89, 0.326, 411, 399, CRYSTAL STRUCTURE OF VITAMIN D HYDROXYLASE CYTOCHROME P450 105A1 (WILD TYPE) WITH IMIDAZOLE BOUND
98, d5gnmA_, 0.8864, 2.27, 0.477, 393, 384, CYTOCHROME P450 VDH (CYP107BR1) L348M MUTANT
99, d5foiA1, 0.8861, 2.45, 0.357, 400, 389, CRYSTAL STRUCTURE OF MYCINAMICIN VIII C21 METHYL HYDROXYLASE MYCCI FROM MICROMONOSPORA GRISEORUBIDA BOUND TO MYCINAMICIN VIII
100, d5foiB_, 0.8858, 2.59, 0.422, 402, 386, CRYSTAL STRUCTURE OF MYCINAMICIN VIII C21 METHYL HYDROXYLASE MYCCI FROM MICROMONOSPORA GRISEORUBIDA BOUND TO MYCINAMICIN VIII
101, d1odoA_, 0.8857, 2.31, 0.479, 393, 384, 1.85 A STRUCTURE OF CYP154A1 FROM STREPTOMYCES COELICOLOR A3(2)
102, p6giiA_, 0.8847, 2.59, 0.429, 399, 389, THE CRYSTAL STRUCTURE OF TEPIDIPHILUS THERMOPHILUS P450 HEME DOMAIN 
103, d2xkrA_, 0.8844, 2.31, 0.290, 426, 386, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP142: A NOVEL CHOLESTEROL OXIDASE
104, d4pxhE_, 0.8840, 2.31, 0.290, 426, 386, STRUCTURE OF P450SKY (CYP163B3) A CYTOCHROME P450 FROM SKYLLAMYCIN BIOSYNTHESIS IN COMPLEX WITH A PEPTIDYL CARRIER PROTEIN DOMAIN
105, d3a4hA_, 0.8834, 2.68, 0.360, 400, 392, STRUCTURE OF CYTOCHROME P450 VDH FROM PSEUDONOCARDIA AUTOTROPHICA (ORTHORHOMBIC CRYSTAL FORM)
106, d4pxhA_, 0.8827, 2.48, 0.355, 393, 389, STRUCTURE OF P450SKY (CYP163B3) A CYTOCHROME P450 FROM SKYLLAMYCIN BIOSYNTHESIS IN COMPLEX WITH A PEPTIDYL CARRIER PROTEIN DOMAIN
107, d4pxhC_, 0.8823, 2.38, 0.363, 395, 386, STRUCTURE OF P450SKY (CYP163B3) A CYTOCHROME P450 FROM SKYLLAMYCIN BIOSYNTHESIS IN COMPLEX WITH A PEPTIDYL CARRIER PROTEIN DOMAIN
108, d5fygA_, 0.8822, 2.63, 0.429, 399, 389, STRUCTURE OF CYP153A FROM MARINOBACTER AQUAEOLEI IN COMPLEX WITH HYDROXYDODECANOIC ACID
109, d3ejbH_, 0.8820, 2.27, 0.329, 388, 383, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH TETRADECANOIC ACID LIGATED ACYL CARRIER PROTEIN
110, d3ejbD_, 0.8816, 2.27, 0.329, 388, 383, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH TETRADECANOIC ACID LIGATED ACYL CARRIER PROTEIN
111, d3ejdD_, 0.8815, 2.28, 0.329, 388, 383, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH HEXADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
112, d1xqdA_, 0.8812, 2.57, 0.342, 395, 389, CRYSTAL STRUCTURE OF P450NOR COMPLEXED WITH 3- PYRIDINEALDEHYDE ADENINE DINUCLEOTIDE
113, d2bvjB_, 0.8808, 2.57, 0.342, 395, 389, LIGAND-FREE STRUCTURE OF CYTOCHROME P450 PIKC (CYP107L1)
114, d3ejeD_, 0.8805, 2.56, 0.256, 416, 390, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH OCTADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
115, d1pkfA_, 0.8804, 2.14, 0.307, 395, 381, CRYSTAL STRUCTURE OF EPOTHILONE D-BOUND CYTOCHROME P450EPOK
116, d5fygB_, 0.8800, 2.63, 0.257, 407, 389, STRUCTURE OF CYP153A FROM MARINOBACTER AQUAEOLEI IN COMPLEX WITH HYDROXYDODECANOIC ACID
117, d5fyfA_, 0.8799, 2.70, 0.427, 400, 389, STRUCTURE OF CYP153A FROM MARINOBACTER AQUAEOLEI
118, d3bujA1, 0.8798, 2.66, 0.257, 417, 389, CRYSTAL STRUCTURE OF CALO2
119, d5gnmD_, 0.8786, 2.67, 0.257, 409, 389, CYTOCHROME P450 VDH (CYP107BR1) L348M MUTANT
120, d2wm5A_, 0.8786, 2.42, 0.229, 422, 385, X-RAY STRUCTURE OF THE SUBSTRATE-FREE MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP124
121, d5gnmC_, 0.8782, 2.42, 0.229, 422, 385, CYTOCHROME P450 VDH (CYP107BR1) L348M MUTANT
122, d5gnlA_, 0.8780, 2.23, 0.344, 387, 381, CYTOCHROME P450 VDH (CYP107BR1) F106V MUTANT
123, d1gwiA_, 0.8780, 2.23, 0.344, 387, 381, THE 1.92 A STRUCTURE OF STREPTOMYCES COELICOLOR A3(2) CYP154C1: A NEW MONOOXYGENASE THAT FUNCTIONALIZES MACROLIDE RING SYSTEMS
124, d3ejdB_, 0.8778, 2.21, 0.342, 386, 380, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH HEXADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
125, d1q5dA_, 0.8776, 2.28, 0.345, 385, 380, EPOTHILONE B-BOUND CYTOCHROME P450EPOK
126, d3a4gA_, 0.8772, 2.54, 0.298, 399, 389, STRUCTURE OF CYTOCHROME P450 VDH FROM PSEUDONOCARDIA AUTOTROPHICA (TRIGONAL CRYSTAL FORM)
127, d3ejeH_, 0.8764, 2.20, 0.468, 391, 378, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH OCTADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
128, d1q5eA_, 0.8762, 2.20, 0.346, 385, 379, SUBSTRATE-FREE CYTOCHROME P450EPOK
129, d3ejdH_, 0.8754, 2.68, 0.283, 403, 392, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH HEXADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
130, d5l92A_, 0.8753, 2.43, 0.226, 419, 385, THE 2.1 A CRYSTAL STRUCTURE OF CYP109E1 FROM BACILLUS MEGATERIUM IN COMPLEX WITH CORTICOSTERONE
131, d3ejdF_, 0.8749, 2.40, 0.229, 420, 384, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH HEXADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
132, d5gweB_, 0.8743, 2.55, 0.302, 396, 388, CYTOCHROME P450 CREJ
133, d5l94A_, 0.8736, 2.55, 0.302, 396, 388, THE 2.25 A CRYSTAL STRUCTURE OF CYP109E1 FROM BACILLUS MEGATERIUM IN COMPLEX WITH TESTOSTERONE
134, d3ejeF_, 0.8735, 2.74, 0.427, 401, 389, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH OCTADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
135, d3wecA_, 0.8732, 2.47, 0.281, 425, 385, STRUCTURE OF P450 RAUA (CYP1050A1) COMPLEXED WITH A BIOSYNTHETIC INTERMEDIATE OF AURACHIN RE
136, d3ejbB_, 0.8727, 2.78, 0.429, 401, 389, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH TETRADECANOIC ACID LIGATED ACYL CARRIER PROTEIN
137, d4triB_, 0.8723, 2.40, 0.399, 395, 381, X-RAY CRYSTAL STRUCTURE OF CYP142A2 FROM MYCOBACTERIUM SMEGMATIS COMPLEXED WITH CHOLESTEROL SULFATE.
138, d2yooA_, 0.8723, 2.81, 0.347, 402, 389, CHOLEST-4-EN-3-ONE BOUND STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
139, d1phfA_, 0.8720, 2.14, 0.345, 382, 377, CRYSTAL STRUCTURES OF METYRAPONE-AND PHENYLIMIDAZOLE- INHIBITED COMPLEXES OF CYTOCHROME P450-CAM
140, d1gebA_, 0.8720, 2.65, 0.282, 401, 390, X-RAY CRYSTAL STRUCTURE AND CATALYTIC PROPERTIES OF THR252ILE MUTANT OF CYTOCHROME P450CAM
141, d2h7qA_, 0.8719, 2.45, 0.402, 395, 381, CYTOCHROME P450CAM COMPLEXED WITH IMIDAZOLE
142, d1phbA_, 0.8719, 2.19, 0.347, 383, 377, INHIBITOR-INDUCED CONFORMATIONAL CHANGE IN CYTOCHROME P450- CAM
143, d1phcA_, 0.8718, 2.75, 0.281, 404, 392, CRYSTAL STRUCTURE OF SUBSTRATE-FREE PSEUDOMONAS PUTIDA CYTOCHROME P450
144, d6cppA_, 0.8717, 2.75, 0.281, 404, 392, CRYSTAL STRUCTURES OF CYTOCHROME P450-CAM COMPLEXED WITH CAMPHANE THIOCAMPHOR AND ADAMANTANE: FACTORS CONTROLLING P450 SUBSTRATE HYDROXYLATION
145, d2x5wA_, 0.8717, 2.23, 0.347, 382, 377, X-RAY STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125 IN COMPLEX WITH SUBSTRATE CHOLEST-4-EN-3-ONE
146, d1phaA_, 0.8717, 2.20, 0.309, 386, 376, INHIBITOR-INDUCED CONFORMATIONAL CHANGE IN CYTOCHROME P450- CAM
147, d1iwkA_, 0.8716, 2.15, 0.346, 381, 376, PUTIDAREDOXIN-BINDING STABLILIZES AN ACTIVE CONFORMER OF CYTOCHROME P450CAM IN ITS REDUCED STATE; CRYSTAL STRUCTURE OF MUTANT(112K) CYTOCHROME P450CAM
148, d1cp4A_, 0.8716, 2.47, 0.291, 396, 381, FORMATION CRYSTAL STRUCTURE AND REARRANGEMENT OF A CYTOCHROME P450-CAM IRON-PHENYL COMPLEX
149, d4l49A_, 0.8715, 2.27, 0.309, 385, 376, STRUCTURE OF L358A MUTANT OF P450CAM BOUND TO CAMPHOR
150, d2z97A_, 0.8715, 2.13, 0.347, 380, 375, CRYSTAL STRUCTURE OF FERRIC CYTOCHROME P450CAM RECONSTITUTED WITH 7- METHYL-7-DEPROPIONATED HEMIN
151, d1re9A_, 0.8715, 2.74, 0.260, 401, 389, CRYSTAL STRUCTURE OF CYTOCHROME P450-CAM WITH A FLUORESCENT PROBE D-8-AD (ADAMANTANE-1-CARBOXYLIC ACID-5-DIMETHYLAMINO- NAPHTHALENE-1-SULFONYLAMINO-OCTYL-AMIDE)
152, d1gemA_, 0.8715, 2.74, 0.260, 401, 389, STRUCTURAL CHARACTERIZATION OF N-BUTYL-ISOCYANIDE COMPLEXES OF CYTOCHROMES P450NOR AND P450CAM
153, d1pheA_, 0.8714, 2.20, 0.341, 380, 375, CRYSTAL STRUCTURES OF METYRAPONE-AND PHENYLIMIDAZOLE-INHIBITED COMPLEXES OF CYTOCHROME P450-CAM
154, d2gr6A_, 0.8713, 2.37, 0.297, 400, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/L244A/V247L/C334A)
155, d1gjmA_, 0.8713, 2.38, 0.297, 396, 381, COVALENT ATTACHMENT OF AN ELECTROACTIVE SULPHYDRYL REAGENT IN THE ACTIVE SITE OF CYTOCHROME P450CAM
156, d4cppA_, 0.8712, 2.34, 0.218, 405, 381, CRYSTAL STRUCTURES OF CYTOCHROME P450-CAM COMPLEXED WITH CAMPHANE THIOCAMPHOR AND ADAMANTANE: FACTORS CONTROLLING P450 SUBSTRATE HYDROXYLATION
157, d2ferA_, 0.8712, 2.34, 0.218, 405, 381, P450CAM FROM PSEUDOMONAS PUTIDA RECONSTITUTED WITH MANGANIC PROTOPORPHYRIN IX
158, d1phdA_, 0.8712, 2.34, 0.218, 405, 381, CRYSTAL STRUCTURES OF METYRAPONE-AND PHENYLIMIDAZOLE-INHIBITED COMPLEXES OF CYTOCHROME P450-CAM
159, d4l4aA_, 0.8711, 2.34, 0.218, 405, 381, STRUCTURE OF L358A/K178G MUTANT OF P450CAM BOUND TO CAMPHOR
160, d8cppA_, 0.8710, 2.34, 0.218, 405, 381, CRYSTAL STRUCTURES OF CYTOCHROME P450-CAM COMPLEXED WITH CAMPHANE THIOCAMPHOR AND ADAMANTANE: FACTORS CONTROLLING P450 SUBSTRATE HYDROXYLATION
161, d1iwjA_, 0.8710, 2.34, 0.218, 405, 381, PUTIDAREDOXIN-BINDING STABLILIZES AN ACTIVE CONFORMER OF CYTOCHROME P450CAM IN ITS REDUCED STATE; CRYSTAL STRUCTURE OF MUTANT(109K) CYTOCHROME P450CAM
162, d1iwiA_, 0.8710, 2.82, 0.271, 409, 391, PUTIDAREDOXIN-BINDING STABLILIZES AN ACTIVE CONFORMER OF CYTOCHROME P450CAM IN ITS REDUCED STATE; CRYSTAL STRUCTURE OF CYTOCHROME P450CAM
163, d7cppA_, 0.8709, 2.34, 0.218, 405, 381, THE STRUCTURAL BASIS FOR SUBSTRATE-INDUCED CHANGES IN REDOX POTENTIAL AND SPIN EQUILIBRIUM IN CYTOCHROME P450(CAM)
164, d3cppA_, 0.8709, 2.35, 0.213, 405, 381, CRYSTAL STRUCTURE OF THE CARBON MONOXY-SUBSTRATE-CYTOCHROME P450-CAM TERNARY COMPLEX
165, d2cp4A_, 0.8709, 2.34, 0.218, 405, 381, CRYSTAL STRUCTURE OF THE CYTOCHROME P450-CAM ACTIVE SITE MUTANT THR252ALA
166, d1t87A_, 0.8709, 2.35, 0.218, 405, 381, CRYSTAL STRUCTURE OF THE FERROUS CO-BOUND CYTOCHROME P450CAM (C334A)
167, d1phgA_, 0.8709, 2.35, 0.220, 405, 381, CRYSTAL STRUCTURES OF METYRAPONE-AND PHENYLIMIDAZOLE- INHIBITED COMPLEXES OF CYTOCHROME P450-CAM
168, d3cp4A_, 0.8708, 2.39, 0.220, 404, 382, CRYSTAL STRUCTURE OF THE CYTOCHROME P450-CAM ACTIVE SITE MUTANT THR252ALA
169, d2yooD_, 0.8708, 2.35, 0.218, 405, 381, CHOLEST-4-EN-3-ONE BOUND STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
170, d1c8jA_, 0.8708, 2.34, 0.218, 405, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F)
171, d4triA1, 0.8707, 2.34, 0.220, 405, 381, X-RAY CRYSTAL STRUCTURE OF CYP142A2 FROM MYCOBACTERIUM SMEGMATIS COMPLEXED WITH CHOLESTEROL SULFATE.
172, d4l4eA_, 0.8707, 2.33, 0.220, 405, 381, STRUCTURE OF CYANIDE AND CAMPHOR BOUND P450CAM MUTANT L358A/K178G
173, d2wioA_, 0.8707, 2.35, 0.218, 405, 381, STRUCTURE OF THE  HISTIDINE TAGGED OPEN CYTOCHROME P450 ERYK FROM S. ERYTHRAEA
174, d2cppA_, 0.8707, 2.36, 0.218, 405, 381, HIGH-RESOLUTION CRYSTAL STRUCTURE OF CYTOCHROME P450-CAM
175, d1t86A_, 0.8707, 2.35, 0.218, 405, 381, CRYSTAL STRUCTURE OF THE FERROUS CYTOCHROME P450CAM MUTANT (L358P/C334A)
176, d1p7rA1, 0.8707, 2.35, 0.220, 405, 381, CRYSTAL STRUCTURE OF REDUCED CO-EXPOSED COMPLEX OF CYTOCHROME P450CAM WITH (S)-(-)-NICOTINE
177, d1nooA_, 0.8707, 2.35, 0.218, 405, 381, CYTOCHROME P450-CAM COMPLEXED WITH 5-EXO-HYDROXYCAMPHOR
178, d5cppA_, 0.8706, 2.36, 0.218, 405, 381, THE STRUCTURAL BASIS FOR SUBSTRATE-INDUCED CHANGES IN REDOX POTENTIAL AND SPIN EQUILIBRIUM IN CYTOCHROME P-450(CAM)
179, d4ek1B_, 0.8706, 2.35, 0.218, 405, 381, CRYSTAL STRUCTURE OF ELECTRON-SPIN LABELED CYTOCHROME P450CAM
180, d4cp4A_, 0.8706, 2.34, 0.218, 405, 381, CRYSTAL STRUCTURE OF THE CYTOCHROME P450-CAM ACTIVE SITE MUTANT THR252ALA
181, d1uyuB_, 0.8706, 2.35, 0.218, 405, 381, XENON COMPLEX OF WILDTYPE P450CAM FROM PSEUDOMONAS PUTIDA
182, d1p2yA1, 0.8706, 2.35, 0.220, 405, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM IN COMPLEX WITH (S)- (-)-NICOTINE
183, d1dz8B_, 0.8706, 2.35, 0.218, 407, 381, OXYGEN COMPLEX OF P450CAM FROM PSEUDOMONAS PUTIDA
184, d3wrlA_, 0.8705, 2.35, 0.218, 405, 381, CRYSTAL STRUCTURE OF P450CAM
185, d3wrhA_, 0.8705, 2.36, 0.215, 405, 381, CRYSTAL STRUCTURE OF P450CAM
186, d3p6pA_, 0.8705, 2.41, 0.297, 394, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC1-C6-BIO
187, d3oiaA_, 0.8705, 2.36, 0.218, 405, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC1-C8GLUETG-BIO
188, d2gqxA_, 0.8705, 2.41, 0.294, 397, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/L244A/V247L/C334A) WITH PENTACHLOROBENZENE
189, d1yrdA_, 0.8705, 2.36, 0.220, 405, 381, X-RAY CRYSTAL STRUCTURE OF PERDEUTERATED CYTOCHROME P450CAM
190, d1lwlA_, 0.8705, 2.38, 0.324, 393, 377, CRYSTAL STRUCTURE OF CYTOCHROME P450-CAM WITH A FLUORESCENT PROBE D-8-AD (ADAMANTANE-1-CARBOXYLIC ACID-5-DIMETHYLAMINO- NAPHTHALENE-1-SULFONYLAMINO-OCTYL-AMIDE)
191, d1j51A_, 0.8705, 2.35, 0.218, 405, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/V247L/C334A) WITH 135-TRICHLOROBENZENE
192, d1gekA_, 0.8705, 2.35, 0.218, 406, 381, STRUCTURAL CHARACTERIZATION OF N-BUTYL-ISOCYANIDE COMPLEXES OF CYTOCHROMES P450NOR AND P450CAM
193, d5cp4A_, 0.8704, 2.36, 0.223, 405, 381, CRYOGENIC STRUCTURE OF P450CAM
194, d3wrjA_, 0.8704, 2.36, 0.218, 405, 381, CRYSTAL STRUCTURE OF P450CAM
195, d3p6oA_, 0.8704, 2.36, 0.218, 405, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC1-ETG-DANS
196, d3p6mA_, 0.8704, 2.36, 0.218, 404, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC1-C8-DANS
197, d2zuhA_, 0.8704, 2.36, 0.218, 405, 381, CRYSTAL STRUCTURE OF CAMPHOR-SOAKED FERRIC CYTOCHROME P450CAM MUTANT (D297A)
198, d1akdA_, 0.8704, 2.36, 0.218, 405, 381, CYTOCHROME P450CAM FROM PSEUDOMONAS PUTIDA COMPLEXED WITH 1S-CAMPHOR
199, d2a1oA_, 0.8703, 2.36, 0.220, 405, 381, CRYSTAL STRUCTURE OF FERROUS DIOXYGEN COMPLEX OF T252A CYTOCHROME P450CAM
200, d1t88A_, 0.8703, 2.36, 0.218, 405, 381, CRYSTAL STRUCTURE OF THE FERROUS CYTOCHROME P450CAM (C334A)
201, d1mpwA_, 0.8703, 2.36, 0.218, 405, 381, MOLECULAR RECOGNITION IN (+)-A-PINENE OXIDATION BY CYTOCHROME P450CAM
202, d1dz9B_, 0.8703, 2.36, 0.218, 405, 381, PUTATIVE OXO COMPLEX OF P450CAM FROM PSEUDOMONAS PUTIDA
203, d1dz8A_, 0.8703, 2.40, 0.220, 407, 382, OXYGEN COMPLEX OF P450CAM FROM PSEUDOMONAS PUTIDA
204, d1dz4B_, 0.8703, 2.39, 0.220, 405, 382, FERRIC P450CAM FROM PSEUDOMONAS PUTIDA
205, p5kdbA_, 0.8702, 2.36, 0.220, 405, 381, THE CRYSTAL STRUCTURE OF 4-ISOPROPYLBENZOATE-BOUND CYP199A4
206, d4l4bA_, 0.8702, 2.36, 0.223, 405, 381, STRUCTURE OF L358A/K178G/D182N MUTANT OF P450CAM BOUND TO CAMPHOR
207, d3r9cA_, 0.8702, 2.39, 0.220, 404, 382, CRYSTAL STRUCTURE OF MYCOBACTERIUM SMEGMATIS CYP164A2 WITH ECONAZOLE BOUND
208, d3fwgB_, 0.8702, 2.36, 0.220, 405, 381, FERRIC CAMPHOR BOUND CYTOCHROME P450CAM ARG365LEU GLU366GLN MONOCLINIC CRYSTAL FORM
209, d2zujA_, 0.8702, 2.37, 0.218, 406, 381, CRYSTAL STRUCTURE OF CAMPHOR-SOAKED FERRIC CYTOCHROME P450CAM MUTANT(D297L)
210, d1uyuA_, 0.8702, 2.37, 0.218, 406, 381, XENON COMPLEX OF WILDTYPE P450CAM FROM PSEUDOMONAS PUTIDA
211, d1o76B_, 0.8702, 2.37, 0.223, 405, 381, CYANIDE COMPLEX OF P450CAM FROM PSEUDOMONAS PUTIDA
212, d1j51C_, 0.8702, 2.40, 0.220, 405, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/V247L/C334A) WITH 135-TRICHLOROBENZENE
213, d1dz9A_, 0.8702, 2.39, 0.220, 404, 382, PUTATIVE OXO COMPLEX OF P450CAM FROM PSEUDOMONAS PUTIDA
214, d4l4fA_, 0.8701, 2.36, 0.223, 405, 381, STRUCTURE OF CYANIDE AND CAMPHOR BOUND P450CAM MUTANT L358A/K178G/D182N
215, d4l4cA_, 0.8701, 2.39, 0.217, 405, 382, STRUCTURE OF L358P/K178G MUTANT OF P450CAM BOUND TO CAMPHOR
216, d3wrjE_, 0.8701, 2.36, 0.220, 405, 381, CRYSTAL STRUCTURE OF P450CAM
217, d2zwuA_, 0.8701, 2.36, 0.218, 407, 381, CRYSTAL STRUCTURE OF CAMPHOR SOAKED FERRIC CYTOCHROME P450CAM
218, d2zaxA_, 0.8701, 2.36, 0.220, 405, 381, CRYSTAL STRUCTURE OF FERRIC CYTOCHROME P450CAM
219, d2xfhA_, 0.8701, 2.36, 0.218, 405, 381, STRUCTURE OF CYTOCHROME P450 ERYK COCRYSTALLIZED WITH INHIBITOR CLOTRIMAZOLE.
220, d2gr6B_, 0.8701, 2.37, 0.223, 404, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/L244A/V247L/C334A)
221, d2feuB_, 0.8701, 2.36, 0.218, 405, 381, P450CAM FROM PSEUDOMONAS PUTIDA RECONSTITUTED WITH MANGANIC PROTOPORPHYRIN IX
222, d2a1nA_, 0.8701, 2.51, 0.282, 393, 383, CRYSTAL STRUCTURE OF FERROUS DIOXYGEN COMPLEX OF D251N CYTOCHROME P450CAM
223, d5l91A1, 0.8700, 2.37, 0.220, 405, 381, THE 2.2 A CRYSTAL STRUCTURE OF CYP109E1 FROM BACILLUS MEGATERIUM BOUND WITH FOUR CORTICOSTERONE MOLECULES
224, d3wrmA_, 0.8700, 2.89, 0.324, 400, 386, CRYSTAL STRUCTURE OF P450CAM
225, d3p6nA_, 0.8700, 2.89, 0.324, 400, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC1-C8-DANS
226, d3ol5A_, 0.8700, 2.37, 0.218, 405, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED WITH A TETHERED SUBSTRATE ANALOG 3OH-ADAC1-C8-DANS
227, d2zuiA_, 0.8700, 2.36, 0.223, 405, 381, CRYSTAL STRUCTURE OF CAMPHOR-SOAKED FERRIC CYTOCHROME P450CAM MUTANT (D297N)
228, d2qbmA_, 0.8700, 2.37, 0.220, 404, 381, CRYSTAL STRUCTURE OF THE P450CAM G248T MUTANT IN THE CYANIDE BOUND STATE
229, d1t86B_, 0.8700, 2.36, 0.218, 405, 381, CRYSTAL STRUCTURE OF THE FERROUS CYTOCHROME P450CAM MUTANT (L358P/C334A)
230, d5wk9A_, 0.8699, 2.36, 0.220, 405, 381, R186AP450CAM WITH CN AND CAMPHOR
231, d5h1zA_, 0.8699, 2.37, 0.223, 404, 381, CYP153D17 FROM SPHINGOMONAS SP. PAMC 26605
232, d3wrlE_, 0.8699, 2.37, 0.220, 405, 381, CRYSTAL STRUCTURE OF P450CAM
233, d2yooB_, 0.8699, 2.37, 0.220, 405, 381, CHOLEST-4-EN-3-ONE BOUND STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
234, d2frzA_, 0.8699, 2.37, 0.223, 405, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/V247L/C334A)
235, d2a1mB_, 0.8699, 2.36, 0.223, 405, 381, CRYSTAL STRUCTURE OF FERROUS DIOXYGEN COMPLEX OF WILD-TYPE CYTOCHROME P450CAM
236, d1t87B_, 0.8699, 2.37, 0.223, 405, 381, CRYSTAL STRUCTURE OF THE FERROUS CO-BOUND CYTOCHROME P450CAM (C334A)
237, d1o76A_, 0.8699, 2.40, 0.325, 394, 379, CYANIDE COMPLEX OF P450CAM FROM PSEUDOMONAS PUTIDA
238, d4l4dA_, 0.8698, 2.37, 0.226, 405, 381, STRUCTURE OF CYANIDE AND CAMPHOR BOUND P450CAM MUTANT L358A
239, d3wrmF_, 0.8698, 2.37, 0.218, 405, 381, CRYSTAL STRUCTURE OF P450CAM
240, d2zwtA_, 0.8698, 2.37, 0.218, 407, 381, CRYSTAL STRUCTURE OF FERRIC CYTOCHROME P450CAM
241, d2a1mA_, 0.8698, 2.54, 0.294, 388, 378, CRYSTAL STRUCTURE OF FERROUS DIOXYGEN COMPLEX OF WILD-TYPE CYTOCHROME P450CAM
242, p5nwsA_, 0.8697, 2.54, 0.294, 388, 378, CRYSTAL STRUCTURE OF SAACMM INVOLVED IN ACTINOMYCIN BIOSYNTHESIS
243, p5kt1A_, 0.8697, 2.38, 0.223, 405, 381, THE CRYSTAL STRUCTURE OF 4-METHYLTHIOBENZOATE-BOUND CYP199A4
244, d4kkyX_, 0.8697, 2.40, 0.220, 404, 382, CRYSTAL STRUCTURE OF N-(1-PYRENE)ACETAMIDE LABELED P450CAM IN SUBSTRATE BOUND FORM.
245, d2a1oB_, 0.8697, 2.40, 0.220, 405, 382, CRYSTAL STRUCTURE OF FERROUS DIOXYGEN COMPLEX OF T252A CYTOCHROME P450CAM
246, d2yooC_, 0.8696, 2.37, 0.223, 405, 381, CHOLEST-4-EN-3-ONE BOUND STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
247, p5u6uA_, 0.8695, 2.37, 0.218, 405, 381, THE CRYSTAL STRUCTURE OF 4-ETHYLTHIOBENZOATE-BOUND CYP199A4 
248, d2zawA_, 0.8695, 2.36, 0.218, 406, 381, CRYSTAL STRUCTURE OF FERRIC CYTOCHROME P450CAM RECONSTITUTED WITH 6- METHYL-6-DEPROPIONATED HEMIN
249, d2a1nB_, 0.8695, 2.41, 0.220, 405, 382, CRYSTAL STRUCTURE OF FERROUS DIOXYGEN COMPLEX OF D251N CYTOCHROME P450CAM
250, d6cp4A_, 0.8694, 2.76, 0.250, 400, 388, P450CAM D251N MUTANT
251, d2vrvA_, 0.8694, 2.76, 0.250, 400, 388,  
252, d2gqxB_, 0.8694, 2.37, 0.218, 405, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/L244A/V247L/C334A) WITH PENTACHLOROBENZENE
253, d1j51D_, 0.8694, 2.42, 0.297, 395, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/V247L/C334A) WITH 135-TRICHLOROBENZENE
254, d1dz6B_, 0.8694, 2.38, 0.220, 405, 381, FERROUS P450CAM FROM PSEUDOMONAS PUTIDA
255, p5mnvB_, 0.8693, 2.38, 0.223, 405, 381, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
256, d3wrhE_, 0.8693, 2.37, 0.218, 405, 381, CRYSTAL STRUCTURE OF P450CAM
257, p5u6wA_, 0.8692, 2.37, 0.218, 404, 381, THE CRYSTAL STRUCTURE OF 4-METHYLAMINOBENZOATE-BOUND CYP199A4 
258, d1yrcA_, 0.8692, 2.37, 0.218, 405, 381, X-RAY CRYSTAL STRUCTURE OF HYDROGENATED CYTOCHROME P450CAM
259, d5wk7A_, 0.8691, 2.37, 0.223, 405, 381, P450CAM MUTANT R186A
260, d5l1pA_, 0.8691, 2.37, 0.223, 405, 381, X-RAY STRUCTURE OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE
261, d4ek1A_, 0.8691, 2.37, 0.218, 405, 381, CRYSTAL STRUCTURE OF ELECTRON-SPIN LABELED CYTOCHROME P450CAM
262, d3fwjA_, 0.8691, 2.43, 0.394, 395, 381, FERRIC CAMPHOR BOUND CYTOCHROME P450CAM CONTAINING A SELENOCYSTEINE AS THE 5TH HEME LIGAND ORTHOROMBIC CRYSTAL FORM
263, p2wivA_, 0.8691, 2.43, 0.394, 395, 381, CYTOCHROME-P450 XPLA HEME DOMAIN P21
264, d2qblA_, 0.8691, 2.52, 0.282, 393, 383, CRYSTAL STRUCTURE OF FERRIC G248T CYTOCHROME P450CAM
265, d1j51B_, 0.8691, 2.37, 0.218, 411, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/V247L/C334A) WITH 135-TRICHLOROBENZENE
266, d1c8jB_, 0.8691, 2.37, 0.218, 411, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F)
267, p5kdyA_, 0.8690, 2.38, 0.220, 405, 381, THE CRYSTAL STRUCTURE OF THE D251N MUTANT OF CYP199A4 IN COMPLEX WITH 4-METHOXYBENZOATE
268, d3fwgA_, 0.8690, 2.36, 0.295, 395, 380, FERRIC CAMPHOR BOUND CYTOCHROME P450CAM ARG365LEU GLU366GLN MONOCLINIC CRYSTAL FORM
269, d3ejeB_, 0.8689, 2.52, 0.282, 393, 383, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH OCTADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
270, d3ejbF_, 0.8689, 2.37, 0.223, 405, 381, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH TETRADECANOIC ACID LIGATED ACYL CARRIER PROTEIN
271, d2fe6A_, 0.8689, 2.38, 0.223, 405, 381, P450CAM FROM PSEUDOMONAS PUTIDA RECONSTITUTED WITH MANGANIC PROTOPORPHYRIN IX
272, d1mpwB_, 0.8689, 2.38, 0.218, 405, 381, MOLECULAR RECOGNITION IN (+)-A-PINENE OXIDATION BY CYTOCHROME P450CAM
273, p5d40A_, 0.8688, 2.50, 0.322, 391, 379, CRYSTAL STRUCTURE OF THE 5-SELECTIVE H176Y MUTANT OF CYTOCHROME TXTE
274, d4c9oA_, 0.8688, 2.38, 0.226, 405, 381, STRUCTURE OF CYANIDE AND CAMPHOR BOUND D259N MUTANT OF CYP101D1
275, d4c9nA_, 0.8688, 2.38, 0.226, 405, 381, STRUCTURE OF CAMPHOR AND HYDROXYCAMPHOR BOUND D259N MUTANT OF CYP101D1
276, d2qbnA_, 0.8688, 2.37, 0.218, 405, 381, CRYSTAL STRUCTURE OF FERRIC G248V CYTOCHROME P450CAM
277, d1t88B_, 0.8688, 2.70, 0.361, 394, 388, CRYSTAL STRUCTURE OF THE FERROUS CYTOCHROME P450CAM (C334A)
278, d4g3rA_, 0.8687, 2.38, 0.223, 405, 381, CRYSTAL STRUCTURE OF NITROSYL CYTOCHROME P450CAM
279, d4ep6A_, 0.8687, 2.53, 0.282, 393, 383, CRYSTAL STRUCTURE OF THE XPLA HEME DOMAIN IN COMPLEX WITH IMIDAZOLE AND PEG
280, d4c9pA_, 0.8687, 2.39, 0.223, 405, 381, STRUCTURE OF CAMPHOR BOUND T260A MUTANT OF CYP101D1
281, d4c9kA_, 0.8687, 2.43, 0.220, 405, 382, STRUCTURE OF CAMPHOR AND HYDROXYCAMPHOR BOUND WILD TYPE CYP101D1
282, p2wivB_, 0.8687, 2.76, 0.345, 397, 388, CYTOCHROME-P450 XPLA HEME DOMAIN P21
283, d1dz6A_, 0.8687, 2.39, 0.218, 403, 381, FERROUS P450CAM FROM PSEUDOMONAS PUTIDA
284, d4c9oB_, 0.8686, 2.39, 0.220, 405, 381, STRUCTURE OF CYANIDE AND CAMPHOR BOUND D259N MUTANT OF CYP101D1
285, d4c9lA_, 0.8686, 2.34, 0.263, 391, 380, STRUCTURE OF CYANIDE AND CAMPHOR BOUND WILD TYPE CYP101D1
286, d2frzB_, 0.8686, 2.39, 0.223, 405, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/V247L/C334A)
287, d4c9pB_, 0.8685, 2.39, 0.226, 405, 381, STRUCTURE OF CAMPHOR BOUND T260A MUTANT OF CYP101D1
288, d4c9lB_, 0.8685, 2.39, 0.223, 405, 381, STRUCTURE OF CYANIDE AND CAMPHOR BOUND WILD TYPE CYP101D1
289, d4c9kB_, 0.8685, 2.54, 0.282, 393, 383, STRUCTURE OF CAMPHOR AND HYDROXYCAMPHOR BOUND WILD TYPE CYP101D1
290, d3fwfB_, 0.8685, 2.39, 0.223, 404, 381, FERRIC CAMPHOR BOUND CYTOCHROME P450CAM CONTAINING A SELENOCYSTEINE AS THE 5TH HEME LIGAND MONOCLINIC CRYSTAL FORM
291, d4l4cB_, 0.8684, 2.14, 0.349, 378, 373, STRUCTURE OF L358P/K178G MUTANT OF P450CAM BOUND TO CAMPHOR
292, d4c9mB_, 0.8684, 2.18, 0.340, 378, 373, STRUCTURE OF SUBSTRATE FREE GLYCEROL BOUND WILD TYPE CYP101D1
293, d3lxhA_, 0.8684, 2.39, 0.220, 405, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101D1
294, d2qboA_, 0.8684, 2.39, 0.226, 405, 381, CRYSTAL STRUCTURE OF THE P450CAM G248V MUTANT IN THE CYANIDE BOUND STATE
295, d2jjpA_, 0.8684, 2.70, 0.265, 403, 388, STRUCTURE OF CYTOCHROME P450 ERYK IN COMPLEX WITH INHIBITOR KETOCONAZOLE (KC)
296, d2h7sA_, 0.8684, 2.45, 0.214, 408, 383, L244A MUTANT OF CYTOCHROME P450CAM
297, d2feuA_, 0.8684, 2.45, 0.214, 408, 383, P450CAM FROM PSEUDOMONAS PUTIDA RECONSTITUTED WITH MANGANIC PROTOPORPHYRIN IX
298, d1dz4A_, 0.8684, 2.39, 0.218, 405, 381, FERRIC P450CAM FROM PSEUDOMONAS PUTIDA
299, p5d3uA_, 0.8683, 2.40, 0.223, 405, 381, CRYSTAL STRUCTURE OF THE 5-SELECTIVE H176F MUTANT OF CYTOCHROME TXTE
300, d3fwiA_, 0.8683, 2.38, 0.218, 407, 381, FERRIC CAMPHOR BOUND CYTOCHROME P450CAM CONTAINING A SELENOCYSTEINE AS THE 5TH HEME LIGAND TETRAGONAL CRYSTAL FORM
301, d4c9mA_, 0.8682, 2.34, 0.268, 392, 380, STRUCTURE OF SUBSTRATE FREE GLYCEROL BOUND WILD TYPE CYP101D1
302, d5l1qA_, 0.8681, 2.45, 0.217, 408, 383, X-RAY STRUCTURE OF CYTOCHROME P450 PNTM WITH DIHYDROPENTALENOLACTONE F
303, d3tktA_, 0.8680, 2.45, 0.214, 408, 383, CRYSTAL STRUCTURE OF CYP108D1 FROM NOVOSPHINGOBIUM AROMATICIVORANS DSM12444
304, d3l63A_, 0.8680, 2.35, 0.263, 391, 380, CRYSTAL STRUCTURE OF CAMPHOR-BOUND P450CAM AT LOW [K+]
305, d4pwvA_, 0.8679, 2.39, 0.218, 404, 381, STRUCTURE OF P450SKY (CYP163B3) A CYTOCHROME P450 FROM SKYLLAMYCIN BIOSYNTHESIS IN COMPLEX WITH A PEPTIDYL CARRIER PROTEIN DOMAIN
306, d4dnzC_, 0.8679, 2.46, 0.214, 407, 383, THE CRYSTAL STRUCTURES OF CYP199A4
307, p2wiyA_, 0.8679, 2.45, 0.214, 408, 383, CYTOCHROME P450 XPLA HEME DOMAIN P21212
308, d2h7sC_, 0.8679, 2.39, 0.226, 405, 381, L244A MUTANT OF CYTOCHROME P450CAM
309, p5kdzA_, 0.8678, 2.46, 0.217, 407, 383, THE CRYSTAL STRUCTURE OF THE T252A MUTANT OF CYP199A4 IN COMPLEX WITH 4-METHOXYBENZOATE
310, d3lxiA_, 0.8678, 2.46, 0.214, 407, 383, CRYSTAL STRUCTURE OF CAMPHOR-BOUND CYP101D1
311, d2jjnA_, 0.8678, 2.46, 0.214, 407, 383, STRUCTURE OF CLOSED CYTOCHROME P450 ERYK
312, d5l1uA_, 0.8677, 2.40, 0.220, 405, 381, X-RAY STRUCTURE OF M81A MUTANT OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE F
313, d4l4gA_, 0.8677, 2.40, 0.226, 405, 381, STRUCTURE OF CYANIDE AND CAMPHOR BOUND P450CAM MUTANT L358P/K178G
314, d5l91B1, 0.8676, 2.46, 0.214, 407, 383, THE 2.2 A CRYSTAL STRUCTURE OF CYP109E1 FROM BACILLUS MEGATERIUM BOUND WITH FOUR CORTICOSTERONE MOLECULES
315, d4c9nB_, 0.8675, 2.46, 0.214, 408, 383, STRUCTURE OF CAMPHOR AND HYDROXYCAMPHOR BOUND D259N MUTANT OF CYP101D1
316, d2m56A_, 0.8675, 2.46, 0.214, 408, 383, THE STRUCTURE OF THE COMPLEX OF CYTOCHROME P450CAM AND ITS ELECTRON DONOR PUTIDAREDOXIN DETERMINED BY PARAMAGNETIC NMR SPECTROSCOPY
317, p5uvbA_, 0.8674, 2.39, 0.218, 405, 381, THE CRYSTAL STRUCTURE OF 4-CYCLOPROPYLBENZOATE-BOUND CYP199A4
318, d4egmC_, 0.8674, 2.55, 0.329, 397, 380, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH 4-ETHYLBENZOIC ACID
319, p5mnsA_, 0.8672, 2.55, 0.329, 397, 380, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN SODIUM FORMATE
320, d5l1vA_, 0.8672, 2.39, 0.215, 405, 381, X-RAY STRUCTURE OF M81C MUTANT OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE F
321, d5l1sA_, 0.8671, 2.40, 0.223, 404, 381, X-RAY STRUCTURE OF F232L MUTANT OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE F
322, d4egnC_, 0.8671, 2.40, 0.218, 404, 381, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH VERATRIC ACID
323, d3lxhB_, 0.8671, 2.71, 0.265, 403, 388, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101D1
324, d4g3rB_, 0.8670, 2.71, 0.268, 403, 388, CRYSTAL STRUCTURE OF NITROSYL CYTOCHROME P450CAM
325, d3lxiB_, 0.8670, 2.40, 0.220, 405, 381, CRYSTAL STRUCTURE OF CAMPHOR-BOUND CYP101D1
326, d4do1C_, 0.8669, 2.46, 0.214, 408, 383, THE CRYSTAL STRUCTURES OF 4-METHOXYBENZOATE BOUND CYP199A4
327, d3fwfA_, 0.8668, 2.77, 0.345, 397, 388, FERRIC CAMPHOR BOUND CYTOCHROME P450CAM CONTAINING A SELENOCYSTEINE AS THE 5TH HEME LIGAND MONOCLINIC CRYSTAL FORM
328, p5mnsB_, 0.8667, 2.68, 0.251, 411, 387, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN SODIUM FORMATE
329, p5d3uB_, 0.8667, 2.68, 0.251, 411, 387, CRYSTAL STRUCTURE OF THE 5-SELECTIVE H176F MUTANT OF CYTOCHROME TXTE
330, p5d40B_, 0.8666, 2.41, 0.218, 405, 381, CRYSTAL STRUCTURE OF THE 5-SELECTIVE H176Y MUTANT OF CYTOCHROME TXTE
331, d4egoC_, 0.8666, 2.66, 0.258, 404, 383, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH INDOLE-6- CARBOXYLIC ACID
332, d1t85A_, 0.8665, 2.58, 0.287, 393, 383, CRYSTAL STRUCTURE OF THE FERROUS CO-BOUND CYTOCHROME P450CAM MUTANT (L358P/C334A)
333, d5l1rA_, 0.8664, 2.35, 0.266, 394, 380, X-RAY STRUCTURE OF THE SUBSTRATE-FREE CYTOCHROME P450 PNTM
334, d2d09A1, 0.8664, 2.35, 0.266, 394, 380, A ROLE FOR ACTIVE SITE WATER MOLECULES AND HYDROXYL GROUPS OF SUBSTRATE FOR OXYGEN ACTIVATION IN CYTOCHROME P450 158A2
335, d5l1tA_, 0.8663, 2.40, 0.215, 405, 381, X-RAY STRUCTURE OF M77S MUTANT OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE F
336, d5l1oA_, 0.8663, 2.56, 0.285, 393, 383, X-RAY STRUCTURE OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE F
337, d4dnjA_, 0.8662, 2.47, 0.214, 408, 383, THE CRYSTAL STRUCTURES OF 4-METHOXYBENZOATE BOUND CYP199A2
338, d1t93A1, 0.8660, 2.42, 0.328, 395, 378, EVIDENCE FOR MULTIPLE SUBSTRATE RECOGNITION AND MOLECULAR MECHANISM OF C-C REACTION BY CYTOCHROME P450 CYP158A2 FROM STREPTOMYCES COELICOLOR A3(2)
339, d2fr7A_, 0.8658, 2.78, 0.348, 397, 388, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP199A2
340, d4do1D_, 0.8656, 2.42, 0.220, 405, 381, THE CRYSTAL STRUCTURES OF 4-METHOXYBENZOATE BOUND CYP199A4
341, d2jjoA_, 0.8656, 2.50, 0.294, 387, 377, STRUCTURE OF CYTOCHROME P450 ERYK IN COMPLEX WITH ITS NATURAL SUBSTRATE ERD
342, d5l1wA_, 0.8654, 2.48, 0.214, 407, 383, X-RAY STRUCTURE OF 2-MERCAPTOETHANOL MODIFIED M81C MUTANT OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE F
343, d2x5lA_, 0.8654, 2.42, 0.223, 404, 381, X-RAY STRUCTURE OF THE SUBSTRATE-FREE MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125 ALTERNATIVE CRYSTAL FORM
344, d3g5fA_, 0.8653, 2.57, 0.282, 393, 383, CRYSTALLOGRAPHIC ANALYSIS OF CYTOCHROME P450 CYP121
345, d4egnD_, 0.8651, 2.58, 0.287, 393, 383, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH VERATRIC ACID
346, d5ibeA_, 0.8650, 2.70, 0.358, 395, 388, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 25A
347, d4ipsA_, 0.8649, 2.78, 0.345, 397, 388, SUBSTRATE AND REACTION SPECIFICITY OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP121
348, d3cxzA_, 0.8649, 2.79, 0.345, 397, 388, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 R386L MUTANT FROM M. TUBERCULOSIS
349, d1n40A_, 0.8649, 2.60, 0.287, 393, 383, ATOMIC STRUCTURE OF CYP121 A MYCOBACTERIAL P450
350, d5edtA_, 0.8647, 2.49, 0.214, 405, 383, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH LIG9
351, d4egoD_, 0.8647, 2.42, 0.223, 405, 381, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH INDOLE-6- CARBOXYLIC ACID
352, d3g5hA_, 0.8647, 2.49, 0.214, 407, 383, CRYSTALLOGRAPHIC ANALYSIS OF CYTOCHROME P450 CYP121
353, d3cxyA_, 0.8647, 2.59, 0.287, 393, 383, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 CYP121 P346L MUTANT FROM M. TUBERCULOSIS
354, d3cxxA_, 0.8647, 2.43, 0.220, 404, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 F338H FROM M. TUBERCULOSIS
355, d2h7rA_, 0.8647, 2.70, 0.358, 395, 388, L244A MUTANT OF CYTOCHROME P450CAM COMPLEXED WITH IMIDAZOLE
356, d3cxvA_, 0.8645, 2.73, 0.265, 403, 388, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 CYP121 A233G MUTANT FROM MYCOBACTERIUM TUBERCULOSIS
357, d5ibdA_, 0.8644, 2.73, 0.265, 403, 388, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 24A
358, d3cy0A_, 0.8643, 2.61, 0.287, 393, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 S237A MUTANT FROM MYCOBACTERIUM TUBERCULOSIS
359, p5o4kA_, 0.8642, 2.44, 0.218, 406, 381, CRYSTAL STRUCTURE OF P450 CYP121 IN COMPLEX WITH COMPOUND 6B.
360, d4ipwA_, 0.8642, 2.79, 0.345, 397, 388, SUBSTRATE AND REACTION SPECIFICITY OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP121
361, d4g46A_, 0.8642, 2.75, 0.338, 401, 388, STRUCTURE OF CYTOCHROME P450 CYP121 IN COMPLEX WITH 4-OXO-4567- TETRAHYDROBENZOFURAN-3-CARBOXYLATE
362, d3cy1A_, 0.8641, 2.80, 0.345, 397, 388, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 CYP121 S279A MUTANT FROM M. TUBERCULOSIS
363, p5wp2A_, 0.8640, 2.80, 0.345, 397, 388, 1.44 ANGSTROM CRYSTAL STRUCTURE OF CYP121 FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH SUBSTRATE AND CN 
364, p5op9A_, 0.8640, 2.80, 0.345, 397, 388, THE CRYSTAL STRUCTURE OF P450 CYP121 IN COMPLEX WITH LEAD COMPOUND 7E
365, d5fyfB_, 0.8640, 2.62, 0.279, 399, 383, STRUCTURE OF CYP153A FROM MARINOBACTER AQUAEOLEI
366, d4g2gA_, 0.8640, 2.62, 0.279, 399, 383, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH 44 -(1H-123-TRIAZOLE-15-DIYL)DIPHENOL
367, d4g1xA_, 0.8640, 2.75, 0.335, 401, 388, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH 4-(1H-124-TRIAZOL-1-YL)QUINOLIN-6-AMINE
368, d3zbyC1, 0.8640, 2.75, 0.335, 401, 388, LIGAND-FREE STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
369, d3zbyB1, 0.8640, 2.44, 0.286, 397, 381, LIGAND-FREE STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
370, d3zbyA1, 0.8640, 2.61, 0.287, 393, 383, LIGAND-FREE STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
371, d5ibjA_, 0.8639, 2.51, 0.326, 393, 377, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 6
372, d4ktjA_, 0.8639, 2.78, 0.349, 396, 387, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH 4-(3-AMINO-1H-PYRAZOL-4-YL)PHENOL
373, d4g48A_, 0.8639, 2.76, 0.262, 414, 386, STRUCTURE OF CYP121 IN COMPLEX WITH 4-(4-PHENOXY-1H-PYRAZOL-3-YL) BENZENE-13-DIOL
374, d4g47A_, 0.8639, 2.76, 0.262, 414, 386, STRUCTURE OF CYTOCHROME P450 CYP121 IN COMPLEX WITH 4-(1H-124- TRIAZOL-1-YL)PHENOL
375, d4g44A_, 0.8639, 2.81, 0.248, 394, 387, STRUCTURE OF P450 CYP121 IN COMPLEX WITH LEAD COMPOUND MB286 3-((1H- 124-TRIAZOL-1-YL)METHYL)ANILINE
376, d2ij7E_, 0.8639, 2.62, 0.287, 393, 383, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH THE ANTIFUNGAL DRUG FLUCONAZOLE
377, d5ibhA_, 0.8638, 2.81, 0.248, 394, 387, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 26H
378, d4iq9A_, 0.8638, 2.82, 0.248, 394, 387, SUBSTRATE AND REACTION SPECIFICITY OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP121
379, d4iq7A_, 0.8638, 2.82, 0.251, 394, 387, SUBSTRATE AND REACTION SPECIFICITY OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP121
380, d4egmD_, 0.8638, 2.82, 0.248, 394, 387, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH 4-ETHYLBENZOIC ACID
381, d3zbyF1, 0.8638, 2.82, 0.248, 394, 387, LIGAND-FREE STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
382, d3zbyD1, 0.8638, 2.82, 0.248, 394, 387, LIGAND-FREE STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
383, d1cptA_, 0.8638, 2.63, 0.287, 393, 383, CRYSTAL STRUCTURE AND REFINEMENT OF CYTOCHROME P450-TERP AT 2.3 ANGSTROMS RESOLUTION
384, d4g45A_, 0.8637, 2.82, 0.248, 394, 387, STRUCTURE OF CYTOCHROME CYP121 IN COMPLEX WITH 2-METHYLQUINOLIN-6- AMINE
385, d4egpB_, 0.8637, 2.82, 0.248, 393, 387, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH 2-NAPHTHOIC ACID
386, d3zbyE1, 0.8637, 2.81, 0.245, 394, 387, LIGAND-FREE STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
387, d2ij5B_, 0.8637, 2.47, 0.218, 405, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 P212121 SPACE GROUP
388, d4uaxA1, 0.8636, 2.82, 0.245, 394, 387, X-RAY CRYSTAL STRUCTURE OF LIGAND FREE CYP142A2 FROM MYCOBACTERIUM SMEGMATIS
389, d4jx1F_, 0.8636, 2.82, 0.245, 394, 387, CRYSTAL STRUCTURE OF REDUCED CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX BOUND TO CAMPHOR AND 5-EXO-HYDROXYCAMPHOR
390, d4dnzD_, 0.8636, 2.82, 0.251, 394, 387, THE CRYSTAL STRUCTURES OF CYP199A4
391, d4ktkA_, 0.8634, 2.82, 0.248, 394, 387, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH 4-(3-AMINO-4-(4-HYDROXYPHENYL)-1H-PYRAZOL-5-YL)BENZENE-13-DIOL
392, d4ictA_, 0.8634, 2.83, 0.248, 394, 387, SUBSTRATE AND REACTION SPECIFICITY OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP121
393, d5ibiA_, 0.8633, 2.83, 0.248, 394, 387, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 26A
394, d5ibfA_, 0.8633, 2.82, 0.248, 394, 387, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 19A
395, d4ktlA_, 0.8633, 2.82, 0.248, 394, 387, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH 44 -(3-((4-HYDROXYPHENYL)AMINO)-1H-PYRAZOLE-45-DIYL)DIPHENOL
396, d4apyA_, 0.8633, 2.83, 0.248, 394, 387, ETHYLENE GLYCOL-BOUND FORM OF P450 CYP125A3 FROM MYCOBACTERIUM SMEGMATIS
397, p5opaA_, 0.8632, 2.39, 0.231, 411, 377, THE CRYSTAL STRUCTURE OF P450 CYP121 IN COMPLEX WITH LEAD COMPOUND 7B
398, d4egoA_, 0.8632, 2.83, 0.248, 394, 387, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH INDOLE-6- CARBOXYLIC ACID
399, d4egmB_, 0.8632, 2.83, 0.248, 394, 387, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH 4-ETHYLBENZOIC ACID
400, d4do1B_, 0.8632, 2.65, 0.283, 400, 381, THE CRYSTAL STRUCTURES OF 4-METHOXYBENZOATE BOUND CYP199A4
401, d5dqnA_, 0.8631, 2.65, 0.283, 400, 381, POLYETHYLENE 600-BOUND FORM OF P450 CYP125A3 MUTANT FROM MYOBACTERIUM SMEGMATIS - W83Y
402, d4wq0A_, 0.8631, 2.65, 0.283, 400, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP107W1 FROM STREPTOMYCES AVERMITILIS IN COMPLEX WITH OLIGOMYCIN A
403, d4egnA_, 0.8631, 2.65, 0.283, 400, 381, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH VERATRIC ACID
404, d4dnzA_, 0.8631, 2.83, 0.248, 393, 387, THE CRYSTAL STRUCTURES OF CYP199A4
405, d3r9bC_, 0.8631, 2.83, 0.248, 394, 387, CRYSTAL STRUCTURE OF MYCOBACTERIUM SMEGMATIS CYP164A2 IN LIGAND FREE STATE
406, d3r9bB_, 0.8630, 2.84, 0.245, 394, 387, CRYSTAL STRUCTURE OF MYCOBACTERIUM SMEGMATIS CYP164A2 IN LIGAND FREE STATE
407, d3r9bA_, 0.8629, 2.83, 0.248, 394, 387, CRYSTAL STRUCTURE OF MYCOBACTERIUM SMEGMATIS CYP164A2 IN LIGAND FREE STATE
408, d4egoB_, 0.8628, 2.83, 0.248, 394, 387, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH INDOLE-6- CARBOXYLIC ACID
409, d5l90A1, 0.8627, 2.68, 0.249, 391, 385, THE CRYSTAL STRUCTURE OF SUBSTRATE-FREE CYP109E1 FROM BACILLUS MEGATERIUM AT 2.55 ANGSTROM RESOLUTION
410, d4dnzB_, 0.8625, 2.83, 0.248, 393, 387, THE CRYSTAL STRUCTURES OF CYP199A4
411, d4egmA_, 0.8624, 2.83, 0.248, 394, 387, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH 4-ETHYLBENZOIC ACID
412, d4do1A_, 0.8624, 2.83, 0.248, 394, 387, THE CRYSTAL STRUCTURES OF 4-METHOXYBENZOATE BOUND CYP199A4
413, p4l36A_, 0.8623, 2.64, 0.287, 393, 383, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 ENZYME TXTE
414, d4egnB_, 0.8623, 2.65, 0.283, 400, 381, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH VERATRIC ACID
415, d2z36A1, 0.8623, 2.65, 0.283, 400, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450 MOXA FROM NONOMURAEA RECTICATENA (CYP105)
416, p5o4lA_, 0.8621, 2.76, 0.220, 412, 386, CRYSTAL STRUCTURE OF P450 CYP121 IN COMPLEX WITH COMPOUND 6A.
417, d3p6tA_, 0.8620, 2.76, 0.220, 412, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC2-C8-DANS
418, d2ij5A_, 0.8617, 2.83, 0.248, 394, 387, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 P212121 SPACE GROUP
419, d2xc3A_, 0.8616, 2.46, 0.291, 393, 381, X-RAY STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP125 BOUND TO THE REVERSE TYPE I INHIBITOR
420, d2d0eA1, 0.8616, 2.66, 0.283, 400, 381, SUBSTRATE ASSITED IN OXYGEN ACTIVATION IN CYTOCHROME P450 158A2
421, d4egpA_, 0.8615, 2.71, 0.244, 390, 385, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH 2-NAPHTHOIC ACID
422, d3iw0A_, 0.8615, 2.71, 0.283, 399, 381, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125 C2221 CRYSTAL FORM
423, d4ktfA_, 0.8614, 2.59, 0.217, 405, 382, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH 44 -(3-AMINO-1H-PYRAZOLE-45-DIYL)DIPHENOL
424, d3nv6A_, 0.8614, 2.64, 0.287, 393, 383, CRYSTAL STRUCTURE OF CAMPHOR-BOUND CYP101D2
425, d1n4gA_, 0.8613, 2.84, 0.248, 394, 387, STRUCTURE OF CYP121 A MYCOBACTERIAL P450 IN COMPLEX WITH IODOPYRAZOLE
426, d4jx1E_, 0.8612, 2.84, 0.245, 394, 387, CRYSTAL STRUCTURE OF REDUCED CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX BOUND TO CAMPHOR AND 5-EXO-HYDROXYCAMPHOR
427, d1rf9A_, 0.8612, 2.84, 0.248, 393, 387, CRYSTAL STRUCTURE OF CYTOCHROME P450-CAM WITH A FLUORESCENT PROBE D-4-AD (ADAMANTANE-1-CARBOXYLIC ACID-5-DIMETHYLAMINO- NAPHTHALENE-1-SULFONYLAMINO-BUTYL-AMIDE)
428, d5l90B1, 0.8610, 2.84, 0.248, 393, 387, THE CRYSTAL STRUCTURE OF SUBSTRATE-FREE CYP109E1 FROM BACILLUS MEGATERIUM AT 2.55 ANGSTROM RESOLUTION
429, d2z36B1, 0.8609, 2.84, 0.245, 394, 387, CRYSTAL STRUCTURE OF CYTOCHROME P450 MOXA FROM NONOMURAEA RECTICATENA (CYP105)
430, d2ij5C_, 0.8608, 3.01, 0.274, 414, 390, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 P212121 SPACE GROUP
431, d4jx1B_, 0.8606, 2.84, 0.248, 393, 387, CRYSTAL STRUCTURE OF REDUCED CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX BOUND TO CAMPHOR AND 5-EXO-HYDROXYCAMPHOR
432, d4jx1A_, 0.8604, 2.66, 0.287, 393, 383, CRYSTAL STRUCTURE OF REDUCED CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX BOUND TO CAMPHOR AND 5-EXO-HYDROXYCAMPHOR
433, d2ij7B_, 0.8604, 2.66, 0.287, 394, 383, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH THE ANTIFUNGAL DRUG FLUCONAZOLE
434, d2l8mA_, 0.8602, 2.66, 0.287, 393, 383, REDUCED AND CO-BOUND CYTOCHROME P450CAM (CYP101A1)
435, d1qmqA_, 0.8600, 2.99, 0.280, 410, 389, OPTICAL DETECTION OF CYTOCHROME P450 BY SENSITIZER-LINKED SUBSTRATES
436, p5mnsF_, 0.8599, 2.60, 0.333, 397, 381, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN SODIUM FORMATE
437, d4jwuA_, 0.8599, 2.60, 0.333, 397, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX
438, d2xn8A_, 0.8598, 2.66, 0.287, 393, 383, X-RAY STRUCTURE OF THE SUBSTRATE-FREE MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125
439, d3zkpA_, 0.8597, 2.66, 0.287, 393, 383, STRUCTURE OF A MUTANT OF P450 ERYK IN COMPLEX WITH ERYTHROMYCIN B.
440, d3ivyA_, 0.8595, 2.67, 0.330, 391, 379, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125 P212121 CRYSTAL FORM
441, d2ij7D_, 0.8592, 2.67, 0.330, 391, 379, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH THE ANTIFUNGAL DRUG FLUCONAZOLE
442, d1k2oB_, 0.8592, 2.67, 0.330, 391, 379, CYTOCHROME P450CAM WITH BOUND BIS(22 -BIPYRIDINE)-(5-METHYL-2-2 - BIPYRIDINE)-C2-ADAMANTANE RUTHENIUM (II)
443, d4dxyA_, 0.8591, 2.67, 0.287, 393, 383, CRYSTAL STRUCTURES OF CYP101D2 Y96A MUTANT
444, d5it1D_, 0.8590, 2.43, 0.297, 384, 374, STREPTOMYCES PEUCETIUS CYP105P2 COMPLEX WITH BIPHENYL COMPOUND
445, d5it1A_, 0.8590, 2.67, 0.287, 393, 383, STREPTOMYCES PEUCETIUS CYP105P2 COMPLEX WITH BIPHENYL COMPOUND
446, d2ij5D_, 0.8590, 2.67, 0.287, 393, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 P212121 SPACE GROUP
447, d5it1C_, 0.8586, 2.67, 0.287, 393, 383, STREPTOMYCES PEUCETIUS CYP105P2 COMPLEX WITH BIPHENYL COMPOUND
448, d5it1B_, 0.8586, 2.65, 0.271, 396, 384, STREPTOMYCES PEUCETIUS CYP105P2 COMPLEX WITH BIPHENYL COMPOUND
449, d4jwuB_, 0.8586, 2.67, 0.287, 393, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX
450, d3p6sA_, 0.8586, 2.73, 0.354, 398, 384, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC2-C8-DANS
451, d2ij7A_, 0.8581, 2.82, 0.249, 393, 386, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH THE ANTIFUNGAL DRUG FLUCONAZOLE
452, d5gxgA_, 0.8580, 2.48, 0.211, 404, 379, HIGH-RESOLUTION CRYSTAL STRUCTURE OF THE ELECTRON TRANSFER COMPLEX OF CYTOCHROME P450CAM WITH PUTIDAREDOXIN
453, d2xbkA_, 0.8580, 2.86, 0.246, 392, 386, X-RAY STRUCTURE OF THE SUBSTRATE-BOUND CYTOCHROME P450 PIMD - A POLYENE MACROLIDE ANTIBIOTIC PIMARICIN EPOXIDASE
454, d1k2oA_, 0.8580, 2.74, 0.260, 409, 384, CYTOCHROME P450CAM WITH BOUND BIS(22 -BIPYRIDINE)-(5-METHYL-2-2 - BIPYRIDINE)-C2-ADAMANTANE RUTHENIUM (II)
455, d5ofqD_, 0.8579, 2.83, 0.340, 401, 388, CRYSTAL STRUCTURE OF SUBSTRATE-FREE CYP109A2 FROM BACILLUS MEGATERIUM
456, d3iw2A_, 0.8578, 2.69, 0.287, 393, 383, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125 IN COMPLEX WITH ECONAZOLE
457, d5vwsA_, 0.8576, 2.89, 0.265, 407, 388, LIGAND FREE STRUCTURE OF CYTOCHROME P450 TBTJ1
458, d5ibgA_, 0.8576, 2.82, 0.249, 392, 386, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 25B
459, d2ij7C_, 0.8576, 2.57, 0.207, 404, 382, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH THE ANTIFUNGAL DRUG FLUCONAZOLE
460, p4l0fA_, 0.8575, 2.78, 0.242, 392, 385, STRUCTURE OF P450SKY (CYP163B3) A CYTOCHROME P450 FROM SKYLLAMYCIN BIOSYNTHESIS (OPEN ACTIVE SITE)
461, d3iw1A_, 0.8574, 2.60, 0.219, 405, 383, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125 IN COMPLEX WITH ANDROSTENEDIONE
462, d3p6uA_, 0.8573, 2.65, 0.220, 404, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC3-C6-DANS
463, d1ulwA_, 0.8573, 2.48, 0.297, 384, 374, CRYSTAL STRUCTURE OF P450NOR SER73GLY/SER75GLY MUTANT
464, d5ofqC_, 0.8572, 2.76, 0.353, 399, 385, CRYSTAL STRUCTURE OF SUBSTRATE-FREE CYP109A2 FROM BACILLUS MEGATERIUM
465, d5hdiA_, 0.8572, 2.76, 0.353, 399, 385, STRUCTURAL CHARACTERIZATION OF CYP144A1 A MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450
466, d1gedA_, 0.8572, 2.86, 0.233, 394, 387, A POSITIVE CHARGE ROUTE FOR THE ACCESS OF NADH TO HEME FORMED IN THE DISTAL HEME POCKET OF CYTOCHROME P450NOR
467, d3w9cA_, 0.8571, 2.50, 0.214, 405, 379, CRYSTAL STRUCTURE OF THE ELECTRON TRANSFER COMPLEX OF CYTOCHROME P450CAM WITH PUTIDAREDOXIN
468, d5ofqA_, 0.8569, 2.60, 0.223, 405, 382, CRYSTAL STRUCTURE OF SUBSTRATE-FREE CYP109A2 FROM BACILLUS MEGATERIUM
469, p5omrA_, 0.8568, 2.79, 0.247, 391, 385, CRYSTAL STRUCTURE OF AMYCOLATOPSIS CYTOCHROME P450 GCOA IN COMPLEX WITH VANILLIN. 
470, d2ij7F_, 0.8568, 2.53, 0.215, 405, 382, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH THE ANTIFUNGAL DRUG FLUCONAZOLE
471, d5ofqB_, 0.8561, 2.52, 0.214, 406, 379, CRYSTAL STRUCTURE OF SUBSTRATE-FREE CYP109A2 FROM BACILLUS MEGATERIUM
472, d3e5lA1, 0.8560, 2.74, 0.355, 393, 386, CRYSTAL STRUCTURE OF CYP105P1 H72A MUTANT
473, d2ygxD_, 0.8559, 2.48, 0.216, 405, 379, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN P21 SPACE GROUP
474, p5omsA_, 0.8558, 2.76, 0.260, 409, 384, CRYSTAL STRUCTURE OF AMYCOLATOPSIS CYTOCHROME P450 GCOA IN COMPLEX WITH GUAETHOL. 
475, d5y5jA_, 0.8555, 2.53, 0.328, 390, 375, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR: DARK-2 DATA IN THE PRESENCE OF NADH (RESTING STATE)
476, d5y5iA_, 0.8555, 2.64, 0.258, 399, 380, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR: 20 MS AFTER PHOTO- IRRADIATION OF CAGED NO IN THE PRESENCE OF NADH (NO-BOUND STATE) LIGHT DATA
477, d2ygxB_, 0.8555, 2.83, 0.247, 391, 385, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN P21 SPACE GROUP
478, d5y5lA_, 0.8554, 2.49, 0.211, 406, 379, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR: DARK-2 DATA IN THE ABSENCE OF NADH (RESTING STATE)
479, d5y5kA_, 0.8554, 2.63, 0.209, 406, 383, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR : 20 MS AFTER PHOTO- IRRADIATION OF CAGED NO IN THE ABSENCE OF NADH (NO-BOUND STATE) LIGHT DATA
480, d2ij5E_, 0.8554, 2.96, 0.373, 395, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 P212121 SPACE GROUP
481, d2ygxA_, 0.8550, 2.96, 0.373, 395, 386, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN P21 SPACE GROUP
482, d1romA_, 0.8547, 2.96, 0.373, 395, 386, CRYSTAL STRUCTURE OF NITRIC REDUCTASE FROM DENITRIFYING FUNGUS FUSARIUM OXYSPORUM
483, d5y5lB_, 0.8546, 2.83, 0.247, 391, 385, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR: DARK-2 DATA IN THE ABSENCE OF NADH (RESTING STATE)
484, d5y5kB_, 0.8545, 2.97, 0.373, 395, 386, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR : 20 MS AFTER PHOTO- IRRADIATION OF CAGED NO IN THE ABSENCE OF NADH (NO-BOUND STATE) LIGHT DATA
485, d5y5jB_, 0.8545, 2.97, 0.370, 395, 386, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR: DARK-2 DATA IN THE PRESENCE OF NADH (RESTING STATE)
486, d3zsnC_, 0.8545, 2.56, 0.218, 403, 380, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG F286A MUTANT IN COMPLEX WITH MYCINAMICIN IV
487, d3zsnB_, 0.8545, 2.44, 0.212, 404, 377, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG F286A MUTANT IN COMPLEX WITH MYCINAMICIN IV
488, d3p6qA_, 0.8545, 2.88, 0.247, 391, 385, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC2-ETG-BOC
489, d5y5iB_, 0.8543, 2.50, 0.217, 401, 378, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR: 20 MS AFTER PHOTO- IRRADIATION OF CAGED NO IN THE PRESENCE OF NADH (NO-BOUND STATE) LIGHT DATA
490, d3zsnA_, 0.8543, 2.70, 0.318, 391, 381, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG F286A MUTANT IN COMPLEX WITH MYCINAMICIN IV
491, d2ygxC_, 0.8542, 2.70, 0.318, 391, 381, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN P21 SPACE GROUP
492, d2romA_, 0.8541, 2.53, 0.214, 406, 379, CRYSTAL STRUCTURE OF NITRIC REDUCTASE FROM DENITRIFYING FUNGUS FUSARIUM OXYSPORUM COMPLEX WITH CARBON MONOXIDE
493, d2ycaA_, 0.8540, 2.49, 0.328, 387, 375, MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN III IN P21212 SPACE GROUP
494, d3rwlA_, 0.8537, 2.49, 0.328, 387, 375, STRUCTURE OF P450PYR HYDROXYLASE
495, d2y5zC_, 0.8537, 2.71, 0.258, 398, 380, MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN III IN C2221 SPACE GROUP
496, d5y1iB_, 0.8536, 1.89, 0.344, 376, 366, THE CRYSTAL STRUCTURE OF GFSF
497, d2y5nA_, 0.8536, 1.89, 0.344, 376, 366, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN V IN P21 SPACE GROUP
498, d2y5zB_, 0.8535, 2.81, 0.247, 390, 384, MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN III IN C2221 SPACE GROUP
499, d2ij5F_, 0.8535, 2.84, 0.234, 391, 385, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 P212121 SPACE GROUP
500, d2y5nB1, 0.8534, 2.85, 0.242, 437, 384, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN V IN P21 SPACE GROUP
501, d5y5hA_, 0.8533, 2.85, 0.242, 437, 384, SF-ROX STRUCTURE OF CYTOCHROME P450NOR (NO-BOUND STATE) DETERMINED AT SACLA
502, d1cl6A_, 0.8533, 2.64, 0.256, 398, 379, CRYSTAL STRUCTURES OF FERRIC-NO COMPLEXES OF FUNGAL NITRIC OXIDE REDUCTASE AND ITS SER286 MUTANTS AT CRYOGENIC TEMPERATURE
503, d3nv5A_, 0.8532, 2.41, 0.215, 402, 376, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101D2
504, d2y46C_, 0.8531, 3.07, 0.297, 399, 390, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN IV IN C 2 2 21 SPACE GROUP
505, d2y46B_, 0.8530, 2.51, 0.328, 386, 375, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN IV IN C 2 2 21 SPACE GROUP
506, d1f26A_, 0.8530, 2.92, 0.282, 397, 383, CRYSTAL STRUCTURE OF NO COMPLEX OF THR243VAL MUTANTS OF CYTOCHROME P450NOR
507, d2y98A_, 0.8529, 2.92, 0.282, 397, 383, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN IV IN P21212 SPACE GROUP
508, d2y46A_, 0.8528, 2.90, 0.301, 399, 385, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN IV IN C 2 2 21 SPACE GROUP
509, d1f24A_, 0.8527, 2.52, 0.217, 401, 378, CRYSTAL STRUCTURE OF NO COMPLEX OF THR243ALA MUTANTS OF CYTOCHROME P450NOR
510, d1jfbA_, 0.8526, 2.53, 0.323, 386, 375, X-RAY STRUCTURE OF NITRIC OXIDE REDUCTASE (CYTOCHROME P450NOR) IN THE FERRIC RESTING STATE AT ATOMIC RESOLUTION
511, d3wriB1, 0.8524, 2.54, 0.218, 403, 381, CRYSTAL STRUCTURE OF P450CAM
512, d5y5gA_, 0.8523, 2.88, 0.247, 391, 385, STRUCTURE OF CYTOCHROME P450NOR IN NO-BOUND STATE: DAMAGED BY LOW-DOSE (0.72 MGY) X-RAY
513, d3wriA1, 0.8522, 2.54, 0.323, 386, 375, CRYSTAL STRUCTURE OF P450CAM
514, d3p6wA_, 0.8522, 2.92, 0.366, 393, 385, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC3-ETG-BOC
515, d2y5zA_, 0.8521, 2.68, 0.373, 393, 381, MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN III IN C2221 SPACE GROUP
516, d1cmjA_, 0.8521, 2.55, 0.218, 403, 381, CRYSTAL STRUCTURES OF FERRIC-NO COMPLEXES OF FUNGAL NITRIC OXIDE REDUCTASE AND THEIR SER286 MUTANTS AT CRYOGENIC TEMPERATURE
517, d5hdiB_, 0.8519, 3.01, 0.299, 399, 388, STRUCTURAL CHARACTERIZATION OF CYP144A1 A MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450
518, d1eheA_, 0.8519, 3.01, 0.299, 399, 388, CRYSTAL STRUCTURES OF CYTOCHROME P450NOR AND ITS MUTANTS (SER286 VAL THR) IN THE FERRIC RESTING STATE AT CRYOGENIC TEMPERATURE: A COMPARATIVE ANALYSIS WITH MONOOXYGENASE CYTOCHROME P450S
519, d3l62A_, 0.8518, 2.68, 0.373, 393, 381, CRYSTAL STRUCTURE OF SUBSTRATE-FREE P450CAM AT LOW [K+]
520, d1ehfA_, 0.8518, 3.01, 0.299, 399, 388, CRYSTAL STRUCTURES OF CYTOCHROME P450NOR AND ITS MUTANTS (SER286 VAL THR) IN THE FERRIC RESTING STATE AT CRYOGENIC TEMPERATURE: A COMPARATIVE ANALYSIS WITH MONOOXYGENASE CYTOCHROME P450S
521, d1jfcA_, 0.8517, 3.01, 0.299, 399, 388, X-RAY STRUCTURE OF NITRIC OXIDE REDUCTASE (CYTOCHROME P450NOR) IN THE FERROUS CO STATE AT ATOMIC RESOLUTION
522, d1gejA_, 0.8514, 2.69, 0.249, 387, 381, STRUCTURAL CHARACTERIZATION OF N-BUTYL-ISOCYANIDE COMPLEXES OF CYTOCHROMES P450NOR AND P450CAM
523, d1geiA_, 0.8514, 2.69, 0.373, 393, 381, STRUCTURAL CHARACTERIZATION OF N-BUTYL-ISOCYANIDE COMPLEXES OF CYTOCHROMES P450NOR AND P450CAM
524, d1f25A_, 0.8514, 2.96, 0.301, 399, 386, CRYSTAL STRUCTURE OF NO COMPLEX OF THR243ASN MUTANTS OF CYTOCHROME P450NOR
525, d5y5fA_, 0.8513, 2.95, 0.301, 399, 385, STRUCTURE OF CYTOCHROME P450NOR IN NO-BOUND STATE: DAMAGED BY LOW-DOSE (0.72 MGY) X-RAY
526, d1ehgA_, 0.8510, 2.95, 0.301, 399, 385, CRYSTAL STRUCTURES OF CYTOCHROME P450NOR AND ITS MUTANTS (SER286 VAL THR) IN THE FERRIC RESTING STATE AT CRYOGENIC TEMPERATURE: A COMPARATIVE ANALYSIS WITH MONOOXYGENASE CYTOCHROME P450S
527, d1cmnA_, 0.8510, 2.96, 0.301, 399, 385, CRYSTAL STRUCTURES OF FERRIC-NO COMPLEXES OF FUNGAL NITRIC OXIDE REDUCTASE AND THEIR SER286 MUTANTS AT CRYOGENIC TEMPERATURE
528, d4z5pA_, 0.8508, 2.72, 0.373, 393, 381, CRYSTAL STRUCTURE OF THE LNMA CYTOCHROME P450 HYDROXYLASE FROM THE LEINAMYCIN BIOSYNTHETIC PATHWAY OF STREPTOMYCES ATROOLIVACEUS S-140 AT 1.9 A RESOLUTION
529, d4aw3B_, 0.8507, 2.72, 0.373, 393, 381, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG F286V MUTANT IN COMPLEX WITH MYCINAMICIN V IN P1 SPACE GROUP
530, d4aw3A_, 0.8507, 2.59, 0.220, 401, 378, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG F286V MUTANT IN COMPLEX WITH MYCINAMICIN V IN P1 SPACE GROUP
531, d3p6xA_, 0.8499, 2.96, 0.301, 399, 385, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC3-C8-DANS
532, d3ofuC_, 0.8493, 2.72, 0.373, 393, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
533, d3p6rA_, 0.8490, 2.71, 0.373, 393, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG 3OH-ADAC1-ETG-BOC
534, d3p6vA_, 0.8489, 2.78, 0.285, 399, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG 3ET-ADAC1-ETG-BOC
535, d4z5pB_, 0.8487, 2.71, 0.373, 393, 381, CRYSTAL STRUCTURE OF THE LNMA CYTOCHROME P450 HYDROXYLASE FROM THE LEINAMYCIN BIOSYNTHETIC PATHWAY OF STREPTOMYCES ATROOLIVACEUS S-140 AT 1.9 A RESOLUTION
536, d3oftA_, 0.8487, 2.97, 0.229, 404, 385, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
537, d3ofuA_, 0.8485, 2.76, 0.374, 394, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
538, d2uuqA_, 0.8484, 2.76, 0.337, 394, 380, CRYSTAL STRUCTURE OF CYP130 FROM MYCOBACTERIUM TUBERCULOSIS IN THE LIGAND-FREE FORM
539, d3ofuB_, 0.8482, 2.76, 0.337, 394, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
540, d3p3zA1, 0.8481, 2.78, 0.374, 394, 382, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 MONOOXYGENASE AURH FROM STREPTOMYCES THIOLUTEUS IN COMPLEX WITH ANCYMIDOL
541, d3nc6B_, 0.8480, 2.76, 0.374, 394, 382, CYP134A1 1-PHENYLIMIDAZOLE BOUND STRUCTURE
542, d5lieB_, 0.8478, 2.63, 0.240, 384, 379, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH IMIDAZOLE
543, d2lqdA_, 0.8478, 2.74, 0.377, 397, 382, REDUCED AND CO-BOUND CYTOCHROME P450CAM (CYP101A1)
544, d4wpzA_, 0.8477, 2.74, 0.377, 397, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP107W1 FROM STREPTOMYCES AVERMITILIS
545, d2whfA_, 0.8473, 3.00, 0.301, 400, 386, INTERACTION OF MYCOBACTERIUM TUBERCULOSIS CYP130 WITH HETEROCYCLIC ARYLAMINES
546, d4xe3B_, 0.8471, 2.93, 0.304, 399, 385, OLEP THE CYTOCHROME P450 EPOXIDASE FROM STREPTOMYCES ANTIBIOTICUS INVOLVED IN OLEANDOMYCIN BIOSYNTHESIS: FUNCTIONAL ANALYSIS AND CRYSTALLOGRAPHIC STRUCTURE IN COMPLEX WITH CLOTRIMAZOLE.
547, d3ofuD_, 0.8468, 2.47, 0.212, 399, 377, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
548, d5y1iA_, 0.8460, 2.74, 0.373, 393, 381, THE CRYSTAL STRUCTURE OF GFSF
549, p6c93A_, 0.8458, 2.74, 0.373, 393, 381, EFFECTS OF THE E310A MUTATION OF CYTOCHROME P450 4B1 (CYP4B1) ON N- OCTANE BINDING AND HEME RUFFLING 
550, p6c94A_, 0.8450, 2.93, 0.304, 399, 385, STRUCTURE OF CYTOCHROME P450 4B1 (CYP4B1) COMPLEXED WITH THE INHIBITOR HET0016 
551, d3p3oA1, 0.8448, 2.74, 0.373, 393, 381, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 MONOOXYGENASE AURH (NTERMII) FROM STREPTOMYCES THIOLUTEUS
552, d2wgyA_, 0.8448, 2.74, 0.373, 393, 381, CRYSTAL STRUCTURE OF THE G243A MUTANT OF CYP130 FROM M. TUBERCULOSIS
553, d3oftB_, 0.8447, 3.05, 0.302, 399, 388, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
554, d5lieA_, 0.8445, 2.97, 0.301, 399, 386, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH IMIDAZOLE
555, d3tywC1, 0.8441, 2.44, 0.211, 401, 375, CRYSTAL STRUCTURE OF CYP105N1 FROM STREPTOMYCES COELICOLOR A3(2)
556, d1s1fA1, 0.8436, 3.02, 0.301, 400, 386, CRYSTAL STRUCTURE OF STREPTOMYCES COELICOLOR A3(2) CYP158A2 FROM ANTIBIOTIC BIOSYNTHETIC PATHWAYS
557, d3tywD1, 0.8434, 3.02, 0.301, 400, 386, CRYSTAL STRUCTURE OF CYP105N1 FROM STREPTOMYCES COELICOLOR A3(2)
558, p5t6qA_, 0.8431, 2.44, 0.211, 401, 375, STRUCTURE OF CYTOCHROME P450 4B1 (CYP4B1) COMPLEXED WITH OCTANE: AN N- ALKANE AND FATTY ACID OMEGA-HYDROXYLASE WITH A COVALENTLY BOUND HEME
559, d4ggvA_, 0.8430, 2.42, 0.217, 400, 374, CRYSTAL STRUCTURE OF HMTT INVOLVED IN HIMASTATIN BIOSYNTHESIS
560, d5ikiB_, 0.8427, 2.74, 0.373, 393, 381, CYP106A2 WITH SUBSTRATE ABIETIC ACID
561, d2z3tA_, 0.8425, 2.95, 0.304, 399, 385, CRYSTAL STRUCTURE OF SUBSTRATE FREE CYTOCHROME P450 STAP (CYP245A1)
562, p5ncbA_, 0.8423, 2.84, 0.282, 393, 379, CRYSTAL STRUCTURE OF AMYCOLATOPSIS CYTOCHROME P450 GCOA IN COMPLEX WITH GUAIACOL. 
563, d3l61A_, 0.8422, 3.10, 0.298, 399, 389, CRYSTAL STRUCTURE OF SUBSTRATE-FREE P450CAM AT 200 MM [K+]
564, d2dkkA1, 0.8417, 2.43, 0.211, 400, 374, STRUCTURE/FUNCTION STUDIES OF CYTOCHROME P450 158A1 FROM STREPTOMYCES COELICOLOR A3(2)
565, d5li8A_, 0.8415, 2.95, 0.304, 399, 385, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH KETOCONAZOLE
566, d4xe3A_, 0.8415, 2.95, 0.304, 399, 385, OLEP THE CYTOCHROME P450 EPOXIDASE FROM STREPTOMYCES ANTIBIOTICUS INVOLVED IN OLEANDOMYCIN BIOSYNTHESIS: FUNCTIONAL ANALYSIS AND CRYSTALLOGRAPHIC STRUCTURE IN COMPLEX WITH CLOTRIMAZOLE.
567, d3p3xA_, 0.8411, 3.11, 0.298, 399, 389, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 MONOOXYGENASE AURH (NTERM- AURH-I) FROM STREPTOMYCES THIOLUTEUS
568, p5mnvA_, 0.8408, 3.11, 0.298, 399, 389, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
569, d3i3kB_, 0.8407, 3.11, 0.298, 399, 389,  
570, d3i3kA_, 0.8407, 3.00, 0.301, 399, 385,  
571, d3abbA1, 0.8407, 2.96, 0.304, 399, 385, CRYSTAL STRUCTURE OF CYP105D6
572, d3ld6A_, 0.8406, 2.96, 0.304, 399, 385, CRYSTAL STRUCTURE OF HUMAN LANOSTEROL 14ALPHA-DEMETHYLASE (CYP51) IN COMPLEX WITH KETOCONAZOLE
573, p5mnvH_, 0.8405, 2.65, 0.400, 388, 380, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
574, d3ld6B_, 0.8405, 2.65, 0.400, 388, 380, CRYSTAL STRUCTURE OF HUMAN LANOSTEROL 14ALPHA-DEMETHYLASE (CYP51) IN COMPLEX WITH KETOCONAZOLE
575, d3jusA_, 0.8402, 2.76, 0.373, 393, 381, CRYSTAL STRUCTURE OF HUMAN LANOSTEROL 14ALPHA-DEMETHYLASE (CYP51) IN COMPLEX WITH ECONAZOLE
576, p4oqsA_, 0.8396, 2.75, 0.375, 393, 381, CRYSTAL STRUCTURE OF CYP105AS1
577, d3p3xB_, 0.8396, 2.42, 0.214, 399, 373, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 MONOOXYGENASE AURH (NTERM- AURH-I) FROM STREPTOMYCES THIOLUTEUS
578, d2wh8A_, 0.8396, 2.54, 0.243, 396, 378, INTERACTION OF MYCOBACTERIUM TUBERCULOSIS CYP130 WITH HETEROCYCLIC ARYLAMINES
579, d3tywA1, 0.8395, 2.55, 0.221, 398, 375, CRYSTAL STRUCTURE OF CYP105N1 FROM STREPTOMYCES COELICOLOR A3(2)
580, d2z3tC_, 0.8394, 2.40, 0.218, 398, 372, CRYSTAL STRUCTURE OF SUBSTRATE FREE CYTOCHROME P450 STAP (CYP245A1)
581, d3tywB1, 0.8393, 2.84, 0.413, 388, 383, CRYSTAL STRUCTURE OF CYP105N1 FROM STREPTOMYCES COELICOLOR A3(2)
582, d4uhiC_, 0.8392, 2.56, 0.241, 396, 378, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN C121 SPACE GROUP
583, d3jusB_, 0.8391, 2.56, 0.241, 396, 378, CRYSTAL STRUCTURE OF HUMAN LANOSTEROL 14ALPHA-DEMETHYLASE (CYP51) IN COMPLEX WITH ECONAZOLE
584, d4uhlF1, 0.8390, 2.58, 0.232, 396, 379, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
585, d4uhlB1, 0.8390, 2.84, 0.281, 394, 377, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
586, d3oftC_, 0.8389, 2.60, 0.232, 396, 379, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
587, d2wh8D_, 0.8389, 2.95, 0.332, 406, 385, INTERACTION OF MYCOBACTERIUM TUBERCULOSIS CYP130 WITH HETEROCYCLIC ARYLAMINES
588, d4uhlE1, 0.8386, 2.30, 0.265, 389, 370, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
589, d3nc3B_, 0.8385, 2.30, 0.265, 389, 370, CYP134A1 STRUCTURE WITH A CLOSED SUBSTRATE BINDING LOOP
590, d3ofuF_, 0.8380, 2.91, 0.326, 397, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
591, d4uhlC1, 0.8379, 2.91, 0.326, 397, 380, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
592, d3ofuE_, 0.8379, 2.75, 0.220, 405, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
593, d5li6B_, 0.8377, 2.41, 0.336, 386, 372, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH N-ISOPROPYL-N-((3-(4-METHOXYPHENYL)-124-OXADIAZOL-5-YL) METHYL)-2-(4-NITROPHENYL)ACETAMIDE
594, p6cr2B_, 0.8376, 2.88, 0.279, 394, 377, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM ASPERGILLUS FUMIGATUS IN COMPLEX WITH THE VNI DERIVATIVE N-(1-(2;4- DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL)-4-(5-(2-FLUORO-4-(2;2;2- TRIFLUOROETHOXY)PHENYL)-1;3;4-OXADIAZOL-2-YL)BENZAMIDE 
595, d4uhlA1, 0.8376, 2.88, 0.340, 394, 382, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
596, d2wh8B_, 0.8375, 2.51, 0.242, 394, 376, INTERACTION OF MYCOBACTERIUM TUBERCULOSIS CYP130 WITH HETEROCYCLIC ARYLAMINES
597, d4uhiD_, 0.8374, 2.78, 0.332, 388, 376, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN C121 SPACE GROUP
598, d5li6A_, 0.8373, 2.84, 0.172, 478, 384, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH N-ISOPROPYL-N-((3-(4-METHOXYPHENYL)-124-OXADIAZOL-5-YL) METHYL)-2-(4-NITROPHENYL)ACETAMIDE
599, d2nz5A1, 0.8373, 2.86, 0.169, 471, 384, STRUCTURE AND FUNCTION STUDIES OF CYTOCHROME P450 158A1 FROM STREPTOMYCES COELICOLOR A3(2)
600, d1uedA_, 0.8373, 3.02, 0.332, 406, 385, CRYSTAL STRUCTURE OF OXYC A CYTOCHROME P450 IMPLICATED IN AN OXIDATIVE C-C COUPLING REACTION DURING VANCOMYCIN BIOSYNTHESIS.
601, d5ik1A_, 0.8371, 3.02, 0.332, 406, 385, OPEN STATE OF P450CAM AFTER SOAKING IN CAMPHOR
602, d4uymA1, 0.8370, 2.88, 0.277, 394, 376, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM A PATHOGENIC FILAMENTOUS FUNGUS ASPERGILLUS FUMIGATUS IN COMPLEX WITH VORICONAZOLE
603, d3p3lA_, 0.8370, 2.50, 0.245, 393, 375, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 MONOOXYGENASE AURH (WILDTYPE) FROM STREPTOMYCES THIOLUTEUS
604, d4uhiA_, 0.8369, 2.47, 0.342, 379, 371, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN C121 SPACE GROUP
605, d2wh8C_, 0.8367, 2.85, 0.348, 395, 379, INTERACTION OF MYCOBACTERIUM TUBERCULOSIS CYP130 WITH HETEROCYCLIC ARYLAMINES
606, p5vbuC_, 0.8364, 2.93, 0.326, 395, 383, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 21A2 HYDROXYPROGESTERONE COMPLEX
607, d4uhlG1, 0.8364, 2.86, 0.348, 395, 379, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
608, p5vbuB_, 0.8363, 2.90, 0.167, 461, 384, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 21A2 HYDROXYPROGESTERONE COMPLEX
609, d4uhlH1, 0.8363, 2.90, 0.167, 461, 384, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
610, d3p3lB_, 0.8363, 2.81, 0.370, 396, 376, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 MONOOXYGENASE AURH (WILDTYPE) FROM STREPTOMYCES THIOLUTEUS
611, p6cr2A_, 0.8361, 2.81, 0.370, 396, 376, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM ASPERGILLUS FUMIGATUS IN COMPLEX WITH THE VNI DERIVATIVE N-(1-(2;4- DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL)-4-(5-(2-FLUORO-4-(2;2;2- TRIFLUOROETHOXY)PHENYL)-1;3;4-OXADIAZOL-2-YL)BENZAMIDE 
612, d5frbA1, 0.8361, 3.06, 0.285, 399, 386, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM A PATHOGENIC FILAMENTOUS FUNGUS ASPERGILLUS FUMIGATUS IN COMPLEX WITH A TETRAZOLE-BASED INHIBITOR VT-1598
613, d4y8wA1, 0.8361, 3.06, 0.285, 399, 386, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 21A2 PROGESTERONE COMPLEX
614, d2uwhF_, 0.8361, 2.79, 0.338, 385, 376, CYTOCHROME P450 BM3 MUTANT IN COMPLEX WITH PALMITIC ACID
615, d2z3tD_, 0.8358, 2.65, 0.223, 396, 376, CRYSTAL STRUCTURE OF SUBSTRATE FREE CYTOCHROME P450 STAP (CYP245A1)
616, d4y8wB1, 0.8357, 2.46, 0.216, 396, 371, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 21A2 PROGESTERONE COMPLEX
617, p5vbuA_, 0.8356, 3.04, 0.339, 395, 384, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 21A2 HYDROXYPROGESTERONE COMPLEX
618, d5l92B_, 0.8355, 2.80, 0.345, 390, 377, THE 2.1 A CRYSTAL STRUCTURE OF CYP109E1 FROM BACILLUS MEGATERIUM IN COMPLEX WITH CORTICOSTERONE
619, d5de9B1, 0.8355, 2.98, 0.340, 394, 382, THE ROLE OF ILE87 OF CYP158A2 IN OXIDATIVE COUPLING REACTION
620, d1uedB_, 0.8354, 2.90, 0.329, 397, 383, CRYSTAL STRUCTURE OF OXYC A CYTOCHROME P450 IMPLICATED IN AN OXIDATIVE C-C COUPLING REACTION DURING VANCOMYCIN BIOSYNTHESIS.
621, d5kyoB_, 0.8353, 2.97, 0.350, 397, 383, CRYSTAL STRUCTURE OF CYP101J2
622, d2ve3B_, 0.8353, 2.97, 0.350, 397, 383, RETINOIC ACID BOUND CYANOBACTERIAL CYP120A1
623, d2ojdB1, 0.8353, 3.00, 0.158, 444, 385,  
624, d2ij4A_, 0.8353, 2.97, 0.161, 445, 385, STRUCTURE OF THE A264K MUTANT OF CYTOCHROME P450 BM3
625, d4uhlD1, 0.8352, 2.41, 0.355, 379, 369, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
626, d3tzoB1, 0.8352, 2.97, 0.161, 445, 385, THE ROLE OF I87 OF CYP158A2 IN OXIDATIVE COUPLING REACTION
627, d3dl9B2, 0.8352, 2.98, 0.347, 395, 383, CRYSTAL STRUCTURE OF CYP2R1 IN COMPLEX WITH 1-ALPHA-HYDROXY- VITAMIN D2
628, d4y8wC1, 0.8351, 3.00, 0.158, 444, 385, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 21A2 PROGESTERONE COMPLEX
629, d3c6gB2, 0.8351, 2.98, 0.161, 445, 385, CRYSTAL STRUCTURE OF CYP2R1 IN COMPLEX WITH VITAMIN D3
630, d4uhiB_, 0.8350, 2.77, 0.365, 384, 373, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN C121 SPACE GROUP
631, d3czhB1, 0.8348, 2.77, 0.365, 384, 373, CRYSTAL STRUCTURE OF CYP2R1 IN COMPLEX WITH VITAMIN D2
632, d5de9A1, 0.8347, 2.92, 0.329, 399, 383, THE ROLE OF ILE87 OF CYP158A2 IN OXIDATIVE COUPLING REACTION
633, d4uylA1, 0.8347, 2.90, 0.278, 392, 374, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM A PATHOGENIC FILAMENTOUS FUNGUS ASPERGILLUS FUMIGATUS IN COMPLEX WITH VNI
634, d4uymB1, 0.8346, 2.98, 0.348, 395, 379, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM A PATHOGENIC FILAMENTOUS FUNGUS ASPERGILLUS FUMIGATUS IN COMPLEX WITH VORICONAZOLE
635, d3nc5A_, 0.8346, 2.98, 0.348, 395, 379, CYP134A1 STRUCTURE WITH AN OPEN SUBSTRATE BINDING LOOP
636, d3tzoA1, 0.8345, 2.85, 0.339, 383, 375, THE ROLE OF I87 OF CYP158A2 IN OXIDATIVE COUPLING REACTION
637, d2ve3A_, 0.8344, 2.96, 0.348, 395, 379, RETINOIC ACID BOUND CYANOBACTERIAL CYP120A1
638, d3e5kA1, 0.8343, 3.02, 0.158, 442, 386, CRYSTAL STRUCTURE OF CYP105P1 WILD-TYPE 4-PHENYLIMIDAZOLE COMPLEX
639, d4uylB1, 0.8340, 3.00, 0.161, 445, 385, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM A PATHOGENIC FILAMENTOUS FUNGUS ASPERGILLUS FUMIGATUS IN COMPLEX WITH VNI
640, d2nz5B1, 0.8335, 3.02, 0.158, 442, 386, STRUCTURE AND FUNCTION STUDIES OF CYTOCHROME P450 158A1 FROM STREPTOMYCES COELICOLOR A3(2)
641, d3gw9C_, 0.8333, 3.00, 0.158, 442, 386, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI BOUND TO AN INHIBITOR N-(1-(24- DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-13 4-OXAZIAZOL-2-YL)BENZAMIDE
642, d2nzaA1, 0.8333, 2.51, 0.241, 390, 373, STRUCTURE AND FUNCTION STUDIES OF CYTOCHROME P450 158A1 FROM STREPTOMYCES COELICOLOR A3(2)
643, d5kyoA_, 0.8332, 2.97, 0.275, 389, 375, CRYSTAL STRUCTURE OF CYP101J2
644, d5jqvA_, 0.8331, 3.03, 0.158, 442, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
645, d1zoaA_, 0.8331, 2.44, 0.266, 385, 368, CRYSTAL STRUCTURE OF A328V MUTANT OF THE HEME DOMAIN OF P450BM-3 WITH N-PALMITOYLGLYCINE
646, d5jqvB_, 0.8329, 2.55, 0.247, 390, 373, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
647, d4kewA_, 0.8329, 3.03, 0.158, 442, 386, STRUCTURE OF THE A82F BM3 HEME DOMAIN IN COMPLEX WITH OMEPRAZOLE
648, d5kyoE_, 0.8328, 2.54, 0.244, 390, 373, CRYSTAL STRUCTURE OF CYP101J2
649, d2uwhE_, 0.8328, 2.46, 0.342, 376, 368, CYTOCHROME P450 BM3 MUTANT IN COMPLEX WITH PALMITIC ACID
650, d4rm4A_, 0.8327, 3.04, 0.155, 469, 386, THE CRYSTAL STRUCTURE OF THE VERSATILE CYTOCHROME P450 ENZYME CYP109B1 FROM BACILLUS SUBTILIS
651, d3czhA1, 0.8327, 3.04, 0.158, 442, 386, CRYSTAL STRUCTURE OF CYP2R1 IN COMPLEX WITH VITAMIN D2
652, d4zfaA_, 0.8325, 2.96, 0.273, 392, 374, CYTOCHROME P450 WILD TYPE FROM BM3 WITH BOUND PEG
653, d4g3jA_, 0.8325, 3.06, 0.158, 442, 386, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(24-DICHLOROPHENYL)-2-(1H-124- TRIAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [R- VNI-TRIAZOLE (VNT)]
654, d5xhjB_, 0.8324, 2.52, 0.344, 377, 369, CRYSTAL STRUCTURE OF P450BM3 WITH 5-CYCLOHEXYLVALEROYL-L-TRYPTOPHAN
655, d3ekbB_, 0.8324, 3.01, 0.325, 395, 382, CRYSTAL STRUCTURE OF THE A264C MUTANT HEME DOMAIN OF CYTOCHROME P450 BM3
656, d1zoaB_, 0.8324, 2.44, 0.289, 391, 367, CRYSTAL STRUCTURE OF A328V MUTANT OF THE HEME DOMAIN OF P450BM-3 WITH N-PALMITOYLGLYCINE
657, d1smjA_, 0.8324, 2.44, 0.289, 391, 367, STRUCTURE OF THE A264E MUTANT OF CYTOCHROME P450 BM3 COMPLEXED WITH PALMITOLEATE
658, d5jquB_, 0.8323, 2.56, 0.224, 394, 370, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
659, d5jq2A_, 0.8323, 3.07, 0.160, 469, 387, CRYSTAL STRUCTURE OF THE RU(BPY)2PHENA FUNCTIONALIZED P450 BM3 L407C HEME DOMAIN MUTANT IN COMPLEX WITH N-PALMITOYLGLYCINE
660, d5dyzA_, 0.8322, 3.04, 0.326, 403, 384, CRYSTAL STRUCTURE OF ASP251GLY/GLN307HIS MUTANT OF CYTOCHROME P450 BM3 IN COMPLEX WITH N-PALMITOYLGLYCINE
661, d3qz1A_, 0.8322, 3.05, 0.158, 442, 386, CRYSTAL STRUCTURE OF BOVINE STEROID OF 21-HYDROXYLASE (P450C21)
662, d3dl9A2, 0.8321, 2.99, 0.278, 388, 374, CRYSTAL STRUCTURE OF CYP2R1 IN COMPLEX WITH 1-ALPHA-HYDROXY- VITAMIN D2
663, d1smjD_, 0.8321, 2.94, 0.188, 442, 383, STRUCTURE OF THE A264E MUTANT OF CYTOCHROME P450 BM3 COMPLEXED WITH PALMITOLEATE
664, d1fagA_, 0.8321, 3.05, 0.158, 442, 386, STRUCTURE OF CYTOCHROME P450
665, d4h24C_, 0.8320, 2.96, 0.188, 441, 383, CYTOCHROME P450BM3-CIS CYCLOPROPANATION CATALYST
666, d2wuzA_, 0.8320, 3.08, 0.158, 442, 386, X-RAY STRUCTURE OF CYP51 FROM TRYPANOSOMA CRUZI IN COMPLEX WITH FLUCONAZOLE IN ALTERNATIVE CONFORMATION
667, d5b2wB_, 0.8319, 3.05, 0.323, 403, 384, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUORODODECANOYL-L-TRYPTOPHAN
668, d1zo9A_, 0.8318, 3.06, 0.158, 469, 386, CRYSTAL STRUCTURE OF THE WILD TYPE HEME DOMAIN OF P450BM-3 WITH N- PALMITOYLMETHIONINE
669, d1jpzA_, 0.8318, 3.10, 0.160, 469, 387, CRYSTAL STRUCTURE OF A COMPLEX OF THE HEME DOMAIN OF P450BM- 3 WITH N-PALMITOYLGLYCINE
670, d3ekbA_, 0.8317, 2.89, 0.186, 439, 382, CRYSTAL STRUCTURE OF THE A264C MUTANT HEME DOMAIN OF CYTOCHROME P450 BM3
671, d3c6gA1, 0.8317, 3.07, 0.145, 458, 385, CRYSTAL STRUCTURE OF CYP2R1 IN COMPLEX WITH VITAMIN D3
672, d1fagC_, 0.8317, 2.64, 0.340, 379, 371, STRUCTURE OF CYTOCHROME P450
673, d5dypA_, 0.8316, 2.97, 0.185, 439, 383, CRYSTAL STRUCTURE OF ASP251GLY/GLN307HIS MUTANT OF CYTOCHROME P450 BM3
674, d3mgxB_, 0.8316, 2.96, 0.185, 442, 383, CRYSTAL STRUCTURE OF P450 OXYD THAT IS INVOLVED IN THE BIOSYNTHESIS OF VANCOMYCIN-TYPE ANTIBIOTICS
675, d3kx3A_, 0.8316, 2.43, 0.298, 370, 363, CRYSTAL STRUCTURE OF BACILLUS MEGATERIUM BM3 HEME DOMAIN MUTANT L86E
676, d1smiB_, 0.8316, 2.97, 0.313, 400, 380, A SINGLE MUTATION OF P450 BM3 INDUCES THE CONFORMATIONAL REARRANGEMENT SEEN UPON SUBSTRATE-BINDING IN WILD-TYPE ENZYME
677, d3kx3B_, 0.8315, 2.50, 0.285, 391, 368, CRYSTAL STRUCTURE OF BACILLUS MEGATERIUM BM3 HEME DOMAIN MUTANT L86E
678, d1fagB_, 0.8315, 2.74, 0.197, 393, 376, STRUCTURE OF CYTOCHROME P450
679, d5jqvD_, 0.8314, 2.91, 0.207, 427, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
680, d1smjB_, 0.8314, 3.08, 0.159, 463, 384, STRUCTURE OF THE A264E MUTANT OF CYTOCHROME P450 BM3 COMPLEXED WITH PALMITOLEATE
681, d1fagD_, 0.8314, 3.11, 0.153, 451, 385, STRUCTURE OF CYTOCHROME P450
682, d5xhjA_, 0.8313, 3.09, 0.158, 442, 386, CRYSTAL STRUCTURE OF P450BM3 WITH 5-CYCLOHEXYLVALEROYL-L-TRYPTOPHAN
683, p5og9B_, 0.8313, 2.96, 0.313, 400, 380, THE BM3 MUTANT WIFI-WC HEME DOMAIN IN COMPLEX WITH TESTOSTERONE 
684, d2ojdA1, 0.8313, 3.08, 0.159, 463, 384,  
685, d1jpzB_, 0.8313, 2.96, 0.188, 441, 383, CRYSTAL STRUCTURE OF A COMPLEX OF THE HEME DOMAIN OF P450BM- 3 WITH N-PALMITOYLGLYCINE
686, d2ij4B_, 0.8312, 3.07, 0.159, 463, 384, STRUCTURE OF THE A264K MUTANT OF CYTOCHROME P450 BM3
687, d5hiwA1, 0.8311, 3.07, 0.158, 442, 386, SORANGIUM CELLULOSUM SO CE56 CYTOCHROME P450 260B1
688, d5jquD_, 0.8310, 3.08, 0.159, 462, 384, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
689, d3k1oA_, 0.8310, 2.99, 0.313, 400, 380, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA CRUZI IN COMPLEX WITH A POTENTIAL ANTICHAGASIC DRUG POSACONAZOLE
690, d3nplA_, 0.8309, 3.09, 0.158, 469, 387, STRUCTURE OF RU(BPY)2(A-PHEN)(K97C) P450 BM3 HEME DOMAIN A RUTHENIUM MODIFIED P450 BM3 MUTANT
691, d2uwhC_, 0.8309, 3.09, 0.158, 469, 387, CYTOCHROME P450 BM3 MUTANT IN COMPLEX WITH PALMITIC ACID
692, d1zo9B_, 0.8308, 2.35, 0.269, 384, 364, CRYSTAL STRUCTURE OF THE WILD TYPE HEME DOMAIN OF P450BM-3 WITH N- PALMITOYLMETHIONINE
693, p5xa3D_, 0.8307, 3.00, 0.313, 400, 380, CRYSTAL STRUCTURE OF P450BM3 WITH BENZYLOXYCARBONYL-L-PROLYL-L- PHENYLALANINE
694, d3kx5B_, 0.8307, 2.99, 0.210, 435, 381, CRYSTAL STRUCTURE OF BACILLUS MEGATERIUM BM3 HEME DOMAIN MUTANT F261E
695, d1smjC_, 0.8307, 2.99, 0.210, 435, 381, STRUCTURE OF THE A264E MUTANT OF CYTOCHROME P450 BM3 COMPLEXED WITH PALMITOLEATE
696, p5xa3A_, 0.8306, 2.70, 0.371, 380, 372, CRYSTAL STRUCTURE OF P450BM3 WITH BENZYLOXYCARBONYL-L-PROLYL-L- PHENYLALANINE
697, d5jquC_, 0.8306, 3.10, 0.158, 469, 387, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
698, d5b2uB_, 0.8306, 3.20, 0.328, 395, 384, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUOROHEXANOYL -L-TRYPTOPHAN
699, d4keyA_, 0.8304, 3.01, 0.167, 449, 383, STRUCTURE OF P450 BM3 A82F F87V IN COMPLEX WITH OMEPRAZOLE
700, d5jquA_, 0.8303, 3.10, 0.327, 395, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
701, d5b2wA_, 0.8303, 2.74, 0.195, 394, 375, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUORODODECANOYL-L-TRYPTOPHAN
702, d2uwhD_, 0.8303, 2.74, 0.195, 394, 375, CYTOCHROME P450 BM3 MUTANT IN COMPLEX WITH PALMITIC ACID
703, d4o4pB_, 0.8302, 3.03, 0.138, 453, 383, STRUCTURE OF P450 BM3 A82F F87V IN COMPLEX WITH S-OMEPRAZOL
704, d3pm0A_, 0.8302, 3.09, 0.148, 457, 384, STRUCTURAL CHARACTERIZATION OF THE COMPLEX BETWEEN ALPHA- NAPHTHOFLAVONE AND HUMAN CYTOCHROME P450 1B1 (CYP1B1)
705, d3kx4B_, 0.8302, 3.13, 0.138, 453, 385, CRYSTAL STRUCTURE OF BACILLUS MEGATERIUM BM3 HEME DOMAIN MUTANT I401E
706, d4wg2A1, 0.8301, 3.11, 0.159, 450, 384, P411BM3-CIS T438S I263F REGIOSELECTIVE C-H AMINATION CATALYST
707, d2uwhA_, 0.8301, 2.79, 0.205, 390, 376, CYTOCHROME P450 BM3 MUTANT IN COMPLEX WITH PALMITIC ACID
708, d3cbdA_, 0.8300, 3.13, 0.145, 458, 385, DIRECTED EVOLUTION OF CYTOCHROME P450 BM3 TO OCTANE MONOXYGENASE 139-3
709, d1se6B1, 0.8300, 1.94, 0.321, 364, 355, CRYSTAL STRUCTURE OF STREPTOMYCES COELICOLOR A3(2) CYP158A2 FROM ANTIBIOTIC BIOSYNTHETIC PATHWAYS
710, p5eacA_, 0.8299, 1.94, 0.321, 364, 355, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR R-TEBUCONAZOLE
711, d5jqvC_, 0.8298, 3.10, 0.156, 462, 384, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
712, d4wg2C_, 0.8298, 3.13, 0.145, 460, 385, P411BM3-CIS T438S I263F REGIOSELECTIVE C-H AMINATION CATALYST
713, p4lxjA_, 0.8298, 3.02, 0.167, 448, 383, SACCHAROMYCES CEREVISIAE LANOSTEROL 14-ALPHA DEMETHYLASE WITH LANOSTEROL BOUND
714, d2z3tB_, 0.8298, 3.06, 0.146, 453, 383, CRYSTAL STRUCTURE OF SUBSTRATE FREE CYTOCHROME P450 STAP (CYP245A1)
715, d4g7gB_, 0.8297, 3.08, 0.141, 457, 384, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(34 -DIFLUOROBIPHENYL-4-YL)-2-(1H- IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [VNI/VNF (VFV)]
716, d3cbdB_, 0.8297, 3.10, 0.148, 457, 384, DIRECTED EVOLUTION OF CYTOCHROME P450 BM3 TO OCTANE MONOXYGENASE 139-3
717, d5jtdA_, 0.8296, 3.08, 0.146, 455, 384, CRYSTAL STRUCTURE OF THE RU(BPY)2PHENA FUNCTIONALIZED P450 BM3 L407C HEME DOMAIN MUTANT IN COMPLEX WITH DMSO.
718, d5dyzC_, 0.8296, 3.06, 0.138, 453, 384, CRYSTAL STRUCTURE OF ASP251GLY/GLN307HIS MUTANT OF CYTOCHROME P450 BM3 IN COMPLEX WITH N-PALMITOYLGLYCINE
719, d4fxbA_, 0.8296, 3.07, 0.146, 457, 383, CRYSTAL STRUCTURE OF CYP105N1 FROM STREPTOMYCES COELICOLOR: A CYTOCHROME P450 OXIDASE IN THE COELIBACTIN SIDEROPHORE BIOSYNTHETIC PATHWAY
720, d4dufC_, 0.8296, 3.13, 0.145, 445, 385, CYTOCHROME P450 BM3H-2G9 MRI SENSOR BOUND TO SEROTONIN
721, d2wuzB_, 0.8296, 3.03, 0.156, 445, 384, X-RAY STRUCTURE OF CYP51 FROM TRYPANOSOMA CRUZI IN COMPLEX WITH FLUCONAZOLE IN ALTERNATIVE CONFORMATION
722, d5kyoC_, 0.8295, 3.03, 0.156, 445, 384, CRYSTAL STRUCTURE OF CYP101J2
723, d4dufD_, 0.8295, 3.11, 0.156, 464, 384, CYTOCHROME P450 BM3H-2G9 MRI SENSOR BOUND TO SEROTONIN
724, d2uwhB_, 0.8295, 3.11, 0.156, 464, 384, CYTOCHROME P450 BM3 MUTANT IN COMPLEX WITH PALMITIC ACID
725, p5xa3C_, 0.8293, 3.07, 0.146, 454, 384, CRYSTAL STRUCTURE OF P450BM3 WITH BENZYLOXYCARBONYL-L-PROLYL-L- PHENYLALANINE
726, p5xa3B_, 0.8293, 3.09, 0.148, 455, 384, CRYSTAL STRUCTURE OF P450BM3 WITH BENZYLOXYCARBONYL-L-PROLYL-L- PHENYLALANINE
727, d4kpaA1, 0.8293, 3.10, 0.151, 456, 384, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM-3 IN COMPLEX WITH N- PALMITOYLGLYCINE (NPG)
728, p5esjA_, 0.8292, 3.12, 0.172, 444, 384, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G464S MUTANT COMPLEXED WITH FLUCONAZOLE
729, d4duaA_, 0.8292, 3.09, 0.148, 452, 384, CYTOCHROME P450 BM3H-9D7 MRI SENSOR NO LIGAND
730, d3mgxA_, 0.8292, 3.11, 0.148, 458, 384, CRYSTAL STRUCTURE OF P450 OXYD THAT IS INVOLVED IN THE BIOSYNTHESIS OF VANCOMYCIN-TYPE ANTIBIOTICS
731, d5dypC_, 0.8291, 3.10, 0.151, 456, 384, CRYSTAL STRUCTURE OF ASP251GLY/GLN307HIS MUTANT OF CYTOCHROME P450 BM3
732, d1p0wB_, 0.8291, 3.13, 0.146, 442, 383, F393W MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
733, p5esfA_, 0.8290, 3.12, 0.156, 462, 384, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G73E MUTANT COMPLEXED WITH FLUCONAZOLE
734, d4wg2B_, 0.8290, 3.10, 0.148, 455, 384, P411BM3-CIS T438S I263F REGIOSELECTIVE C-H AMINATION CATALYST
735, d4ck8A1, 0.8290, 3.17, 0.151, 440, 385, STEROL 14-ALPHA DEMETHYLASE (CYP51)FROM TRYPANOSOMA CRUZI IN COMPLEX WITH (R)-1-(24-DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL 4-(4-(34-DICHLOROPHENYL)PIPERAZIN-1-YL)PHENYLCARBAMATE (LFD)
736, p5eafA_, 0.8289, 2.93, 0.283, 391, 375, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR FLUQUINCONAZOLE
737, p5eabA_, 0.8289, 2.93, 0.283, 391, 375, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR S-TEBUCONAZOLE
738, p4zdzA_, 0.8289, 3.11, 0.151, 454, 384, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) Y140F MUTANT COMPLEXED WITH FLUCONAZOLE
739, d4dueB_, 0.8289, 3.10, 0.151, 455, 384, CYTOCHROME P450 BM3H-2G9C6 MRI SENSOR BOUND TO SEROTONIN
740, d4dueA_, 0.8289, 3.11, 0.148, 456, 384, CYTOCHROME P450 BM3H-2G9C6 MRI SENSOR BOUND TO SEROTONIN
741, d2bmhB_, 0.8289, 3.10, 0.148, 455, 384, MODELING PROTEIN-SUBSTRATE INTERACTIONS IN THE HEME DOMAIN OF CYTOCHROME P450BM-3
742, d1fahB_, 0.8289, 3.08, 0.141, 454, 384, STRUCTURE OF CYTOCHROME P450
743, p5esmA_, 0.8288, 3.05, 0.144, 455, 383, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) T322I MUTANT COMPLEXED WITH FLUCONAZOLE
744, p5eseA_, 0.8288, 3.10, 0.148, 455, 384, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G73R MUTANT COMPLEXED WITH FLUCONAZOLE
745, p5eagA_, 0.8288, 3.11, 0.146, 453, 384, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR PROCHLORAZ
746, p4wmzA_, 0.8288, 3.13, 0.143, 454, 385, S. CEREVISIAE CYP51 COMPLEXED WITH FLUCONAZOLE IN THE ACTIVE SITE
747, d4hgjB_, 0.8288, 3.12, 0.156, 463, 384, CRYSTAL STRUCTURE OF P450 BM3 5F5 HEME DOMAIN VARIANT
748, d4ck8B1, 0.8288, 3.11, 0.148, 458, 384, STEROL 14-ALPHA DEMETHYLASE (CYP51)FROM TRYPANOSOMA CRUZI IN COMPLEX WITH (R)-1-(24-DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL 4-(4-(34-DICHLOROPHENYL)PIPERAZIN-1-YL)PHENYLCARBAMATE (LFD)
749, d3qz1C_, 0.8288, 3.09, 0.148, 455, 384, CRYSTAL STRUCTURE OF BOVINE STEROID OF 21-HYDROXYLASE (P450C21)
750, d1p0xB_, 0.8288, 2.96, 0.225, 390, 377, F393Y MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
751, d5ucwA_, 0.8287, 2.96, 0.225, 390, 377, CYTOCHROME P411 P-4 A82L A78V F263L AMINATION CATALYST
752, d5b2xA_, 0.8287, 3.05, 0.133, 454, 383, CRYSTAL STRUCTURE OF P450BM3 MUTANT WITH N-PERFLUOROHEPTANOYL-L- TRYPTOPHAN
753, d4c28A_, 0.8287, 3.14, 0.172, 442, 384, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)-4-(4-(4-CHLOROPHENYL)PIPERAZIN-1-YL)- 2-FLUOROBENZAMIDE.
754, d2ij3B_, 0.8287, 3.09, 0.148, 456, 384, STRUCTURE OF THE A264H MUTANT OF CYTOCHROME P450 BM3
755, d5ucwB_, 0.8286, 3.16, 0.145, 458, 385, CYTOCHROME P411 P-4 A82L A78V F263L AMINATION CATALYST
756, p4zdyA_, 0.8286, 3.12, 0.148, 458, 384, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) Y140F MUTANT COMPLEXED WITH ITRACONAZOLE
757, d5li7A_, 0.8285, 3.06, 0.146, 453, 383, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH 1-(3-(1H-IMIDAZOL-1-YL)PROPYL)-3-((3S5S7S)-ADAMANTAN-1-YL)UREA
758, d5jqvG_, 0.8285, 3.12, 0.146, 455, 384, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
759, d5jqvF_, 0.8285, 3.07, 0.144, 455, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
760, d5jquF_, 0.8285, 3.06, 0.146, 453, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
761, d5b2yB_, 0.8285, 3.07, 0.138, 453, 383, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUORODECANOYL-L-TRYPTOPHAN
762, d5b2xB_, 0.8285, 3.06, 0.146, 453, 383, CRYSTAL STRUCTURE OF P450BM3 MUTANT WITH N-PERFLUOROHEPTANOYL-L- TRYPTOPHAN
763, d4dufA_, 0.8285, 3.15, 0.159, 450, 384, CYTOCHROME P450 BM3H-2G9 MRI SENSOR BOUND TO SEROTONIN
764, d2hpdB_, 0.8285, 3.03, 0.139, 452, 382, CRYSTAL STRUCTURE OF HEMOPROTEIN DOMAIN OF P450BM-3 A PROTOTYPE FOR MICROSOMAL P450 S
765, d5b2vB_, 0.8284, 3.11, 0.146, 452, 384, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUOROHEXANOYL-L-TRYPTOPHAN
766, d4kewB_, 0.8284, 3.12, 0.148, 458, 384, STRUCTURE OF THE A82F BM3 HEME DOMAIN IN COMPLEX WITH OMEPRAZOLE
767, p4h23A_, 0.8284, 3.14, 0.159, 446, 384, CYTOCHROME P411BM3-CIS CYCLOPROPANATION CATALYST
768, d2x80A_, 0.8284, 2.81, 0.168, 459, 376, P450 BM3 F87A IN COMPLEX WITH DMSO
769, p5jlcA_, 0.8283, 2.81, 0.168, 459, 376, STRUCTURE OF CYP51 FROM THE PATHOGEN CANDIDA GLABRATA
770, p5esnA_, 0.8283, 3.12, 0.146, 454, 384, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) T322I MUTANT STRUCTURE
771, p5eqbA_, 0.8283, 3.09, 0.156, 460, 384, CRYSTAL STRUCTURE OF LANOSTEROL 14-ALPHA DEMETHYLASE WITH INTACT TRANSMEMBRANE DOMAIN BOUND TO ITRACONAZOLE
772, d4zfbA_, 0.8283, 3.09, 0.156, 460, 384, CYTOCHROME P450 PENTAMUTANT FROM BM3 BOUND TO PALMITIC ACID
773, p4ze1A_, 0.8283, 3.12, 0.148, 458, 384, SACCHAROMYCES CEREVISIAE CYP51 Y140F MUTANT COMPLEXED WITH POSACONAZOLE IN THE ACTIVE SITE
774, d4ducA_, 0.8283, 3.17, 0.151, 455, 385, CYTOCHROME P450 BM3H-2G9 MRI SENSOR NO LIGAND
775, d3wspB_, 0.8283, 3.13, 0.310, 400, 381, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUORONONANOYL-L-TRYPTOPHAN
776, d5jquG_, 0.8282, 3.15, 0.150, 498, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
777, d2x80B_, 0.8282, 3.13, 0.151, 452, 384, P450 BM3 F87A IN COMPLEX WITH DMSO
778, d5jqvE_, 0.8281, 3.10, 0.154, 460, 384, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
779, p5hs1A_, 0.8281, 3.15, 0.150, 498, 386, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) COMPLEXED WITH VORICONAZOLE
780, p5esgA_, 0.8281, 2.54, 0.341, 376, 367, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G73E MUTANT COMPLEXED WITH ITRACONAZOLE
781, d3e5jA1, 0.8281, 3.06, 0.164, 448, 383, CRYSTAL STRUCTURE OF CYP105P1 WILD-TYPE LIGAND-FREE FORM
782, d1zo4B_, 0.8281, 3.13, 0.154, 455, 384, CRYSTAL STRUCTURE OF A328S MUTANT OF THE HEME DOMAIN OF P450BM-3
783, p5eslA_, 0.8280, 3.07, 0.144, 458, 383, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) T322I MUTANT COMPLEXED WITH ITRACONAZOLE
784, p5eaeA_, 0.8280, 3.17, 0.145, 453, 385, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR R-DESTHIO-PROTHIOCONAZOLE
785, d4c27A_, 0.8280, 3.01, 0.343, 390, 376, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4-YLAMINO)PROPAN-2-YL)-2- FLUORO-4-(4-(4-(TRIFLUOROMETHYL)PHENYL)PIPERAZIN-1-YL)BENZAMIDE
786, d3qz1D_, 0.8280, 3.07, 0.146, 456, 383, CRYSTAL STRUCTURE OF BOVINE STEROID OF 21-HYDROXYLASE (P450C21)
787, d1bu7B_, 0.8280, 3.19, 0.172, 444, 384, CRYOGENIC STRUCTURE OF CYTOCHROME P450BM-3 HEME DOMAIN
788, d5jquE_, 0.8279, 2.72, 0.196, 390, 373, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
789, p5eshA_, 0.8279, 3.13, 0.148, 456, 384, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G73W MUTANT IN COMPLEX WITH ITRACONAZOLE
790, d4o4pA_, 0.8279, 3.13, 0.148, 458, 384, STRUCTURE OF P450 BM3 A82F F87V IN COMPLEX WITH S-OMEPRAZOL
791, p5eahA_, 0.8278, 3.07, 0.146, 453, 383, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR DIFENOCONAZOLE
792, p5eadA_, 0.8278, 3.07, 0.146, 453, 383, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR S-DESTHIO-PROTHIOCONAZOLE
793, d3wrkD1, 0.8278, 3.21, 0.156, 456, 385, CRYSTAL STRUCTURE OF P450CAM
794, p5tz1B_, 0.8277, 3.15, 0.148, 498, 386, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM CANDIDA ALBICANS IN COMPLEX WITH THE TETRAZOLE-BASED ANTIFUNGAL DRUG CANDIDATE VT1161 (VT1)
795, p4ze3A_, 0.8277, 3.17, 0.145, 457, 385, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) Y140H MUTANT COMPLEXED WITH FLUCONAZOLE
796, d4hghB_, 0.8277, 2.90, 0.283, 387, 374, CRYSTAL STRUCTURE OF P450 BM3 5F5 HEME DOMAIN VARIANT COMPLEXED WITH STYRENE (DATASET I)
797, d4h24A_, 0.8277, 3.17, 0.148, 450, 385, CYTOCHROME P450BM3-CIS CYCLOPROPANATION CATALYST
798, d3ekfA_, 0.8277, 3.18, 0.145, 448, 385, CRYSTAL STRUCTURE OF THE A264Q HEME DOMAIN OF CYTOCHROME P450 BM3
799, d5e7yB_, 0.8276, 3.16, 0.150, 493, 386, CRYSTAL STRUCTURE OF P450 BM3 HEME DOMAIN M7 VARIANT
800, p4ze0A_, 0.8276, 3.15, 0.154, 451, 384, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) Y140F MUTANT COMPLEXED WITH VORICONAZOLE
801, d4dudB_, 0.8276, 3.17, 0.172, 446, 384, CYTOCHROME P450 BM3H-2G9C6 MRI SENSOR NO LIGAND
802, d3wspA_, 0.8276, 3.15, 0.153, 498, 386, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUORONONANOYL-L-TRYPTOPHAN
803, d2uvnA1, 0.8276, 3.15, 0.150, 495, 386, CRYSTAL STRUCTURE OF ECONAZOLE-BOUND CYP130 FROM MYCOBACTERIUM TUBERCULOSIS
804, d2ij2B_, 0.8276, 3.16, 0.150, 497, 386, ATOMIC STRUCTURE OF THE HEME DOMAIN OF FLAVOCYTOCHROME P450- BM3
805, d5e9zA_, 0.8275, 3.08, 0.146, 450, 383, CYTOCHROME P450 BM3 MUTANT M11
806, d4dubA_, 0.8275, 3.08, 0.146, 453, 383, CYTOCHROME P450 BM3H-9D7 MRI SENSOR BOUND TO DOPAMINE
807, d2j1mA_, 0.8275, 3.16, 0.135, 455, 384, P450 BM3 HEME DOMAIN IN COMPLEX WITH DMSO
808, d1smiA_, 0.8275, 3.15, 0.143, 455, 384, A SINGLE MUTATION OF P450 BM3 INDUCES THE CONFORMATIONAL REARRANGEMENT SEEN UPON SUBSTRATE-BINDING IN WILD-TYPE ENZYME
809, p5og9A_, 0.8274, 3.15, 0.150, 497, 386, THE BM3 MUTANT WIFI-WC HEME DOMAIN IN COMPLEX WITH TESTOSTERONE 
810, d4dudA_, 0.8274, 3.17, 0.150, 497, 386, CYTOCHROME P450 BM3H-2G9C6 MRI SENSOR NO LIGAND
811, d2ij2A_, 0.8274, 3.17, 0.150, 497, 386, ATOMIC STRUCTURE OF THE HEME DOMAIN OF FLAVOCYTOCHROME P450- BM3
812, d5li7B_, 0.8273, 3.17, 0.150, 496, 386, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH 1-(3-(1H-IMIDAZOL-1-YL)PROPYL)-3-((3S5S7S)-ADAMANTAN-1-YL)UREA
813, d3qz1B_, 0.8273, 3.08, 0.146, 451, 383, CRYSTAL STRUCTURE OF BOVINE STEROID OF 21-HYDROXYLASE (P450C21)
814, d3dgiA_, 0.8273, 3.15, 0.174, 446, 384, CRYSTAL STRUCTURE OF F87A/T268A MUTANT OF CYP BM3
815, d1bu7A_, 0.8273, 2.90, 0.158, 437, 379, CRYOGENIC STRUCTURE OF CYTOCHROME P450BM-3 HEME DOMAIN
816, p5ul0A_, 0.8272, 3.16, 0.143, 448, 384, S. CEREVISIAE CYP51 COMPLEXED WITH VT-1161
817, p5eafB_, 0.8272, 3.14, 0.154, 453, 384, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR FLUQUINCONAZOLE
818, d4h24D_, 0.8272, 3.10, 0.146, 453, 383, CYTOCHROME P450BM3-CIS CYCLOPROPANATION CATALYST
819, d4h24B_, 0.8272, 3.14, 0.172, 443, 384, CYTOCHROME P450BM3-CIS CYCLOPROPANATION CATALYST
820, p2hi4A_, 0.8272, 3.19, 0.135, 454, 385, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 1A2 IN COMPLEX WITH ALPHA-NAPHTHOFLAVONE
821, d5jquH_, 0.8271, 3.06, 0.160, 453, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
822, d2j1mB_, 0.8271, 3.17, 0.150, 497, 386, P450 BM3 HEME DOMAIN IN COMPLEX WITH DMSO
823, d5b2uA_, 0.8270, 2.50, 0.345, 373, 365, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUOROHEXANOYL -L-TRYPTOPHAN
824, p4ze2A_, 0.8270, 3.21, 0.148, 451, 385, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) Y140H MUTANT COMPLEXED WITH ITRACONAZOLE
825, d4hgiB_, 0.8270, 3.13, 0.141, 455, 384, CRYSTAL STRUCTURE OF P450 BM3 5F5 HEME DOMAIN VARIANT COMPLEXED WITH STYRENE (DATASET II)
826, p4h23B_, 0.8270, 3.12, 0.138, 455, 384, CYTOCHROME P411BM3-CIS CYCLOPROPANATION CATALYST
827, d3g1qD_, 0.8270, 3.09, 0.146, 452, 383, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN LIGAND FREE STATE
828, p5esiA_, 0.8269, 3.09, 0.146, 453, 383, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G73W MUTANT
829, d2x7yB_, 0.8269, 3.14, 0.159, 456, 384, P450 BM3 F87A IN COMPLEX WITH DMSO
830, d2ij3A_, 0.8269, 3.18, 0.133, 457, 384, STRUCTURE OF THE A264H MUTANT OF CYTOCHROME P450 BM3
831, d5e9zC1, 0.8268, 3.09, 0.146, 453, 383, CYTOCHROME P450 BM3 MUTANT M11
832, d4zf8A_, 0.8268, 3.10, 0.157, 443, 382, CYTOCHROME P450 PENTAMUTANT FROM BM3 WITH BOUND METYRAPONE
833, p5eskA_, 0.8267, 3.13, 0.154, 454, 384, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G464S MUTANT COMPLEXED WITH ITRACONAZOLE
834, d5b2yA_, 0.8267, 3.10, 0.159, 455, 383, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUORODECANOYL-L-TRYPTOPHAN
835, d4zf6A_, 0.8267, 3.20, 0.153, 487, 386, CYTOCHROME P450 PENTAMUTANT FROM BM3 WITH BOUND PEG
836, d4dufB_, 0.8267, 3.17, 0.150, 497, 386, CYTOCHROME P450 BM3H-2G9 MRI SENSOR BOUND TO SEROTONIN
837, d5b2vA_, 0.8265, 3.17, 0.150, 499, 386, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUOROHEXANOYL-L-TRYPTOPHAN
838, d5jq2B_, 0.8264, 3.17, 0.150, 499, 386, CRYSTAL STRUCTURE OF THE RU(BPY)2PHENA FUNCTIONALIZED P450 BM3 L407C HEME DOMAIN MUTANT IN COMPLEX WITH N-PALMITOYLGLYCINE
839, d4ducB_, 0.8264, 3.21, 0.140, 460, 385, CYTOCHROME P450 BM3H-2G9 MRI SENSOR NO LIGAND
840, d4c27B_, 0.8264, 3.17, 0.150, 497, 386, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4-YLAMINO)PROPAN-2-YL)-2- FLUORO-4-(4-(4-(TRIFLUOROMETHYL)PHENYL)PIPERAZIN-1-YL)BENZAMIDE
841, d3l4dB1, 0.8264, 3.15, 0.154, 456, 384, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM LEISHMANIA INFANTUM IN COMPLEX WITH FLUCONAZOLE
842, d5jqvH_, 0.8263, 3.09, 0.146, 453, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
843, d5ex6C_, 0.8263, 3.06, 0.139, 451, 382, STRUCTURE OF P450 STAH FROM GLYCOPEPTIDE ANTIBIOTIC A47934 BIOSYNTHESIS
844, d4hgjA_, 0.8263, 3.18, 0.151, 455, 385, CRYSTAL STRUCTURE OF P450 BM3 5F5 HEME DOMAIN VARIANT
845, d1fahA_, 0.8263, 3.14, 0.149, 451, 383, STRUCTURE OF CYTOCHROME P450
846, d5jtdB_, 0.8262, 3.17, 0.150, 497, 386, CRYSTAL STRUCTURE OF THE RU(BPY)2PHENA FUNCTIONALIZED P450 BM3 L407C HEME DOMAIN MUTANT IN COMPLEX WITH DMSO.
847, d4c28B_, 0.8262, 3.17, 0.150, 496, 386, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)-4-(4-(4-CHLOROPHENYL)PIPERAZIN-1-YL)- 2-FLUOROBENZAMIDE.
848, d3kx5A_, 0.8262, 3.05, 0.376, 389, 378, CRYSTAL STRUCTURE OF BACILLUS MEGATERIUM BM3 HEME DOMAIN MUTANT F261E
849, d3benA_, 0.8262, 3.18, 0.148, 457, 385, STRUCTURE OF N-(12-IMIDAZOLYL-DODECANOYL)-L-LEUCINE INHIBITOR BOUND TO THE HEME DOMAIN OF CYTOCHROME P450-BM3
850, d4keyB_, 0.8261, 3.18, 0.150, 497, 386, STRUCTURE OF P450 BM3 A82F F87V IN COMPLEX WITH OMEPRAZOLE
851, d3nplB_, 0.8261, 3.17, 0.150, 498, 386, STRUCTURE OF RU(BPY)2(A-PHEN)(K97C) P450 BM3 HEME DOMAIN A RUTHENIUM MODIFIED P450 BM3 MUTANT
852, d5e78B_, 0.8260, 3.15, 0.172, 444, 384, CRYSTAL STRUCTURE OF P450 BM3 HEME DOMAIN VARIANT COMPLEXED WITH CO(III)SEP
853, d3khmA_, 0.8260, 2.90, 0.158, 434, 379, CRYSTAL STRUCTURE OF STEROL 14ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA CRUZI IN COMPLEX WITH INHIBITOR FLUCONAZOLE
854, d5l94B_, 0.8259, 3.19, 0.148, 455, 385, THE 2.25 A CRYSTAL STRUCTURE OF CYP109E1 FROM BACILLUS MEGATERIUM IN COMPLEX WITH TESTOSTERONE
855, d1yqoB_, 0.8259, 3.12, 0.141, 451, 383, T268A MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
856, p5v5zA_, 0.8257, 3.19, 0.150, 497, 386, STRUCTURE OF CYP51 FROM THE PATHOGEN CANDIDA ALBICANS
857, d3g1qB_, 0.8257, 3.19, 0.159, 450, 384, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN LIGAND FREE STATE
858, d4dtyB_, 0.8256, 3.18, 0.150, 497, 386, CYTOCHROME P450 BM3H-8C8 MRI SENSOR NO LIGAND
859, d5e9zB_, 0.8255, 3.17, 0.150, 497, 386, CYTOCHROME P450 BM3 MUTANT M11
860, d3kx4A_, 0.8255, 2.44, 0.212, 390, 364, CRYSTAL STRUCTURE OF BACILLUS MEGATERIUM BM3 HEME DOMAIN MUTANT I401E
861, d2hpdA_, 0.8255, 3.15, 0.151, 484, 385, CRYSTAL STRUCTURE OF HEMOPROTEIN DOMAIN OF P450BM-3 A PROTOTYPE FOR MICROSOMAL P450 S
862, d2bmhA_, 0.8255, 3.18, 0.150, 496, 386, MODELING PROTEIN-SUBSTRATE INTERACTIONS IN THE HEME DOMAIN OF CYTOCHROME P450BM-3
863, d2x7yA_, 0.8254, 3.13, 0.146, 455, 383, P450 BM3 F87A IN COMPLEX WITH DMSO
864, d3wrkA1, 0.8253, 3.16, 0.154, 457, 384, CRYSTAL STRUCTURE OF P450CAM
865, p5tz1A_, 0.8252, 3.14, 0.152, 441, 381, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM CANDIDA ALBICANS IN COMPLEX WITH THE TETRAZOLE-BASED ANTIFUNGAL DRUG CANDIDATE VT1161 (VT1)
866, d4dtzB_, 0.8252, 3.19, 0.151, 452, 385, CYTOCHROME P450 BM3H-8C8 MRI SENSOR BOUND TO DOPAMINE
867, d4kpbB_, 0.8251, 3.17, 0.150, 498, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM-3 R47E MUTANT
868, d5e7yA_, 0.8250, 3.13, 0.143, 456, 384, CRYSTAL STRUCTURE OF P450 BM3 HEME DOMAIN M7 VARIANT
869, d1p0vB_, 0.8250, 3.11, 0.146, 453, 383, F393A MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
870, d3l4dA1, 0.8249, 3.33, 0.271, 397, 377, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM LEISHMANIA INFANTUM IN COMPLEX WITH FLUCONAZOLE
871, d5e78A_, 0.8247, 3.33, 0.271, 397, 377, CRYSTAL STRUCTURE OF P450 BM3 HEME DOMAIN VARIANT COMPLEXED WITH CO(III)SEP
872, d4dtwB_, 0.8247, 3.08, 0.144, 448, 383, CYTOCHROME P450 BM3H-8C8 MRI SENSOR BOUND TO SEROTONIN
873, d3ekfB_, 0.8247, 3.20, 0.145, 452, 385, CRYSTAL STRUCTURE OF THE A264Q HEME DOMAIN OF CYTOCHROME P450 BM3
874, d5m0oA_, 0.8246, 3.19, 0.145, 456, 385, CRYSTAL STRUCTURE OF CYTOCHROME P450 OLET H85Q IN COMPLEX WITH ARACHIDONIC ACID
875, d4hghA_, 0.8246, 3.14, 0.146, 454, 383, CRYSTAL STRUCTURE OF P450 BM3 5F5 HEME DOMAIN VARIANT COMPLEXED WITH STYRENE (DATASET I)
876, p5fsaA_, 0.8245, 3.11, 0.147, 439, 380, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM A PATHOGENIC YEAST CANDIDA ALBICANS IN COMPLEX WITH THE ANTIFUNGAL DRUG POSACONAZOLE
877, d4jwsB_, 0.8245, 3.23, 0.153, 454, 385, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX
878, d4by0B1, 0.8245, 3.16, 0.151, 456, 384, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)-33 -DIFLUORO-(11 -BIPHENYL)-4- CARBOXAMIDE
879, d3g1qA_, 0.8245, 3.22, 0.143, 450, 385, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN LIGAND FREE STATE
880, d2nnbB_, 0.8245, 2.48, 0.346, 372, 364, THE Q403K MUTNAT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
881, d1zo4A_, 0.8245, 2.88, 0.159, 436, 378, CRYSTAL STRUCTURE OF A328S MUTANT OF THE HEME DOMAIN OF P450BM-3
882, d4hgiA_, 0.8244, 3.15, 0.159, 449, 383, CRYSTAL STRUCTURE OF P450 BM3 5F5 HEME DOMAIN VARIANT COMPLEXED WITH STYRENE (DATASET II)
883, d4dubB_, 0.8243, 3.09, 0.146, 455, 383, CYTOCHROME P450 BM3H-9D7 MRI SENSOR BOUND TO DOPAMINE
884, d4g3jB_, 0.8242, 3.19, 0.150, 497, 386, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(24-DICHLOROPHENYL)-2-(1H-124- TRIAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [R- VNI-TRIAZOLE (VNT)]
885, d4bmmA1, 0.8242, 3.17, 0.153, 497, 386, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)- 2 35 -TRIFLUORO-(11 -BIPHENYL)-4-CARBOXAMIDE
886, d3nc3A_, 0.8242, 3.15, 0.159, 455, 383, CYP134A1 STRUCTURE WITH A CLOSED SUBSTRATE BINDING LOOP
887, d2nzaB1, 0.8242, 3.08, 0.160, 452, 381, STRUCTURE AND FUNCTION STUDIES OF CYTOCHROME P450 158A1 FROM STREPTOMYCES COELICOLOR A3(2)
888, d4duaB_, 0.8241, 3.11, 0.154, 480, 383, CYTOCHROME P450 BM3H-9D7 MRI SENSOR NO LIGAND
889, d2wv2A_, 0.8241, 3.11, 0.154, 480, 383, X-RAY STRUCTURE OF CYP51 FROM THE HUMAN PATHOGEN TRYPANOSOMA BRUCEI IN COMPLEX WITH FLUCONAZOLE
890, d3benB_, 0.8240, 3.15, 0.133, 450, 383, STRUCTURE OF N-(12-IMIDAZOLYL-DODECANOYL)-L-LEUCINE INHIBITOR BOUND TO THE HEME DOMAIN OF CYTOCHROME P450-BM3
891, p3qm4A_, 0.8239, 3.11, 0.146, 454, 383, HUMAN CYTOCHROME P450 (CYP) 2D6 - PRINOMASTAT COMPLEX
892, d3gw9B_, 0.8239, 3.11, 0.146, 453, 383, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI BOUND TO AN INHIBITOR N-(1-(24- DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-13 4-OXAZIAZOL-2-YL)BENZAMIDE
893, d3g1qC_, 0.8239, 3.19, 0.150, 497, 386, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN LIGAND FREE STATE
894, d4dtwA_, 0.8238, 3.14, 0.146, 453, 383, CYTOCHROME P450 BM3H-8C8 MRI SENSOR BOUND TO SEROTONIN
895, d3l4dD1, 0.8238, 3.15, 0.164, 448, 383, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM LEISHMANIA INFANTUM IN COMPLEX WITH FLUCONAZOLE
896, d4g7gC_, 0.8237, 3.13, 0.162, 448, 383, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(34 -DIFLUOROBIPHENYL-4-YL)-2-(1H- IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [VNI/VNF (VFV)]
897, d5m0pB_, 0.8236, 3.18, 0.150, 498, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450 OLET F79A IN COMPLEX WITH ARACHIDONIC ACID
898, d4g3jC_, 0.8236, 3.13, 0.152, 439, 382, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(24-DICHLOROPHENYL)-2-(1H-124- TRIAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [R- VNI-TRIAZOLE (VNT)]
899, p3tdaC_, 0.8236, 3.15, 0.135, 453, 384, COMPETITIVE REPLACEMENT OF THIORIDAZINE BY PRINOMASTAT IN CRYSTALS OF CYTOCHROME P450 2D6
900, d5ex6A_, 0.8235, 3.23, 0.145, 444, 385, STRUCTURE OF P450 STAH FROM GLYCOPEPTIDE ANTIBIOTIC A47934 BIOSYNTHESIS
901, d5ajrA1, 0.8235, 3.20, 0.140, 460, 385, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA CRUZI IN COMPLEX WITH THE 1-TETRAZOLE DERIVATIVE VT-1161 ((R)-2-( 24-DIFLUOROPHENYL)-11-DIFLUORO-3-(1H-TETRAZOL-1-YL)-1-(5- (4-(222-TRIFLUOROETHOXY)PHENYL)PYRIDIN-2-YL)PROPAN-2-OL)
902, d4jwsA_, 0.8234, 3.19, 0.148, 497, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX
903, d4dtzA_, 0.8234, 3.11, 0.146, 452, 383, CYTOCHROME P450 BM3H-8C8 MRI SENSOR BOUND TO DOPAMINE
904, p3tbgC_, 0.8231, 3.22, 0.143, 460, 385, HUMAN CYTOCHROME P450 2D6 WITH TWO THIORIDAZINES BOUND IN ACTIVE SITE
905, d3l4dC1, 0.8231, 3.18, 0.154, 456, 384, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM LEISHMANIA INFANTUM IN COMPLEX WITH FLUCONAZOLE
906, d1yqpB_, 0.8231, 3.12, 0.146, 453, 383, T268N MUTANT CYTOCHROME DOMAIN OF FLAVOCYTOCHROME P450 BM3
907, d3tikB1, 0.8230, 3.17, 0.146, 459, 384, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE TIPIFARNIB DERIVATIVE 6-((4-CHLOROPHENYL)(METHOXY)(1-METHYL- 1H-IMIDAZOL-5-YL)METHYL)-4-(26-DIFLUOROPHENYL)-1-METHYLQUINOLIN- 2(1H)-ONE
908, d4g7gD_, 0.8228, 3.16, 0.146, 456, 384, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(34 -DIFLUOROBIPHENYL-4-YL)-2-(1H- IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [VNI/VNF (VFV)]
909, d4rsnB1, 0.8227, 3.18, 0.172, 443, 384, CRYSTAL STRUCTURE OF THE E267V MUTANT OF CYTOCHROME P450 BM3
910, d4rsnA1, 0.8227, 3.13, 0.149, 445, 383, CRYSTAL STRUCTURE OF THE E267V MUTANT OF CYTOCHROME P450 BM3
911, d3m4vA_, 0.8227, 3.22, 0.146, 450, 384, CRYSTAL STRUCTURE OF THE A330P MUTANT OF CYTOCHROME P450 BM3
912, d5m0pA1, 0.8226, 2.88, 0.321, 388, 371, CRYSTAL STRUCTURE OF CYTOCHROME P450 OLET F79A IN COMPLEX WITH ARACHIDONIC ACID
913, p5livD_, 0.8226, 3.13, 0.146, 448, 383, CRYSTAL STRUCTURE OF MYXOBACTERIAL CYP260A1
914, d5ikiA_, 0.8226, 3.14, 0.144, 455, 383, CYP106A2 WITH SUBSTRATE ABIETIC ACID
915, d4dtyA_, 0.8226, 3.12, 0.146, 458, 383, CYTOCHROME P450 BM3H-8C8 MRI SENSOR NO LIGAND
916, d3tikC1, 0.8226, 3.20, 0.172, 441, 384, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE TIPIFARNIB DERIVATIVE 6-((4-CHLOROPHENYL)(METHOXY)(1-METHYL- 1H-IMIDAZOL-5-YL)METHYL)-4-(26-DIFLUOROPHENYL)-1-METHYLQUINOLIN- 2(1H)-ONE
917, d3gw9D_, 0.8226, 3.12, 0.141, 455, 383, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI BOUND TO AN INHIBITOR N-(1-(24- DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-13 4-OXAZIAZOL-2-YL)BENZAMIDE
918, d3gw9A_, 0.8225, 3.12, 0.146, 454, 383, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI BOUND TO AN INHIBITOR N-(1-(24- DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-13 4-OXAZIAZOL-2-YL)BENZAMIDE
919, p5fsaB_, 0.8224, 3.22, 0.146, 442, 384, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM A PATHOGENIC YEAST CANDIDA ALBICANS IN COMPLEX WITH THE ANTIFUNGAL DRUG POSACONAZOLE
920, p3tbgA_, 0.8224, 3.21, 0.145, 456, 385, HUMAN CYTOCHROME P450 2D6 WITH TWO THIORIDAZINES BOUND IN ACTIVE SITE
921, d1jmeB_, 0.8224, 3.10, 0.144, 454, 383, CRYSTAL STRUCTURE OF PHE393HIS CYTOCHROME P450 BM3
922, d4ckaA1, 0.8223, 3.21, 0.172, 441, 384, STEROL 14-ALPHA DEMETHYLASE (CYP51)FROM TRYPANOSOMA CRUZI IN COMPLEX WITH (S)-1-(4-FLUOROPHENYL)-2-(1H-IMIDAZOL-1-YL) ETHYL 4-ISOPROPYLPHENYLCARBAMATE (LFS)
923, d4ck9A1, 0.8223, 1.95, 0.303, 360, 353, STEROL 14-ALPHA DEMETHYLASE (CYP51)FROM TRYPANOSOMA CRUZI IN COMPLEX WITH (S)-1-(4-CHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL) ETHYL 4-ISOPROPYLPHENYLCARBAMATE (LFT)
924, p3tdaA_, 0.8223, 3.22, 0.148, 441, 385, COMPETITIVE REPLACEMENT OF THIORIDAZINE BY PRINOMASTAT IN CRYSTALS OF CYTOCHROME P450 2D6
925, p4wnvA_, 0.8222, 3.18, 0.153, 488, 385, HUMAN CYTOCHROME P450 2D6 QUININE COMPLEX
926, d4g3jD_, 0.8222, 3.10, 0.168, 444, 382, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(24-DICHLOROPHENYL)-2-(1H-124- TRIAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [R- VNI-TRIAZOLE (VNT)]
927, d3p99D_, 0.8221, 3.13, 0.149, 453, 383, STEROL 14ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH DELTA7-14ALPHA-METHYLENE-CYCLOPROPYL-DIHYDROLANOSTEROL
928, d3o1aA_, 0.8221, 3.17, 0.146, 451, 384, STRUCTURE OF OXYE (CYP165D3) A CYTOCHROME P450 INVOLVED IN TEICOPLANIN BIOSYNTHESIS
929, d2j4sB_, 0.8221, 3.13, 0.141, 453, 383, P450 BM3 HEME DOMAIN IN COMPLEX WITH DMSO
930, d3juvA_, 0.8219, 3.18, 0.141, 457, 384, CRYSTAL STRUCTURE OF HUMAN LANOSTEROL 14ALPHA-DEMETHYLASE (CYP51)
931, d2nnbA_, 0.8219, 3.18, 0.143, 455, 384, THE Q403K MUTNAT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
932, d4by0A1, 0.8218, 3.13, 0.149, 437, 382, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)-33 -DIFLUORO-(11 -BIPHENYL)-4- CARBOXAMIDE
933, d2p85B_, 0.8218, 2.44, 0.209, 389, 363, STRUCTURE OF HUMAN LUNG CYTOCHROME P450 2A13 WITH INDOLE BOUND IN TWO ALTERNATE CONFORMATIONS
934, d1p0vA_, 0.8218, 3.19, 0.156, 484, 385, F393A MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
935, d4bmmB1, 0.8217, 3.11, 0.149, 453, 383, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)- 2 35 -TRIFLUORO-(11 -BIPHENYL)-4-CARBOXAMIDE
936, d4bmmC1, 0.8216, 3.26, 0.143, 444, 385, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)- 2 35 -TRIFLUORO-(11 -BIPHENYL)-4-CARBOXAMIDE
937, d3zg2A_, 0.8216, 3.14, 0.144, 451, 383, STEROL 14 ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA CRUZI IN COMPLEX WITH THE PYRIDINE INHIBITOR (S)-2-(4-CHLOROPHENYL)-2- (PYRIDIN-3-YL)-1-(4-(4-(TRIFLUOROMETHYL)PHENYL)PIPERAZIN-1-YL) ETHANONE (EPL-BS1246UDO)
938, d1yqoA_, 0.8216, 3.28, 0.140, 444, 385, T268A MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
939, d3nc6A_, 0.8215, 3.18, 0.149, 445, 383, CYP134A1 1-PHENYLIMIDAZOLE BOUND STRUCTURE
940, d2x2nA_, 0.8215, 3.18, 0.141, 447, 383, X-RAY STRUCTURE OF CYP51 FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH POSACONAZOLE IN TWO DIFFERENT CONFORMATIONS
941, p5tftA_, 0.8214, 3.15, 0.149, 453, 383, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
942, d4ejhG_, 0.8214, 3.11, 0.147, 452, 381, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
943, d2x9pA_, 0.8212, 3.06, 0.136, 419, 381, X-RAY STRUCTURE OF THE SUBSTRATE-FREE CYTOCHROME P450 PIMD - A POLYENE MACROLIDE ANTIBIOTIC PIMARICIN EPOXIDASE
944, d3vooA_, 0.8211, 3.16, 0.149, 455, 383, CYTOCHROME P450SP ALPHA (CYP152B1) MUTANT A245E
945, p3qm4B_, 0.8211, 3.21, 0.151, 484, 385, HUMAN CYTOCHROME P450 (CYP) 2D6 - PRINOMASTAT COMPLEX
946, d3awqA_, 0.8211, 2.62, 0.216, 395, 366, CYTOCHROME P450SP ALPHA (CYP152B1) MUTANT L78F
947, d5m0nA1, 0.8209, 3.18, 0.172, 440, 384, CRYSTAL STRUCTURE OF CYTOCHROME P450 OLET IN COMPLEX WITH FORMATE
948, d2zqjB_, 0.8209, 3.17, 0.162, 448, 383, SUBSTRATE-FREE FORM OF CYTOCHROME P450BSBETA
949, d5yhjB_, 0.8208, 3.28, 0.140, 441, 386, CYTOCHROME P450EX ALPHA (CYP152N1) WILD-TYPE WITH MYRISTIC ACID
950, p4xrzB_, 0.8208, 3.14, 0.146, 456, 383, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 6 COMPLEX
951, d4g7gA_, 0.8208, 3.16, 0.149, 455, 383, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(34 -DIFLUOROBIPHENYL-4-YL)-2-(1H- IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [VNI/VNF (VFV)]
952, d4l54A_, 0.8207, 3.12, 0.149, 456, 383, STRUCTURE OF CYTOCHROME P450 OLET LIGAND-FREE
953, d2x2nD_, 0.8207, 3.17, 0.167, 448, 383, X-RAY STRUCTURE OF CYP51 FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH POSACONAZOLE IN TWO DIFFERENT CONFORMATIONS
954, d1p0xA_, 0.8207, 3.22, 0.174, 439, 384, F393Y MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
955, d3tikA1, 0.8206, 2.38, 0.272, 380, 360, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE TIPIFARNIB DERIVATIVE 6-((4-CHLOROPHENYL)(METHOXY)(1-METHYL- 1H-IMIDAZOL-5-YL)METHYL)-4-(26-DIFLUOROPHENYL)-1-METHYLQUINOLIN- 2(1H)-ONE
956, d4l40A_, 0.8205, 2.89, 0.327, 386, 373, STRUCTURE OF THE P450 OLET WITH A C20 FATTY ACID SUBSTRATE BOUND
957, d3vtjA_, 0.8205, 3.18, 0.146, 457, 384, CYTOCHROME P450SP ALPHA (CYP152B1) MUTANT A245H
958, d3awpA_, 0.8205, 3.24, 0.161, 443, 384, CYTOCHROME P450SP ALPHA (CYP152B1) MUTANT F288G
959, d3tikD1, 0.8204, 3.18, 0.146, 457, 383, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE TIPIFARNIB DERIVATIVE 6-((4-CHLOROPHENYL)(METHOXY)(1-METHYL- 1H-IMIDAZOL-5-YL)METHYL)-4-(26-DIFLUOROPHENYL)-1-METHYLQUINOLIN- 2(1H)-ONE
960, p2q9fA_, 0.8204, 3.40, 0.145, 465, 385, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 46A1 IN COMPLEX WITH CHOLESTEROL-3-SULPHATE
961, d1yqpA_, 0.8204, 3.18, 0.167, 449, 383, T268N MUTANT CYTOCHROME DOMAIN OF FLAVOCYTOCHROME P450 BM3
962, d2zqxC_, 0.8203, 3.16, 0.162, 447, 383, CYTOCHROME P450BSBETA COCRYSTALLIZED WITH HEPTANOIC ACID
963, p6b82B_, 0.8202, 3.15, 0.149, 453, 383, ZEBRA FISH CYP-450 17A1 MUTANT ABIRATERONE COMPLEX
964, d4du2B_, 0.8202, 3.18, 0.149, 441, 383, CYTOCHROME P450 BM3H-B7 MRI SENSOR BOUND TO DOPAMINE
965, d4yt3A_, 0.8201, 3.23, 0.161, 448, 384, CYP106A2
966, d4kf2A_, 0.8201, 3.06, 0.136, 421, 381, STRUCTURE OF THE P4509 BM3 A82F F87V HEME DOMAIN
967, d1p0wA_, 0.8201, 3.24, 0.161, 448, 384, F393W MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
968, d1jmeA_, 0.8201, 3.28, 0.148, 467, 384, CRYSTAL STRUCTURE OF PHE393HIS CYTOCHROME P450 BM3
969, d5kyoD_, 0.8200, 2.88, 0.328, 386, 369, CRYSTAL STRUCTURE OF CYP101J2
970, d2zqxB_, 0.8200, 3.16, 0.172, 446, 383, CYTOCHROME P450BSBETA COCRYSTALLIZED WITH HEPTANOIC ACID
971, d2zqjC_, 0.8200, 2.57, 0.219, 392, 366, SUBSTRATE-FREE FORM OF CYTOCHROME P450BSBETA
972, d1izoA_, 0.8200, 3.17, 0.144, 453, 383, CYTOCHROME P450 BS BETA COMPLEXED WITH FATTY ACID
973, d5uhuA_, 0.8199, 3.24, 0.144, 467, 383, SOLUTION CONFORMATION OF CYTOCHROME P450 MYCG WITH MYCINAMICIN IV BOUND
974, d2j4sA_, 0.8199, 3.09, 0.153, 444, 380, P450 BM3 HEME DOMAIN IN COMPLEX WITH DMSO
975, d4yt3B_, 0.8198, 3.22, 0.143, 441, 384, CYP106A2
976, d3vm4A_, 0.8198, 3.18, 0.164, 446, 383, CYTOCHROME P450SP ALPHA (CYP152B1) IN COMPLEX WITH (R)-IBUPROPHEN
977, d2x2nC_, 0.8197, 3.17, 0.162, 448, 383, X-RAY STRUCTURE OF CYP51 FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH POSACONAZOLE IN TWO DIFFERENT CONFORMATIONS
978, d3vnoA_, 0.8195, 3.22, 0.143, 456, 384, CYTOCHROME P450SP ALPHA (CYP152B1) MUTANT R241E
979, d6aycA1, 0.8194, 3.22, 0.143, 456, 384, NAEGLERIA FOWLERI CYP51-ITRACONAZOLE COMPLEX
980, d5m0oC1, 0.8194, 3.15, 0.146, 451, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450 OLET H85Q IN COMPLEX WITH ARACHIDONIC ACID
981, p4wnwA_, 0.8193, 3.12, 0.126, 422, 381, HUMAN CYTOCHROME P450 2D6 THIORIDAZINE COMPLEX
982, d4kpbA_, 0.8193, 3.09, 0.251, 389, 378, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM-3 R47E MUTANT
983, d3nc5B_, 0.8193, 3.09, 0.251, 389, 378, CYP134A1 STRUCTURE WITH AN OPEN SUBSTRATE BINDING LOOP
984, d3awmA_, 0.8192, 2.58, 0.266, 383, 364, CYTOCHROME P450SP ALPHA (CYP152B1) WILD-TYPE WITH PALMITIC ACID
985, d4bmmD1, 0.8191, 3.17, 0.149, 453, 383, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)- 2 35 -TRIFLUORO-(11 -BIPHENYL)-4-CARBOXAMIDE
986, d2zqjA_, 0.8190, 3.20, 0.162, 446, 383, SUBSTRATE-FREE FORM OF CYTOCHROME P450BSBETA
987, d4i8vB1, 0.8189, 3.26, 0.161, 449, 384, HUMAN CYTOCHROME P450 1A1 IN COMPLEX WITH ALPHA-NAPHTHOFLAVONE
988, d3p99A_, 0.8188, 3.18, 0.162, 450, 383, STEROL 14ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH DELTA7-14ALPHA-METHYLENE-CYCLOPROPYL-DIHYDROLANOSTEROL
989, d3ekdA_, 0.8188, 3.18, 0.162, 450, 383, CRYSTAL STRUCTURE OF THE A264M HEME DOMAIN OF CYTOCHROME P450 BM3
990, d1izoB_, 0.8188, 3.23, 0.151, 483, 385, CYTOCHROME P450 BS BETA COMPLEXED WITH FATTY ACID
991, p5mnvG_, 0.8187, 3.23, 0.141, 467, 383, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
992, d4du2A_, 0.8187, 3.23, 0.141, 467, 383, CYTOCHROME P450 BM3H-B7 MRI SENSOR BOUND TO DOPAMINE
993, d2x2nB_, 0.8187, 3.31, 0.137, 441, 386, X-RAY STRUCTURE OF CYP51 FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH POSACONAZOLE IN TWO DIFFERENT CONFORMATIONS
994, d3zg3A_, 0.8185, 3.16, 0.173, 431, 382, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA CRUZI IN COMPLEX WITH THE PYRIDINE INHIBITOR N-(1-(5-( TRIFLUOROMETHYL)(PYRIDIN-2-YL))PIPERIDIN-4YL)-N-(4-( TRIFLUOROMETHYL)PHENYL)PYRIDIN-3-AMINE (EPL-BS967 UDD)
995, d4uvrA1, 0.8183, 3.17, 0.173, 431, 382, BINDING MODE SELECTIVITY AND POTENCY OF N-INDOLYL- OXOPYRIDINYL-4-AMINO-PROPANYL-BASED INHIBITORS TARGETING TRYPANOSOMA CRUZI CYP51
996, d4bjkC1, 0.8183, 3.32, 0.148, 467, 384, CYP51 OF TRYPANOSOMA BRUCEI BOUND TO (S)-N-(3-(1H-INDOL-3- YL)-1-OXO-1-(PYRIDIN-4-YLAMINO)PROPAN-2-YL)-33 -DIFLUORO-( 11 -BIPHENYL)-4-CARBOXAMIDE
997, d3p99B_, 0.8183, 3.24, 0.144, 464, 382, STEROL 14ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH DELTA7-14ALPHA-METHYLENE-CYCLOPROPYL-DIHYDROLANOSTEROL
998, d2zqxA_, 0.8183, 3.18, 0.162, 448, 383, CYTOCHROME P450BSBETA COCRYSTALLIZED WITH HEPTANOIC ACID
999, d5kyoF_, 0.8182, 3.27, 0.164, 448, 384, CRYSTAL STRUCTURE OF CYP101J2
1000, d2fdwC_, 0.8182, 2.92, 0.331, 383, 369, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH THE INHIBITOR (5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
1001, p6b82A_, 0.8181, 2.92, 0.331, 383, 369, ZEBRA FISH CYP-450 17A1 MUTANT ABIRATERONE COMPLEX
1002, d4bjkD1, 0.8181, 3.04, 0.153, 450, 379, CYP51 OF TRYPANOSOMA BRUCEI BOUND TO (S)-N-(3-(1H-INDOL-3- YL)-1-OXO-1-(PYRIDIN-4-YLAMINO)PROPAN-2-YL)-33 -DIFLUORO-( 11 -BIPHENYL)-4-CARBOXAMIDE
1003, d2pg5C_, 0.8181, 3.41, 0.155, 448, 386, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q
1004, d4h6oA1, 0.8180, 3.41, 0.155, 448, 386, STEROL 14-ALPHA DEMETHYLASE (CYP51)FROM TRYPANOSOMA CRUZI IN COMPLEX WITH THE INHIBITOR NEU321 (1-(3-(4-CHLORO-35-DIMETHYLPHENOXY) BENZYL)-1H-IMIDAZOLE
1005, d1izoC_, 0.8180, 3.16, 0.144, 441, 383, CYTOCHROME P450 BS BETA COMPLEXED WITH FATTY ACID
1006, d3oo3A_, 0.8178, 3.22, 0.175, 439, 383, CRYSTAL STRUCTURE OF THE ORF6* (CYP165D3) MONOOXYGENASE INVOLVED IN TEICOPLANIN BIOSYNTHESIS
1007, d2fdyC_, 0.8178, 3.20, 0.162, 464, 382, MICROSOMAL P450 2A6 WITH THE INHIBITOR ADRITHIOL BOUND
1008, d1bvyA_, 0.8178, 3.18, 0.141, 441, 383, COMPLEX OF THE HEME AND FMN-BINDING DOMAINS OF THE CYTOCHROME P450(BM-3)
1009, d4cohB_, 0.8177, 3.25, 0.172, 440, 384, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE SULFONAMIDE DERIVATIVE OF THE 4-AMINOPYRIDYL-BASED INHIBITOR
1010, d4cohA_, 0.8176, 3.29, 0.172, 438, 383, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE SULFONAMIDE DERIVATIVE OF THE 4-AMINOPYRIDYL-BASED INHIBITOR
1011, d3m4vB_, 0.8176, 3.18, 0.175, 449, 383, CRYSTAL STRUCTURE OF THE A330P MUTANT OF CYTOCHROME P450 BM3
1012, d5e9zD_, 0.8175, 3.18, 0.146, 441, 383, CYTOCHROME P450 BM3 MUTANT M11
1013, d4ejgG_, 0.8174, 2.19, 0.277, 374, 357, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
1014, d2pg7C_, 0.8174, 3.26, 0.161, 448, 384, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q/I300V
1015, p6chiC_, 0.8173, 3.28, 0.144, 467, 383, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 AMIDE 
1016, d3p99C_, 0.8173, 3.21, 0.165, 463, 382, STEROL 14ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH DELTA7-14ALPHA-METHYLENE-CYCLOPROPYL-DIHYDROLANOSTEROL
1017, d3ekdB_, 0.8173, 2.98, 0.300, 385, 370, CRYSTAL STRUCTURE OF THE A264M HEME DOMAIN OF CYTOCHROME P450 BM3
1018, d1z11C_, 0.8173, 3.24, 0.173, 407, 382, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH METHOXSALEN BOUND
1019, d4i8vD_, 0.8172, 3.43, 0.145, 457, 385, HUMAN CYTOCHROME P450 1A1 IN COMPLEX WITH ALPHA-NAPHTHOFLAVONE
1020, d1z10C_, 0.8171, 3.25, 0.170, 407, 382, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH COUMARIN BOUND
1021, d6ay4A1, 0.8170, 3.12, 0.136, 422, 381, NAEGLERIA FOWLERI CYP51-FLUCONAZOLE COMPLEX
1022, d4bjkB1, 0.8170, 3.12, 0.136, 422, 381, CYP51 OF TRYPANOSOMA BRUCEI BOUND TO (S)-N-(3-(1H-INDOL-3- YL)-1-OXO-1-(PYRIDIN-4-YLAMINO)PROPAN-2-YL)-33 -DIFLUORO-( 11 -BIPHENYL)-4-CARBOXAMIDE
1023, p4xrzA_, 0.8169, 3.17, 0.139, 411, 382, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 6 COMPLEX
1024, d2fdvC_, 0.8169, 3.03, 0.161, 411, 378, MICROSOMAL P450 2A6 WITH THE INHIBITOR N-METHYL(5-(PYRIDIN- 3-YL)FURAN-2-YL)METHANAMINE BOUND
1025, p4xryA_, 0.8168, 3.03, 0.161, 411, 378, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 5 COMPLEX
1026, d2pg6C_, 0.8168, 3.42, 0.151, 458, 385, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 L240C/N297Q
1027, p6cizA_, 0.8167, 3.21, 0.162, 448, 383, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 NITRILE 
1028, d4i8vA_, 0.8167, 3.12, 0.136, 419, 381, HUMAN CYTOCHROME P450 1A1 IN COMPLEX WITH ALPHA-NAPHTHOFLAVONE
1029, p6cizC_, 0.8166, 3.27, 0.161, 447, 384, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 NITRILE 
1030, p6cizB_, 0.8165, 3.19, 0.144, 441, 383, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 NITRILE 
1031, d4kf0A_, 0.8165, 3.21, 0.162, 446, 383, STRUCTURE OF THE A82F P450 BM3 HEME DOMAIN
1032, d2fduC_, 0.8165, 3.13, 0.136, 419, 381, MICROSOMAL P450 2A6 WITH THE INHIBITOR NN-DIMETHYL(5- (PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
1033, d4hggB_, 0.8164, 3.27, 0.170, 407, 382, CRYSTAL STRUCTURE OF P450 BM3 5F5R HEME DOMAIN VARIANT COMPLEXED WITH STYRENE
1034, p3mdmA_, 0.8164, 3.27, 0.170, 407, 382, THIOPERAMIDE COMPLEX OF CYTOCHROME P450 46A1
1035, d4z5qA_, 0.8163, 3.24, 0.164, 446, 383, CRYSTAL STRUCTURE OF THE LNMZ CYTOCHROME P450 HYDROXYLASE FROM THE LEINAMYCIN BIOSYNTHETIC PATHWAY OF STREPTOMYCES ATROOLIVACEUS S-140 AT 1.8 A RESOLUTION
1036, d4kf2B_, 0.8162, 2.93, 0.168, 433, 375, STRUCTURE OF THE P4509 BM3 A82F F87V HEME DOMAIN
1037, d4bjkA1, 0.8162, 3.19, 0.144, 441, 383, CYP51 OF TRYPANOSOMA BRUCEI BOUND TO (S)-N-(3-(1H-INDOL-3- YL)-1-OXO-1-(PYRIDIN-4-YLAMINO)PROPAN-2-YL)-33 -DIFLUORO-( 11 -BIPHENYL)-4-CARBOXAMIDE
1038, p6chiB_, 0.8161, 3.17, 0.139, 411, 382, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 AMIDE 
1039, d2fdwD_, 0.8161, 3.28, 0.167, 470, 384, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH THE INHIBITOR (5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
1040, d1bvyB_, 0.8161, 3.28, 0.167, 470, 384, COMPLEX OF THE HEME AND FMN-BINDING DOMAINS OF THE CYTOCHROME P450(BM-3)
1041, p6chiA_, 0.8160, 3.23, 0.146, 444, 383, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 AMIDE 
1042, d6ay6A1, 0.8160, 2.78, 0.269, 388, 368, NAEGLERIA FOWLERI CYP51-VORICONAZOLE COMPLEX
1043, d4i8vC_, 0.8160, 3.44, 0.148, 451, 385, HUMAN CYTOCHROME P450 1A1 IN COMPLEX WITH ALPHA-NAPHTHOFLAVONE
1044, d2fdwB1, 0.8160, 3.20, 0.144, 441, 383, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH THE INHIBITOR (5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
1045, p4wnvC_, 0.8159, 3.20, 0.141, 441, 383, HUMAN CYTOCHROME P450 2D6 QUININE COMPLEX
1046, d2nnhB_, 0.8159, 2.78, 0.203, 384, 370, CYP2C8DH COMPLEXED WITH 2 MOLECULES OF 9-CIS RETINOIC ACID
1047, p4wnwB_, 0.8158, 3.18, 0.139, 411, 382, HUMAN CYTOCHROME P450 2D6 THIORIDAZINE COMPLEX
1048, p3tdaD_, 0.8157, 3.11, 0.139, 411, 381, COMPETITIVE REPLACEMENT OF THIORIDAZINE BY PRINOMASTAT IN CRYSTALS OF CYTOCHROME P450 2D6
1049, d2pg7B1, 0.8157, 3.17, 0.134, 411, 382, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q/I300V
1050, d1z11B1, 0.8156, 3.17, 0.134, 411, 382, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH METHOXSALEN BOUND
1051, p6chiD_, 0.8155, 3.23, 0.372, 393, 379, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 AMIDE 
1052, p5uysD_, 0.8154, 3.23, 0.144, 452, 383, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 WITH 3ALPHAOH-5ALPHA- ABIRATERONE ANALOG
1053, d4fxbB_, 0.8154, 2.79, 0.266, 388, 368, CRYSTAL STRUCTURE OF CYP105N1 FROM STREPTOMYCES COELICOLOR: A CYTOCHROME P450 OXIDASE IN THE COELIBACTIN SIDEROPHORE BIOSYNTHETIC PATHWAY
1054, d4ejhH_, 0.8154, 3.26, 0.170, 407, 382, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
1055, d4c0cA1, 0.8154, 3.27, 0.161, 441, 384, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)-4-(4-(24-DIFLUOROPHENYL)PIPERAZIN-1- YL)-2-FLUOROBENZAMIDE.
1056, p3tdaB_, 0.8153, 3.27, 0.170, 407, 382, COMPETITIVE REPLACEMENT OF THIORIDAZINE BY PRINOMASTAT IN CRYSTALS OF CYTOCHROME P450 2D6
1057, d3t3rA_, 0.8153, 3.32, 0.172, 447, 384, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH PILOCARPINE
1058, d3ebsC_, 0.8153, 3.16, 0.126, 419, 381, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PHENACETIN
1059, d5a1pA_, 0.8152, 3.47, 0.140, 461, 385, CRYSTAL STRUCTURE OF CYTOCHROME P450 3A4 BOUND TO PROGESTERONE AND CITRATE
1060, d3t3qD_, 0.8152, 3.31, 0.143, 440, 384, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PILOCARPINE
1061, d2uvnB_, 0.8151, 2.22, 0.275, 373, 356, CRYSTAL STRUCTURE OF ECONAZOLE-BOUND CYP130 FROM MYCOBACTERIUM TUBERCULOSIS
1062, d2fduD_, 0.8151, 3.29, 0.170, 407, 382, MICROSOMAL P450 2A6 WITH THE INHIBITOR NN-DIMETHYL(5- (PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
1063, p6cizD_, 0.8150, 3.29, 0.170, 407, 382, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 NITRILE 
1064, d4ejhE_, 0.8149, 3.29, 0.172, 440, 383, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
1065, d3t3qC_, 0.8149, 3.20, 0.136, 411, 382, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PILOCARPINE
1066, p3qi8B_, 0.8149, 3.34, 0.148, 471, 384, EVOLVED VARIANT OF CYTOCHROME P450 (BM3 CYP102A1)
1067, d2pg5D_, 0.8149, 3.32, 0.164, 448, 384, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q
1068, d1z10D_, 0.8149, 3.32, 0.148, 454, 384, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH COUMARIN BOUND
1069, d2nnhA_, 0.8148, 3.20, 0.139, 411, 382, CYP2C8DH COMPLEXED WITH 2 MOLECULES OF 9-CIS RETINOIC ACID
1070, d1z11D_, 0.8148, 2.71, 0.353, 380, 368, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH METHOXSALEN BOUND
1071, d5yhjA_, 0.8147, 3.24, 0.154, 443, 383, CYTOCHROME P450EX ALPHA (CYP152N1) WILD-TYPE WITH MYRISTIC ACID
1072, d2wx2A_, 0.8146, 3.25, 0.162, 444, 383, X-RAY STRUCTURE OF CYP51 FROM THE HUMAN PATHOGEN TRYPANOSOMA CRUZI IN COMPLEX WITH FLUCONAZOLE
1073, d2pg5B1, 0.8146, 3.20, 0.175, 445, 382, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q
1074, d1lgfA_, 0.8146, 3.32, 0.174, 436, 384, CRYSTAL STRUCTURE OF OXYB A CYTOCHROME P450 IMPLICATED IN AN OXIDATIVE PHENOL COUPLING REACTION DURING VANCOMYCIN BIOSYNTHESIS
1075, p5tfuB_, 0.8145, 3.32, 0.161, 447, 384, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
1076, p3tbgB_, 0.8145, 3.22, 0.162, 448, 382, HUMAN CYTOCHROME P450 2D6 WITH TWO THIORIDAZINES BOUND IN ACTIVE SITE
1077, p5uysC_, 0.8144, 3.22, 0.136, 411, 382, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 WITH 3ALPHAOH-5ALPHA- ABIRATERONE ANALOG
1078, p4xrzD_, 0.8144, 2.74, 0.207, 383, 368, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 6 COMPLEX
1079, d2pg6B1, 0.8144, 3.29, 0.172, 464, 383, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 L240C/N297Q
1080, d2fdvD_, 0.8143, 3.21, 0.160, 465, 381, MICROSOMAL P450 2A6 WITH THE INHIBITOR N-METHYL(5-(PYRIDIN- 3-YL)FURAN-2-YL)METHANAMINE BOUND
1081, d4tx3A_, 0.8142, 3.29, 0.161, 441, 384, COMPLEX OF THE X-DOMAIN AND OXYB FROM TEICOPLANIN BIOSYNTHESIS
1082, d4ruiA_, 0.8142, 3.28, 0.172, 463, 383, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2A6 IN COMPLEX WITH A MONOTERPENE - SABINENE.
1083, p3tbgD_, 0.8142, 3.23, 0.170, 434, 383, HUMAN CYTOCHROME P450 2D6 WITH TWO THIORIDAZINES BOUND IN ACTIVE SITE
1084, d2pg6D_, 0.8142, 3.22, 0.139, 411, 382, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 L240C/N297Q
1085, p5uysA_, 0.8141, 2.63, 0.331, 371, 362, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 WITH 3ALPHAOH-5ALPHA- ABIRATERONE ANALOG
1086, d1z10B1, 0.8141, 3.29, 0.172, 464, 383, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH COUMARIN BOUND
1087, d1og5B_, 0.8141, 3.16, 0.150, 439, 379, STRUCTURE OF HUMAN CYTOCHROME P450 CYP2C9
1088, p5uysB_, 0.8140, 3.25, 0.172, 445, 383, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 WITH 3ALPHAOH-5ALPHA- ABIRATERONE ANALOG
1089, p4xryB_, 0.8140, 3.24, 0.172, 442, 383, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 5 COMPLEX
1090, p5irqC_, 0.8139, 3.25, 0.144, 438, 383, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITORS (R)- AND (S)- ORTERONEL
1091, p4wnvB_, 0.8138, 3.41, 0.148, 444, 385, HUMAN CYTOCHROME P450 2D6 QUININE COMPLEX
1092, p4wntA_, 0.8138, 3.24, 0.168, 463, 382, HUMAN CYTOCHROME P450 2D6 AJMALICINE COMPLEX
1093, d2vn0A_, 0.8138, 3.30, 0.172, 464, 383, CYP2C8DH COMPLEXED WITH TROGLITAZONE
1094, d2fduB_, 0.8138, 3.29, 0.162, 465, 382, MICROSOMAL P450 2A6 WITH THE INHIBITOR NN-DIMETHYL(5- (PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
1095, d1z11A1, 0.8138, 3.22, 0.165, 444, 382, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH METHOXSALEN BOUND
1096, p4j14A_, 0.8137, 3.26, 0.141, 455, 383, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 CYP46A1 WITH POSACONAZOLE BOUND
1097, d3t3qB_, 0.8137, 3.30, 0.172, 464, 383, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PILOCARPINE
1098, p3mdrA_, 0.8137, 3.24, 0.150, 467, 381, TRANYLCYPROMINE COMPLEX OF CYTOCHROME P450 46A1
1099, d3hf2A_, 0.8137, 3.30, 0.172, 464, 383, CRYSTAL STRUCTURE OF THE I401P MUTANT OF CYTOCHROME P450 BM3
1100, p4xrzC_, 0.8136, 3.33, 0.169, 448, 384, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 6 COMPLEX
1101, d4ejjA_, 0.8136, 3.33, 0.169, 448, 384, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH NICOTINE
1102, p5e0eA_, 0.8135, 3.35, 0.161, 447, 384, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B37 FROM DESERT WOODRAT IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
1103, d4ejiA_, 0.8135, 3.50, 0.145, 457, 385, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH TWO MOLECULES OF 4- (METHYLNITROSAMINO)-1-(3-PURIDYL)-1-BUTANONE
1104, p3rukD_, 0.8135, 3.30, 0.172, 464, 383, HUMAN CYTOCHROME P450 CYP17A1 IN COMPLEX WITH ABIRATERONE
1105, d3ebsB1, 0.8135, 3.31, 0.144, 464, 381, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PHENACETIN
1106, d2ve4A_, 0.8135, 3.30, 0.172, 464, 383, SUBSTRATE FREE CYANOBACTERIAL CYP120A1
1107, d2pg7D_, 0.8135, 3.33, 0.162, 457, 382, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q/I300V
1108, d1og5A_, 0.8135, 3.42, 0.151, 477, 385, STRUCTURE OF HUMAN CYTOCHROME P450 CYP2C9
1109, d5a1rA_, 0.8134, 3.23, 0.163, 464, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450 3A4 BOUND TO PROGESTERONE
1110, d4uqhA1, 0.8134, 3.32, 0.162, 458, 382, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)-4-(4-(34-DIFLUOROPHENYL)PIPERAZIN-1- YL)-2-FLUOROBENZAMIDE.
1111, d4ejhC_, 0.8134, 3.45, 0.151, 451, 384, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
1112, d1tqnA_, 0.8134, 3.30, 0.172, 464, 383, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 3A4
1113, d5tl8A1, 0.8133, 3.39, 0.154, 441, 383, NAEGLERIA FOWLERI CYP51-POSACONAZOLE COMPLEX
1114, p3mdrB_, 0.8133, 3.07, 0.167, 435, 377, TRANYLCYPROMINE COMPLEX OF CYTOCHROME P450 46A1
1115, d4ejgH_, 0.8132, 2.50, 0.338, 363, 358, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
1116, d1og2A_, 0.8132, 3.43, 0.151, 448, 384, STRUCTURE OF HUMAN CYTOCHROME P450 CYP2C9
1117, d4ejhD_, 0.8131, 3.34, 0.161, 447, 384, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
1118, d4ejgA_, 0.8131, 3.32, 0.160, 457, 382, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
1119, d2fdwA_, 0.8131, 3.34, 0.175, 464, 383, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH THE INHIBITOR (5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
1120, d4ruiB1, 0.8130, 3.16, 0.151, 438, 378, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2A6 IN COMPLEX WITH A MONOTERPENE - SABINENE.
1121, d4r21B_, 0.8130, 3.33, 0.165, 455, 382, ZEBRA FISH CYTOCHROME P450 17A2 WITH PROGESTERONE
1122, d4nz2A1, 0.8130, 3.34, 0.172, 446, 383, CRYSTAL STRUCTURE OF CYP2C9 IN COMPLEX WITH AN INHIBITOR
1123, p4nkvB_, 0.8130, 3.35, 0.149, 468, 383, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH INHIBITOR ABIRATERONE
1124, d4gqsA1, 0.8130, 3.37, 0.172, 463, 383, STRUCTURE OF HUMAN MICROSOMAL CYTOCHROME P450 (CYP) 2C19
1125, d4ejgE1, 0.8130, 3.28, 0.145, 454, 379, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
1126, d2ve4B_, 0.8130, 3.18, 0.163, 463, 381, SUBSTRATE FREE CYANOBACTERIAL CYP120A1
1127, d2pg7A_, 0.8130, 3.51, 0.141, 452, 384, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q/I300V
1128, d2fdvB1, 0.8130, 3.32, 0.152, 456, 382, MICROSOMAL P450 2A6 WITH THE INHIBITOR N-METHYL(5-(PYRIDIN- 3-YL)FURAN-2-YL)METHANAMINE BOUND
1129, p4wnvD_, 0.8129, 3.37, 0.172, 463, 383, HUMAN CYTOCHROME P450 2D6 QUININE COMPLEX
1130, d4ruiF1, 0.8129, 3.36, 0.172, 463, 383, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2A6 IN COMPLEX WITH A MONOTERPENE - SABINENE.
1131, d1suoA1, 0.8129, 3.29, 0.155, 456, 381, STRUCTURE OF MAMMALIAN CYTOCHROME P450 2B4 WITH BOUND 4-(4- CHLOROPHENYL)IMIDAZOLE
1132, d4ruiE1, 0.8128, 3.17, 0.153, 462, 379, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2A6 IN COMPLEX WITH A MONOTERPENE - SABINENE.
1133, d4ejjC_, 0.8128, 2.55, 0.361, 370, 360, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH NICOTINE
1134, d3t3qA_, 0.8128, 3.29, 0.160, 459, 382, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PILOCARPINE
1135, p3swzA_, 0.8128, 3.37, 0.174, 443, 385, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH TOK-001
1136, d3ibdA1, 0.8128, 3.41, 0.146, 456, 383, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2B6 GENETIC VARIANT IN COMPLEX WITH THE INHIBITOR 4-(4-CHLOROPHENYL)IMIDAZOLE
1137, d3ebsD_, 0.8128, 3.33, 0.175, 463, 383, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PHENACETIN
1138, d4ruiD1, 0.8127, 3.33, 0.175, 464, 383, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2A6 IN COMPLEX WITH A MONOTERPENE - SABINENE.
1139, d4ejjB_, 0.8127, 3.23, 0.207, 465, 382, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH NICOTINE
1140, d2pg5A_, 0.8127, 3.33, 0.172, 463, 383, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q
1141, d2fdyD_, 0.8127, 3.35, 0.280, 391, 372, MICROSOMAL P450 2A6 WITH THE INHIBITOR ADRITHIOL BOUND
1142, d1og2B_, 0.8127, 3.35, 0.175, 464, 383, STRUCTURE OF HUMAN CYTOCHROME P450 CYP2C9
1143, d4kf0B_, 0.8126, 3.27, 0.163, 457, 381, STRUCTURE OF THE A82F P450 BM3 HEME DOMAIN
1144, d4gqsB1, 0.8126, 3.25, 0.165, 464, 382, STRUCTURE OF HUMAN MICROSOMAL CYTOCHROME P450 (CYP) 2C19
1145, d4ejhA_, 0.8126, 3.28, 0.176, 463, 381, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
1146, d3t3rC_, 0.8126, 3.27, 0.155, 452, 380, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH PILOCARPINE
1147, d3t3sC_, 0.8125, 3.35, 0.175, 464, 383, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
1148, d2fduA_, 0.8125, 3.35, 0.175, 464, 383, MICROSOMAL P450 2A6 WITH THE INHIBITOR NN-DIMETHYL(5- (PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
1149, p5tfuD_, 0.8124, 3.21, 0.160, 463, 381, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
1150, p5irqB_, 0.8124, 3.35, 0.175, 464, 383, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITORS (R)- AND (S)- ORTERONEL
1151, p4nkvC_, 0.8124, 3.06, 0.162, 406, 376, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH INHIBITOR ABIRATERONE
1152, d2fdvA_, 0.8123, 3.47, 0.174, 441, 384, MICROSOMAL P450 2A6 WITH THE INHIBITOR N-METHYL(5-(PYRIDIN- 3-YL)FURAN-2-YL)METHANAMINE BOUND
1153, d6aybA1, 0.8122, 3.38, 0.172, 463, 383, NAEGLERIA FOWLERI CYP51-KETOCONAZOLE COMPLEX
1154, p5irvD_, 0.8122, 3.19, 0.278, 388, 371, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITOR VT-464
1155, d1z10A_, 0.8121, 3.19, 0.278, 388, 371, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH COUMARIN BOUND
1156, p4nkwA_, 0.8120, 3.33, 0.145, 451, 380, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PREGNENOLONE
1157, d4ejhF_, 0.8120, 3.32, 0.144, 456, 381, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
1158, d4ejgC_, 0.8120, 3.27, 0.163, 462, 380, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
1159, d4ruiC_, 0.8119, 3.36, 0.150, 455, 381, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2A6 IN COMPLEX WITH A MONOTERPENE - SABINENE.
1160, d4nz2B1, 0.8119, 3.35, 0.170, 463, 382, CRYSTAL STRUCTURE OF CYP2C9 IN COMPLEX WITH AN INHIBITOR
1161, p4fiaA_, 0.8119, 3.31, 0.175, 464, 382, CRYSTAL STRUCTURE OF HUMAN CYP46A1 P450 WITH BICALUTAMIDE BOUND
1162, d4e2pA_, 0.8119, 2.65, 0.316, 373, 361, CRYSTAL STRUCTURE OF A POST-TAILORING HYDROXYLASE (HMTN) INVOLVED IN THE HIMASTATIN BIOSYNTHESIS
1163, d2nniA_, 0.8119, 3.28, 0.175, 464, 382, CYP2C8DH COMPLEXED WITH MONTELUKAST
1164, d4ejhB_, 0.8118, 3.36, 0.144, 456, 382, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
1165, d3t3rD1, 0.8118, 3.31, 0.175, 464, 382, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH PILOCARPINE
1166, p5irvC_, 0.8117, 3.33, 0.163, 460, 381, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITOR VT-464
1167, p4nkwB_, 0.8117, 3.39, 0.172, 463, 383, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PREGNENOLONE
1168, p4nkvA_, 0.8117, 3.21, 0.178, 461, 381, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH INHIBITOR ABIRATERONE
1169, d4hgfB_, 0.8117, 3.31, 0.163, 459, 381, CRYSTAL STRUCTURE OF P450 BM3 5F5K HEME DOMAIN VARIANT COMPLEXED WITH STYRENE
1170, d1nr6A1, 0.8117, 3.47, 0.146, 455, 383, MICROSOMAL CYTOCHROME P450 2C5/3LVDH COMPLEX WITH DICLOFENAC
1171, d3t3rB_, 0.8116, 3.28, 0.163, 461, 380, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH PILOCARPINE
1172, d1io9A_, 0.8116, 3.32, 0.142, 455, 380, THERMOPHILIC CYTOCHROME P450 (CYP119) FROM SULFOLOBUS SOLFATARICUS: HIGH RESOLUTION STRUCTURAL ORIGIN OF ITS THERMOSTABILITY AND FUNCTIONAL PROPERTIES
1173, p4nkyC_, 0.8115, 3.51, 0.146, 457, 384, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPROGESTERONE
1174, p3mdvB_, 0.8115, 3.21, 0.163, 464, 381, CLOTRIMAZOLE COMPLEX OF CYTOCHROME P450 46A1
1175, p3mdvA_, 0.8115, 3.21, 0.163, 464, 381, CLOTRIMAZOLE COMPLEX OF CYTOCHROME P450 46A1
1176, d6bczA_, 0.8114, 3.39, 0.172, 463, 383, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
1177, p3rukB_, 0.8114, 3.35, 0.170, 465, 382, HUMAN CYTOCHROME P450 CYP17A1 IN COMPLEX WITH ABIRATERONE
1178, d3ebsA_, 0.8114, 3.15, 0.167, 436, 378, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PHENACETIN
1179, d2pg6A_, 0.8114, 3.15, 0.167, 436, 378, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 L240C/N297Q
1180, d2p85E_, 0.8114, 3.35, 0.170, 463, 382, STRUCTURE OF HUMAN LUNG CYTOCHROME P450 2A13 WITH INDOLE BOUND IN TWO ALTERNATE CONFORMATIONS
1181, d1n6bA1, 0.8113, 3.06, 0.168, 427, 376, MICROSOMAL CYTOCHROME P450 2C5/3LVDH COMPLEX WITH A DIMETHYL DERIVATIVE OF SULFAPHENAZOLE
1182, d3t3sD_, 0.8112, 3.35, 0.142, 428, 381, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
1183, p6cirC_, 0.8111, 3.41, 0.149, 455, 382, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 OXIME 
1184, p5irqA_, 0.8111, 3.36, 0.175, 465, 383, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITORS (R)- AND (S)- ORTERONEL
1185, p3rukA_, 0.8110, 3.25, 0.152, 463, 382, HUMAN CYTOCHROME P450 CYP17A1 IN COMPLEX WITH ABIRATERONE
1186, d2nnjA_, 0.8110, 3.28, 0.168, 464, 382, CYP2C8DH COMPLEXED WITH FELODIPINE
1187, d2fdyA_, 0.8110, 3.19, 0.161, 462, 379, MICROSOMAL P450 2A6 WITH THE INHIBITOR ADRITHIOL BOUND
1188, d4ejgB_, 0.8109, 3.39, 0.172, 464, 383, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
1189, d6bdiA_, 0.8108, 3.22, 0.203, 431, 379, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
1190, d5veuI_, 0.8108, 3.31, 0.175, 464, 382, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
1191, d4gqsC1, 0.8108, 3.22, 0.186, 461, 381, STRUCTURE OF HUMAN MICROSOMAL CYTOCHROME P450 (CYP) 2C19
1192, d4ejgD1, 0.8108, 3.22, 0.210, 462, 381, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
1193, p3rukC_, 0.8108, 3.41, 0.171, 439, 385, HUMAN CYTOCHROME P450 CYP17A1 IN COMPLEX WITH ABIRATERONE
1194, d1pq2A_, 0.8108, 3.25, 0.160, 464, 381, CRYSTAL STRUCTURE OF HUMAN DRUG METABOLIZING CYTOCHROME P450 2C8
1195, p5tftD_, 0.8107, 3.32, 0.204, 468, 383, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
1196, p4nkwD_, 0.8107, 3.36, 0.173, 446, 382, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PREGNENOLONE
1197, d4hggA_, 0.8107, 3.07, 0.168, 425, 376, CRYSTAL STRUCTURE OF P450 BM3 5F5R HEME DOMAIN VARIANT COMPLEXED WITH STYRENE
1198, p6cirD_, 0.8106, 3.37, 0.157, 458, 383, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 OXIME 
1199, p6cirA_, 0.8106, 3.23, 0.178, 461, 381, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 OXIME 
1200, p4nkyA_, 0.8106, 3.30, 0.165, 464, 382, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPROGESTERONE
1201, p4nkxC_, 0.8106, 3.26, 0.163, 464, 381, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PROGESTERONE
1202, d4i3qA_, 0.8106, 3.30, 0.171, 465, 381, CRYSTAL STRUCTURE OF HUMAN CYP3A4 COORDINATED TO A WATER MOLECULE
1203, d4hgfA_, 0.8106, 3.30, 0.175, 464, 382, CRYSTAL STRUCTURE OF P450 BM3 5F5K HEME DOMAIN VARIANT COMPLEXED WITH STYRENE
1204, d4ejjD_, 0.8106, 3.16, 0.173, 423, 376, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH NICOTINE
1205, d1se6A1, 0.8106, 3.16, 0.173, 423, 376, CRYSTAL STRUCTURE OF STREPTOMYCES COELICOLOR A3(2) CYP158A2 FROM ANTIBIOTIC BIOSYNTHETIC PATHWAYS
1206, d5a5jA1, 0.8105, 3.22, 0.178, 462, 381, CYTOCHROME 2C9 P450 INHIBITOR COMPLEX
1207, d3ua5A1, 0.8105, 3.39, 0.162, 456, 382, CRYSTAL STRUCTURE OF P450 2B6 (Y226H/K262R) IN COMPLEX WITH TWO MOLECULES OF AMLODIPINE
1208, d1pq2B_, 0.8105, 3.26, 0.188, 461, 382, CRYSTAL STRUCTURE OF HUMAN DRUG METABOLIZING CYTOCHROME P450 2C8
1209, p5irvA_, 0.8104, 3.27, 0.162, 464, 382, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITOR VT-464
1210, d3t3sB_, 0.8103, 3.26, 0.211, 432, 379, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
1211, d2p85C_, 0.8103, 3.31, 0.171, 464, 381, STRUCTURE OF HUMAN LUNG CYTOCHROME P450 2A13 WITH INDOLE BOUND IN TWO ALTERNATE CONFORMATIONS
1212, p5tfuC_, 0.8102, 3.40, 0.172, 463, 383, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
1213, p4nkxB_, 0.8102, 3.28, 0.145, 453, 379, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PROGESTERONE
1214, d3t3sA_, 0.8102, 3.30, 0.175, 464, 382, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
1215, p6cirB_, 0.8101, 3.37, 0.170, 464, 383, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 OXIME 
1216, d5veuC_, 0.8101, 3.30, 0.175, 464, 382, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
1217, d4ejgF1, 0.8101, 3.35, 0.173, 464, 382, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
1218, d3ua5B1, 0.8101, 3.32, 0.175, 463, 382, CRYSTAL STRUCTURE OF P450 2B6 (Y226H/K262R) IN COMPLEX WITH TWO MOLECULES OF AMLODIPINE
1219, p3swzC_, 0.8101, 3.36, 0.162, 460, 382, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH TOK-001
1220, d6bd7A_, 0.8100, 3.33, 0.159, 462, 383, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
1221, p4wntB_, 0.8100, 3.32, 0.175, 464, 382, HUMAN CYTOCHROME P450 2D6 AJMALICINE COMPLEX
1222, p4nkyB_, 0.8100, 3.36, 0.172, 464, 383, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPROGESTERONE
1223, p4nkxA_, 0.8099, 3.38, 0.175, 464, 383, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PROGESTERONE
1224, p3me6A_, 0.8099, 3.37, 0.170, 464, 382, CRYSTAL STRUCTURE OF CYTOCHROME 2B4 IN COMPLEX WITH THE ANTI-PLATELET DRUG CLOPIDOGREL
1225, p5irvB_, 0.8098, 3.33, 0.175, 464, 382, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITOR VT-464
1226, p3me6C_, 0.8098, 3.22, 0.178, 461, 381, CRYSTAL STRUCTURE OF CYTOCHROME 2B4 IN COMPLEX WITH THE ANTI-PLATELET DRUG CLOPIDOGREL
1227, d1r9oA1, 0.8098, 3.47, 0.149, 441, 382, CRYSTAL STRUCTURE OF P4502C9 WITH FLURBIPROFEN BOUND
1228, d6bdkA_, 0.8097, 3.23, 0.192, 455, 381, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
1229, p5irqD_, 0.8097, 3.30, 0.168, 464, 382, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITORS (R)- AND (S)- ORTERONEL
1230, p3swzB_, 0.8097, 3.32, 0.175, 463, 382, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH TOK-001
1231, p3me6D_, 0.8097, 3.31, 0.165, 464, 382, CRYSTAL STRUCTURE OF CYTOCHROME 2B4 IN COMPLEX WITH THE ANTI-PLATELET DRUG CLOPIDOGREL
1232, d2fdyB1, 0.8097, 3.37, 0.170, 465, 382, MICROSOMAL P450 2A6 WITH THE INHIBITOR ADRITHIOL BOUND
1233, p4enhA_, 0.8096, 3.37, 0.145, 453, 380, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 CYP46A1 WITH FLUVOXAMINE BOUND
1234, d1io8A_, 0.8096, 3.36, 0.163, 456, 381, THERMOPHILIC CYTOCHROME P450 (CYP119) FROM SULFOLOBUS SOLFATARICUS: HIGH RESOLUTION STRUCTURAL ORIGIN OF ITS THERMOSTABILITY AND FUNCTIONAL PROPERTIES
1235, d1io7A_, 0.8096, 3.30, 0.163, 460, 380, THERMOPHILIC CYTOCHROME P450 (CYP119) FROM SULFOLOBUS SOLFATARICUS: HIGH RESOLUTION STRUCTURAL ORIGIN OF ITS THERMOSTABILITY AND FUNCTIONAL PROPERTIES
1236, d4d75A_, 0.8095, 3.38, 0.170, 465, 382, CYTOCHROME P450 3A4 BOUND TO AN INHIBITOR
1237, p3me6B_, 0.8095, 3.32, 0.173, 445, 381, CRYSTAL STRUCTURE OF CYTOCHROME 2B4 IN COMPLEX WITH THE ANTI-PLATELET DRUG CLOPIDOGREL
1238, p3tk3B_, 0.8093, 3.28, 0.158, 461, 380, CYTOCHROME P450 2B4 MUTANT L437A IN COMPLEX WITH 4-(4-CHLOROPHENYL) IMIDAZOLE
1239, d3dgiB_, 0.8093, 3.38, 0.170, 465, 382, CRYSTAL STRUCTURE OF F87A/T268A MUTANT OF CYP BM3
1240, p3swzD_, 0.8092, 3.38, 0.170, 465, 382, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH TOK-001
1241, d2p85D_, 0.8092, 3.38, 0.163, 453, 381, STRUCTURE OF HUMAN LUNG CYTOCHROME P450 2A13 WITH INDOLE BOUND IN TWO ALTERNATE CONFORMATIONS
1242, p4nkwC_, 0.8091, 3.32, 0.165, 464, 382, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PREGNENOLONE
1243, p3tk3A_, 0.8091, 3.28, 0.163, 464, 381, CYTOCHROME P450 2B4 MUTANT L437A IN COMPLEX WITH 4-(4-CHLOROPHENYL) IMIDAZOLE
1244, d3ua1A_, 0.8090, 3.32, 0.175, 464, 382, CRYSTAL STRUCTURE OF THE CYTOCHROME P4503A4-BROMOERGOCRYPTINE COMPLEX
1245, p3tk3D_, 0.8090, 3.24, 0.178, 462, 381, CYTOCHROME P450 2B4 MUTANT L437A IN COMPLEX WITH 4-(4-CHLOROPHENYL) IMIDAZOLE
1246, p3mdtB_, 0.8090, 3.12, 0.167, 426, 377, VORICONAZOLE COMPLEX OF CYTOCHROME P450 46A1
1247, p3lc4A_, 0.8090, 2.57, 0.344, 370, 358, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH OMEGA-IMIDAZOLYL-DODECANOIC ACID
1248, p3kohB_, 0.8090, 2.57, 0.344, 370, 358, CYTOCHROME P450 2E1 WITH OMEGA-IMIDAZOLYL OCTANOIC ACID
1249, p5tfuA_, 0.8089, 3.25, 0.160, 463, 381, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
1250, d4r21A_, 0.8089, 3.31, 0.165, 464, 382, ZEBRA FISH CYTOCHROME P450 17A2 WITH PROGESTERONE
1251, d5vcgA_, 0.8088, 3.39, 0.170, 463, 382, CRYSTAL STRUCTURE OF THE CYSTEINE DEPLETED CYP3A4 BOUND TO BROMOERGOCRYPTINE
1252, p3tk3C_, 0.8088, 3.29, 0.158, 464, 380, CYTOCHROME P450 2B4 MUTANT L437A IN COMPLEX WITH 4-(4-CHLOROPHENYL) IMIDAZOLE
1253, d3b4xA_, 0.8088, 3.29, 0.158, 464, 380, CRYSTAL STRUCTURE ANALYSIS OF SULFOLOBUS TOKODAII STRAIN7 CYTOCHROM P450
1254, p4nkxD_, 0.8087, 3.36, 0.165, 453, 381, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PROGESTERONE
1255, p4nkvD_, 0.8087, 3.35, 0.163, 455, 381, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH INHIBITOR ABIRATERONE
1256, d6bd8A_, 0.8086, 3.46, 0.152, 441, 381, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
1257, p4xryD_, 0.8086, 3.31, 0.164, 461, 383, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 5 COMPLEX
1258, p4nkzB_, 0.8086, 3.31, 0.171, 463, 381, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPREGNENOLONE
1259, p5k7kA_, 0.8085, 2.37, 0.295, 366, 353, DESIGN AND OPTIMIZATION OF BIARYL ETHER ARYL SULFONAMIDES AS SELECTIVE INHIBITORS OF NAV1.7: DISCOVERY OF CLINICAL CANDIDATE PF-05089771
1260, p4wnuD_, 0.8085, 3.26, 0.153, 456, 379, HUMAN CYTOCHROME P450 2D6 QUINIDINE COMPLEX
1261, p3kohA_, 0.8085, 3.07, 0.168, 424, 375, CYTOCHROME P450 2E1 WITH OMEGA-IMIDAZOLYL OCTANOIC ACID
1262, p4nkzA_, 0.8082, 3.07, 0.168, 424, 375, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPREGNENOLONE
1263, d3t3sF_, 0.8082, 3.19, 0.213, 461, 380, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
1264, d2q6nG1, 0.8082, 3.38, 0.163, 454, 381, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
1265, p4nkyD_, 0.8081, 3.31, 0.171, 465, 381, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPROGESTERONE
1266, p4nkzC_, 0.8078, 3.32, 0.171, 465, 381, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPREGNENOLONE
1267, p2q9gA_, 0.8078, 3.33, 0.165, 464, 382, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 46A1
1268, d1lg9A_, 0.8078, 3.36, 0.169, 461, 384, CRYSTAL STRUCTURE OF OXYB A CYTOCHROME P450 IMPLICATED IN AN OXIDATIVE PHENOL COUPLING REACTION DURING VANCOMYCIN BIOSYNTHESIS
1269, d3qu8A1, 0.8077, 3.28, 0.160, 464, 381, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-(4-NITROBENZYL)PYRIDINE.
1270, d3na0A_, 0.8077, 3.27, 0.158, 461, 379, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH 2022- DIHYDROXYCHOLESTEROL
1271, d5vccA_, 0.8076, 3.33, 0.155, 455, 380, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO GLYCEROL
1272, p4wnuB_, 0.8076, 3.31, 0.158, 453, 380, HUMAN CYTOCHROME P450 2D6 QUINIDINE COMPLEX
1273, d3uasA1, 0.8076, 3.26, 0.165, 463, 381, CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR 9-ETHYNYLPHENANTHRENE
1274, d3na0B_, 0.8076, 3.32, 0.171, 465, 381, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH 2022- DIHYDROXYCHOLESTEROL
1275, d5x23A_, 0.8075, 3.32, 0.168, 464, 382, CRYSTAL STRUCTURE OF CYP2C9 GENETIC VARIANT A477T (*30) IN COMPLEX WITH MULTIPLE LOSARTAN MOLECULES
1276, p4wnuA_, 0.8075, 3.13, 0.214, 462, 378, HUMAN CYTOCHROME P450 2D6 QUINIDINE COMPLEX
1277, d3t3sE_, 0.8075, 3.31, 0.186, 464, 381, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
1278, d6bd5A_, 0.8074, 3.25, 0.186, 461, 381, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
1279, d3na1A_, 0.8074, 3.34, 0.168, 464, 382, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH 20- HYDROXYCHOLESTEROL
1280, p3lc4B_, 0.8074, 3.18, 0.159, 461, 378, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH OMEGA-IMIDAZOLYL-DODECANOIC ACID
1281, d2p85F_, 0.8074, 3.26, 0.163, 463, 381, STRUCTURE OF HUMAN LUNG CYTOCHROME P450 2A13 WITH INDOLE BOUND IN TWO ALTERNATE CONFORMATIONS
1282, d5vcdA_, 0.8073, 3.38, 0.145, 453, 380, CRYSTAL STRUCTURE OF THE CYSTEINE DEPLETED CYP3A4 BOUND TO GLYCEROL
1283, d3na1B_, 0.8073, 3.31, 0.153, 456, 379, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH 20- HYDROXYCHOLESTEROL
1284, p3mdtA_, 0.8073, 3.33, 0.158, 435, 379, VORICONAZOLE COMPLEX OF CYTOCHROME P450 46A1
1285, p3e6iA_, 0.8073, 3.21, 0.159, 459, 378, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH THE INHIBITOR INDAZOLE
1286, d2p85A_, 0.8073, 3.39, 0.163, 455, 381, STRUCTURE OF HUMAN LUNG CYTOCHROME P450 2A13 WITH INDOLE BOUND IN TWO ALTERNATE CONFORMATIONS
1287, p5iuzB_, 0.8072, 3.35, 0.153, 451, 380, STRUCTURE OF P450 2B4 F202W MUTANT (CYMAL-5)
1288, p3t3zA_, 0.8072, 3.20, 0.164, 458, 378, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH PILOCARPINE
1289, p4nkzD_, 0.8071, 3.24, 0.207, 465, 381, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPREGNENOLONE
1290, p3t3zB_, 0.8070, 3.45, 0.157, 442, 381, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH PILOCARPINE
1291, d3t3sH_, 0.8070, 3.40, 0.172, 464, 383, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
1292, d3t3sG_, 0.8070, 2.85, 0.335, 382, 367, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
1293, p3e6iB_, 0.8070, 3.42, 0.185, 452, 384, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH THE INHIBITOR INDAZOLE
1294, p4wnuC_, 0.8069, 3.29, 0.162, 464, 382, HUMAN CYTOCHROME P450 2D6 QUINIDINE COMPLEX
1295, d3tmzA1, 0.8069, 3.27, 0.163, 463, 381, CRYSTAL STRUCTURE OF P450 2B4(H226Y) IN COMPLEX WITH AMLODIPINE
1296, d5xxiA_, 0.8068, 3.33, 0.158, 460, 380, CRYSTAL STRUCTURE OF CYP2C9 IN COMPLEX WITH MULTIPLE LOSARTAN MOLECULES
1297, d5te8B_, 0.8068, 3.35, 0.165, 464, 382, CRYSTAL STRUCTURE OF THE MIDAZOLAM-BOUND HUMAN CYP3A4
1298, p5tftC_, 0.8067, 3.32, 0.165, 464, 382, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
1299, d3n9yB_, 0.8067, 3.41, 0.145, 450, 380, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH CHOLESTEROL
1300, d3n9yA_, 0.8067, 3.38, 0.160, 457, 381, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH CHOLESTEROL
1301, p3e4eA_, 0.8067, 3.33, 0.168, 464, 382, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH THE INHIBITOR 4- METHYLPYRAZOLE
1302, p5wbgB_, 0.8066, 3.35, 0.155, 455, 380, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH AN ANALOG OF A DRUG EFAVIRENZ 
1303, p5e58D_, 0.8066, 3.35, 0.186, 469, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B35 FROM DESERT WOODRAT NEOTOMA LEPIDA IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
1304, d3n9zA_, 0.8066, 3.34, 0.165, 464, 382, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH 22- HYDROXYCHOLESTEROL
1305, p5iuzA_, 0.8064, 3.26, 0.150, 461, 381, STRUCTURE OF P450 2B4 F202W MUTANT (CYMAL-5)
1306, p3t3zC_, 0.8064, 3.29, 0.158, 459, 379, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH PILOCARPINE
1307, p3r1aC_, 0.8064, 3.23, 0.213, 462, 381, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1308, d3n9zB_, 0.8064, 3.43, 0.150, 455, 381, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH 22- HYDROXYCHOLESTEROL
1309, p3e4eB_, 0.8064, 3.41, 0.155, 453, 381, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH THE INHIBITOR 4- METHYLPYRAZOLE
1310, p5e58A_, 0.8062, 3.37, 0.160, 455, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B35 FROM DESERT WOODRAT NEOTOMA LEPIDA IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
1311, d3qu8C1, 0.8062, 3.35, 0.178, 465, 382, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-(4-NITROBENZYL)PYRIDINE.
1312, d2q6nF1, 0.8062, 3.27, 0.158, 460, 379, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
1313, p5wbgC_, 0.8060, 3.41, 0.172, 465, 383, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH AN ANALOG OF A DRUG EFAVIRENZ 
1314, p5wbgF_, 0.8059, 3.42, 0.185, 453, 384, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH AN ANALOG OF A DRUG EFAVIRENZ 
1315, d5te8A_, 0.8059, 3.15, 0.217, 461, 378, CRYSTAL STRUCTURE OF THE MIDAZOLAM-BOUND HUMAN CYP3A4
1316, p4xryC_, 0.8059, 3.30, 0.161, 454, 379, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 5 COMPLEX
1317, d3qu8B1, 0.8059, 3.36, 0.155, 454, 380, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-(4-NITROBENZYL)PYRIDINE.
1318, d4ny4A_, 0.8058, 3.35, 0.178, 465, 382, CRYSTAL STRUCTURE OF CYP3A4 IN COMPLEX WITH AN INHIBITOR
1319, p3t3zD_, 0.8058, 3.43, 0.170, 463, 382, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH PILOCARPINE
1320, d1w0fA_, 0.8058, 3.10, 0.168, 426, 375, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 3A4
1321, d5x24A_, 0.8057, 2.40, 0.295, 366, 353, CRYSTAL STRUCTURE OF CYP2C9 GENETIC VARIANT I359L (*3) IN COMPLEX WITH MULTIPLE LOSARTAN MOLECULES
1322, p5wbgA_, 0.8057, 2.40, 0.295, 366, 353, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH AN ANALOG OF A DRUG EFAVIRENZ 
1323, d5veuF_, 0.8057, 3.24, 0.207, 460, 381, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
1324, p3r1aG_, 0.8057, 3.42, 0.172, 465, 383, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1325, p3gphA_, 0.8057, 3.42, 0.172, 465, 383, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH OMEGA-IMIDAZOLYL-DECANOIC ACID
1326, d5vceA_, 0.8056, 3.04, 0.151, 425, 372, CRYSTAL STRUCTURE OF THE CYSTEINE DEPLETED CYP3A4 BOUND TO RITONAVIR
1327, p3gphB_, 0.8056, 3.29, 0.161, 455, 379, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH OMEGA-IMIDAZOLYL-DECANOIC ACID
1328, d6bdmA_, 0.8055, 3.35, 0.165, 464, 382, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
1329, p5wbgD_, 0.8055, 3.24, 0.159, 456, 378, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH AN ANALOG OF A DRUG EFAVIRENZ 
1330, d4k9vA_, 0.8055, 3.42, 0.172, 465, 383, COMPLEX OF CYP3A4 WITH A DESOXYRITONAVIR ANALOG
1331, d3hf2B_, 0.8055, 3.27, 0.213, 456, 380, CRYSTAL STRUCTURE OF THE I401P MUTANT OF CYTOCHROME P450 BM3
1332, p5wbgE_, 0.8053, 3.43, 0.172, 465, 383, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH AN ANALOG OF A DRUG EFAVIRENZ 
1333, d5ex6B_, 0.8053, 3.09, 0.168, 424, 375, STRUCTURE OF P450 STAH FROM GLYCOPEPTIDE ANTIBIOTIC A47934 BIOSYNTHESIS
1334, p5e58B_, 0.8053, 3.36, 0.181, 460, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B35 FROM DESERT WOODRAT NEOTOMA LEPIDA IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
1335, d3qu8E1, 0.8053, 3.35, 0.181, 463, 381, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-(4-NITROBENZYL)PYRIDINE.
1336, d3qu8D_, 0.8053, 3.34, 0.149, 451, 377, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-(4-NITROBENZYL)PYRIDINE.
1337, d2q6nB1, 0.8053, 3.16, 0.179, 422, 374, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
1338, d5veuB_, 0.8052, 3.28, 0.213, 461, 380, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
1339, d2wx2B1, 0.8052, 3.43, 0.172, 465, 383, X-RAY STRUCTURE OF CYP51 FROM THE HUMAN PATHOGEN TRYPANOSOMA CRUZI IN COMPLEX WITH FLUCONAZOLE
1340, p5iutA_, 0.8051, 2.56, 0.297, 367, 353, STRUCTURE OF P450 2B4 F202W MUTANT
1341, d4k9tA_, 0.8051, 3.24, 0.156, 457, 378, COMPLEX OF CYP3A4 WITH A DESOXYRITONAVIR ANALOG
1342, p3r1aH_, 0.8051, 3.31, 0.158, 454, 379, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1343, p5e58C_, 0.8049, 3.13, 0.218, 457, 377, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B35 FROM DESERT WOODRAT NEOTOMA LEPIDA IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
1344, p3r1aD_, 0.8049, 3.36, 0.148, 452, 378, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1345, d3mzsC_, 0.8049, 3.39, 0.153, 450, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP11A1 IN COMPLEX WITH 22- HYDROXY-CHOLESTEROL
1346, d3kw4A1, 0.8049, 3.46, 0.187, 455, 384, CRYSTAL STRUCTURE OF CYTOCHROME 2B4 IN COMPLEX WITH THE ANTI-PLATELET DRUG TICLOPIDINE
1347, d2v0mC1, 0.8049, 3.29, 0.142, 450, 379, CRYSTAL STRUCTURE OF HUMAN P450 3A4 IN COMPLEX WITH KETOCONAZOLE
1348, d2j0cC_, 0.8049, 3.36, 0.181, 463, 381,  
1349, d6bd6A_, 0.8048, 3.39, 0.153, 452, 380, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
1350, d3mzsD_, 0.8048, 3.39, 0.162, 464, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP11A1 IN COMPLEX WITH 22- HYDROXY-CHOLESTEROL
1351, d5veuH_, 0.8047, 3.41, 0.178, 464, 382, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
1352, p5e58E_, 0.8046, 3.23, 0.156, 454, 377, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B35 FROM DESERT WOODRAT NEOTOMA LEPIDA IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
1353, d4d6zA_, 0.8046, 3.26, 0.161, 453, 378, CYTOCHROME P450 3A4 BOUND TO IMIDAZOLE AND AN INHIBITOR
1354, d5w0cA1, 0.8045, 3.15, 0.168, 422, 375, CYTOCHROME P450 (CYP) 2C9 TCA007 INHIBITOR COMPLEX
1355, d3qoaA1, 0.8044, 2.80, 0.281, 377, 360, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-BENZYLPYRIDINE.
1356, d1ue8A_, 0.8044, 3.37, 0.162, 461, 382, CRYSTAL STRUCTURE OF THERMOPHILIC CYTOCHROME P450 FROM SULFOLOBUS TOKODAII
1357, d5veuD_, 0.8042, 3.44, 0.158, 470, 385, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
1358, p4zv8A_, 0.8042, 3.33, 0.213, 457, 381, STRUCTURE OF CYP2B6 (Y226H/K262R) WITH ADDITIONAL MUTATION Y244W IN COMPLEX WITH ALPHA-PINENE
1359, d2q6nC1, 0.8041, 3.27, 0.143, 453, 378, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
1360, d3mzsB_, 0.8040, 3.46, 0.172, 460, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP11A1 IN COMPLEX WITH 22- HYDROXY-CHOLESTEROL
1361, d5g5jA_, 0.8038, 3.42, 0.156, 470, 384, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO METFORMIN
1362, d4tuvA_, 0.8038, 3.32, 0.181, 463, 381, X-RAY CRYSTAL STRUCTURE OF CYP119 FROM SULFOLOBUS ACIDOCALDARIUS COMPLEXED WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
1363, d1dt6A1, 0.8038, 3.28, 0.146, 449, 377, STRUCTURE OF MAMMALIAN CYTOCHROME P450 2C5
1364, d5a5iA1, 0.8037, 3.33, 0.163, 464, 381, CYTOCHROME 2C9 P450 INHIBITOR COMPLEX
1365, d4wqjA_, 0.8037, 3.29, 0.211, 457, 380, CRYSTAL STRUCTURE OF CYP119 FROM SULFOLOBUS ACIDOCALDARIUS COLLECTED AT 298K AND COMPLEXED WITH 4-(4-BROMOPHENYL)-1H IMIDAZOLE
1366, d5veuJ_, 0.8035, 3.45, 0.158, 472, 385, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
1367, d5veuA_, 0.8034, 3.45, 0.158, 472, 385, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
1368, d4rqlB1, 0.8034, 3.38, 0.181, 459, 381, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH A MONOTERPENE - SABINENE
1369, p3r1aF_, 0.8033, 3.36, 0.163, 464, 381, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1370, d4rqlA1, 0.8031, 3.29, 0.213, 460, 380, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH A MONOTERPENE - SABINENE
1371, p5uapA_, 0.8030, 3.43, 0.156, 471, 384, CRYSTAL STRUCTURE OF CYP2B6 (Y226H/K262R) IN COMPLEX WITH BORNYL BROMIDE
1372, d1f4tB_, 0.8029, 3.13, 0.168, 424, 375, THERMOPHILIC P450: CYP119 FROM SULFOLOBUS SOLFACTARICUS WITH 4- PHENYLIMIDAZOLE BOUND
1373, p3r1aA_, 0.8028, 3.38, 0.181, 462, 381, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1374, p4h1nA_, 0.8027, 3.38, 0.162, 464, 382, CRYSTAL STRUCTURE OF P450 2B4 F297A MUTANT IN COMPLEX WITH ANTI- PLATELET DRUG CLOPIDOGREL
1375, d3mzsA_, 0.8027, 3.45, 0.170, 464, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP11A1 IN COMPLEX WITH 22- HYDROXY-CHOLESTEROL
1376, d5te8C_, 0.8026, 3.35, 0.181, 464, 381, CRYSTAL STRUCTURE OF THE MIDAZOLAM-BOUND HUMAN CYP3A4
1377, p3r1aE_, 0.8026, 3.29, 0.161, 454, 378, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1378, p5udaA_, 0.8025, 3.35, 0.181, 464, 381, CRYSTAL STRUCTURE OF CYP2B6 (Y226H/K262R) IN COMPLEX WITH A MONOTERPENE BORNANE
1379, d4rrtB_, 0.8025, 3.46, 0.160, 464, 382, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH (+)-3-CARENE
1380, p5uapB_, 0.8024, 3.39, 0.168, 464, 382, CRYSTAL STRUCTURE OF CYP2B6 (Y226H/K262R) IN COMPLEX WITH BORNYL BROMIDE
1381, d4tt5A_, 0.8024, 3.38, 0.181, 461, 381, CRYSTAL STRUCTURE OF CYP119 FROM SULFOLOBUS ACIDOCALDARIUS COMPLEXED WITH 4-(4-BROMOPHENYL)-1H IMIDAZOLE
1382, d2q6nA1, 0.8024, 3.26, 0.143, 452, 377, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
1383, d5veuG_, 0.8023, 3.35, 0.173, 462, 381, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
1384, d4jltA1, 0.8023, 3.33, 0.176, 463, 381, CRYSTAL STRUCTURE OF P450 2B4(H226Y) IN COMPLEX WITH PAROXETINE
1385, d4rrtA_, 0.8022, 3.30, 0.195, 471, 380, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH (+)-3-CARENE
1386, p4kq8A_, 0.8021, 3.30, 0.195, 471, 380, STRUCTURE OF RECOMBINANT HUMAN CYTOCHROME P450 AROMATASE
1387, d1lfkA_, 0.8021, 3.42, 0.145, 447, 379, CRYSTAL STRUCTURE OF OXYB A CYTOCHROME P450 IMPLICATED IN AN OXIDATIVE PHENOL COUPLING REACTION DURING VANCOMYCIN BIOSYNTHESIS
1388, p5udaB_, 0.8020, 3.43, 0.156, 470, 384, CRYSTAL STRUCTURE OF CYP2B6 (Y226H/K262R) IN COMPLEX WITH A MONOTERPENE BORNANE
1389, d4wpdB_, 0.8020, 3.46, 0.158, 471, 385, X-RAY CRYSTAL STRUCTURE OF CYP119 COMPLEXED WITH 4-(4-FLOUROPHENYL)- 1H-IMIDAZOLE
1390, p3r1aB_, 0.8017, 3.38, 0.181, 461, 381, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1391, d2q6nD1, 0.8015, 3.42, 0.162, 464, 382, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
1392, d4i91A1, 0.8014, 3.49, 0.162, 463, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH ALPHA-PINENE.
1393, d5vc0A_, 0.8013, 3.46, 0.158, 470, 385, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO RITONAVIR
1394, p5uecA_, 0.8012, 3.46, 0.173, 459, 382, CRYSTAL STRUCTURE OF CYP2B6 (Y226H/K262R) IN COMPLEX WITH MYRTENYL BROMIDE.
1395, p5jl9A_, 0.8010, 3.36, 0.181, 464, 381, HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1): ANDROSTENEDIONE COMPLEX #4
1396, d3mvrB1, 0.8010, 3.50, 0.172, 465, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4-H226Y IN A CLOSED CONFORMATION
1397, d1f4tA_, 0.8010, 3.43, 0.156, 470, 384, THERMOPHILIC P450: CYP119 FROM SULFOLOBUS SOLFACTARICUS WITH 4- PHENYLIMIDAZOLE BOUND
1398, d4r20B1, 0.8009, 3.38, 0.181, 461, 381, ZEBRA FISH CYTOCHROME P450 17A2 WITH ABIRATERONE
1399, d3mvrA1, 0.8009, 3.43, 0.157, 464, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4-H226Y IN A CLOSED CONFORMATION
1400, d2q6nE1, 0.8006, 3.40, 0.165, 461, 382, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
1401, d4i4gA_, 0.8004, 3.44, 0.175, 464, 382, CRYSTAL STRUCTURE OF CYP3A4 LIGATED TO OXAZOLE-SUBSTITUTED DESOXYRITONAVIR
1402, d4i4hA_, 0.8003, 3.43, 0.162, 464, 382, CRYSTAL STRUCTURE OF CYP3A4 LIGATED TO PYRIDINE-SUBSTITUTED DESOXYRITONAVIR
1403, p3s79A_, 0.8002, 3.43, 0.162, 464, 382, HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1) REFINED AT 2.75 ANGSTROM
1404, d1io8B_, 0.8002, 3.34, 0.207, 470, 381, THERMOPHILIC CYTOCHROME P450 (CYP119) FROM SULFOLOBUS SOLFATARICUS: HIGH RESOLUTION STRUCTURAL ORIGIN OF ITS THERMOSTABILITY AND FUNCTIONAL PROPERTIES
1405, p5ufgA_, 0.7999, 3.41, 0.146, 446, 378, CRYSTAL STRUCTURE OF CYP2B6 (Y226H/K262R/I114V) IN COMPLEX WITH MYRTENYL BROMIDE
1406, p3eqmA_, 0.7999, 3.37, 0.163, 458, 381, CRYSTAL STRUCTURE OF HUMAN PLACENTAL AROMATASE CYTOCHROME P450 IN COMPLEX WITH ANDROSTENEDIONE
1407, d1io7B_, 0.7999, 3.32, 0.205, 460, 380, THERMOPHILIC CYTOCHROME P450 (CYP119) FROM SULFOLOBUS SOLFATARICUS: HIGH RESOLUTION STRUCTURAL ORIGIN OF ITS THERMOSTABILITY AND FUNCTIONAL PROPERTIES
1408, d5veuL_, 0.7998, 3.37, 0.181, 464, 381, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
1409, p5jl6A_, 0.7998, 3.26, 0.209, 459, 378, HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1): ANDROSTENEDIONE COMPLEX #2
1410, d4wpdA_, 0.7998, 3.27, 0.179, 463, 380, X-RAY CRYSTAL STRUCTURE OF CYP119 COMPLEXED WITH 4-(4-FLOUROPHENYL)- 1H-IMIDAZOLE
1411, d4gqsD1, 0.7998, 3.43, 0.162, 463, 382, STRUCTURE OF HUMAN MICROSOMAL CYTOCHROME P450 (CYP) 2C19
1412, p3s7sA_, 0.7998, 3.39, 0.195, 456, 380, CRYSTAL STRUCTURE OF HUMAN PLACENTAL AROMATASE COMPLEXED WITH BREAST CANCER DRUG EXEMESTANE
1413, d3qu8F_, 0.7998, 3.52, 0.172, 465, 383, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-(4-NITROBENZYL)PYRIDINE.
1414, p5em4A_, 0.7996, 3.42, 0.181, 461, 381, STRUCTURE OF CYP2B4 F244W IN A LIGAND FREE CONFORMATION
1415, p5jkwA_, 0.7995, 3.25, 0.211, 457, 379, HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1) COMPLEXED WITH TESTOSTERONE
1416, p5jkvA_, 0.7995, 3.39, 0.181, 461, 381, HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1) AT 2.75 ANGSTROM WITH BOUND POLYETHYLENE GLYCOL
1417, d4k9wC_, 0.7995, 3.10, 0.219, 456, 375, COMPLEX OF HUMAN CYP3A4 WITH A DESOXYRITONAVIR ANALOG
1418, p4gl5A_, 0.7995, 3.44, 0.162, 464, 382, STRUCTURE OF HUMAN PLACENTAL AROMATASE COMPLEXED WITH DESIGNED INHIBITOR HDDG029 (COMPOUND 4)
1419, p5jl7A_, 0.7994, 3.14, 0.210, 456, 376, HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1): ANDROSTENEDIONE COMPLEX #3
1420, p5em4B_, 0.7994, 3.25, 0.141, 423, 375, STRUCTURE OF CYP2B4 F244W IN A LIGAND FREE CONFORMATION
1421, p5e58F_, 0.7993, 3.43, 0.162, 463, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B35 FROM DESERT WOODRAT NEOTOMA LEPIDA IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
1422, d4d78A_, 0.7993, 2.68, 0.330, 371, 358, CYTOCHROME P450 3A4 BOUND TO AN INHIBITOR
1423, d5veuK_, 0.7991, 3.51, 0.159, 458, 383, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
1424, d3nxuA_, 0.7991, 3.37, 0.163, 458, 381, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P4503A4 BOUND TO AN INHIBITOR RITONAVIR
1425, d3nxuB_, 0.7990, 3.38, 0.163, 458, 381, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P4503A4 BOUND TO AN INHIBITOR RITONAVIR
1426, d4k9wD_, 0.7988, 3.44, 0.175, 464, 382, COMPLEX OF HUMAN CYP3A4 WITH A DESOXYRITONAVIR ANALOG
1427, d4k9wA_, 0.7988, 3.33, 0.198, 458, 379, COMPLEX OF HUMAN CYP3A4 WITH A DESOXYRITONAVIR ANALOG
1428, d3k9yA_, 0.7987, 3.50, 0.175, 440, 383, CRYSTAL STRUCTURE OF RAT MITOCHONDRIAL P450 24A1 S57D IN COMPLEX WITH CYMAL-5
1429, p4gl7A_, 0.7984, 3.36, 0.176, 460, 380, STRUCTURE OF HUMAN PLACENTAL AROMATASE COMPLEXED WITH DESIGNED INHIBITOR HDDG046 (COMPOUND 5)
1430, d2j0dA1, 0.7982, 3.19, 0.204, 455, 377, CRYSTAL STRUCTURE OF HUMAN P450 3A4 IN COMPLEX WITH ERYTHROMYCIN
1431, d4d7dA_, 0.7981, 3.52, 0.175, 464, 383, CYTOCHROME P450 3A4 BOUND TO AN INHIBITOR
1432, p2rcmA_, 0.7980, 3.51, 0.162, 465, 383, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE VARIANT (F137L) (AT-AOS(F137L) CYTOCHROME P450 74A) AT 1.73 A RESOLUTION
1433, p4mgjA_, 0.7971, 3.53, 0.172, 465, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 F429H IN COMPLEX WITH 4-CPI
1434, d2v0mA1, 0.7967, 3.50, 0.158, 470, 385, CRYSTAL STRUCTURE OF HUMAN P450 3A4 IN COMPLEX WITH KETOCONAZOLE
1435, d2j0cA_, 0.7967, 3.48, 0.168, 465, 382,  
1436, d3k9vA_, 0.7966, 3.48, 0.206, 465, 383, CRYSTAL STRUCTURE OF RAT MITOCHONDRIAL P450 24A1 S57D IN COMPLEX WITH CHAPS
1437, p3dsjA_, 0.7964, 3.48, 0.206, 465, 383, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE VARIANT (F137L) (AT-AOS(F137L) CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 13(S)-HOD AT 1.60 A RESOLUTION
1438, d4fdhF1, 0.7963, 3.21, 0.212, 457, 378, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
1439, p2f9qC_, 0.7962, 3.46, 0.156, 470, 384, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2D6
1440, p3el3A_, 0.7961, 3.31, 0.201, 459, 379, DISTINCT MONOOXYGENASE AND FARNESENE SYNTHASE ACTIVE SITES IN CYTOCHROME P450 170A1
1441, d4k9wB_, 0.7960, 3.47, 0.157, 462, 383, COMPLEX OF HUMAN CYP3A4 WITH A DESOXYRITONAVIR ANALOG
1442, p3dsiA_, 0.7960, 3.27, 0.212, 460, 378, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 13(S)-HOT AT 1.60 A RESOLUTION
1443, d4dvqF1, 0.7959, 3.31, 0.188, 463, 378, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
1444, d4fdhE1, 0.7958, 3.45, 0.165, 459, 382, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
1445, p3dskA_, 0.7958, 2.63, 0.297, 367, 353, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE VARIANT (F137L) (AT-AOS(F137L) CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 12R13S-VERNOLIC ACID AT 1.55 A RESOLUTION
1446, d1w0gA_, 0.7958, 3.36, 0.206, 459, 379, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 3A4
1447, d1f4uB_, 0.7957, 3.45, 0.162, 465, 382, THERMOPHILIC P450: CYP119 FROM SULFOLOBUS SOLFACTARICUS
1448, d1f4uA_, 0.7957, 3.51, 0.170, 464, 383, THERMOPHILIC P450: CYP119 FROM SULFOLOBUS SOLFACTARICUS
1449, d5hh3A_, 0.7955, 3.51, 0.158, 470, 385, OXYA FROM ACTINOPLANES TEICHOMYCETICUS
1450, p2rchA_, 0.7955, 3.21, 0.210, 452, 376, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 13(S)-HOD AT 1.85 A RESOLUTION
1451, p3cliA_, 0.7954, 2.67, 0.292, 367, 353, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) AT 1.80 A RESOLUTION
1452, p2f9qA_, 0.7954, 3.44, 0.159, 447, 383, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2D6
1453, d2v0mD1, 0.7952, 3.49, 0.180, 450, 383, CRYSTAL STRUCTURE OF HUMAN P450 3A4 IN COMPLEX WITH KETOCONAZOLE
1454, p2rclA_, 0.7952, 2.67, 0.292, 367, 353, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 12R13S-VERNOLIC ACID AT 2.4 A RESOLUTION
1455, d3kswA_, 0.7951, 3.48, 0.192, 458, 381, CRYSTAL STRUCTURE OF STEROL 14ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA CRUZI IN COMPLEX WITH AN INHIBITOR VNF ((4-(4- CHLOROPHENYL)-N-[2-(1H-IMIDAZOL-1-YL)-1-PHENYLETHYL]BENZAMIDE)
1456, d3k9yB_, 0.7951, 3.28, 0.188, 462, 378, CRYSTAL STRUCTURE OF RAT MITOCHONDRIAL P450 24A1 S57D IN COMPLEX WITH CYMAL-5
1457, d2j0cD_, 0.7951, 3.46, 0.165, 464, 382,  
1458, d4dvqG_, 0.7950, 3.54, 0.170, 465, 383, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
1459, d4dvqE1, 0.7947, 3.53, 0.159, 464, 383, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
1460, d4fdhA_, 0.7939, 3.47, 0.165, 464, 382, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
1461, d2j0cB_, 0.7937, 2.68, 0.293, 367, 352,  
1462, d4r20A_, 0.7936, 3.54, 0.172, 465, 383, ZEBRA FISH CYTOCHROME P450 17A2 WITH ABIRATERONE
1463, p2f9qB_, 0.7930, 3.46, 0.171, 459, 380, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2D6
1464, d4dvqA_, 0.7929, 3.53, 0.158, 470, 385, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
1465, d3k9vB_, 0.7929, 3.33, 0.208, 469, 379, CRYSTAL STRUCTURE OF RAT MITOCHONDRIAL P450 24A1 S57D IN COMPLEX WITH CHAPS
1466, d2v0mB1, 0.7929, 3.49, 0.178, 465, 382, CRYSTAL STRUCTURE OF HUMAN P450 3A4 IN COMPLEX WITH KETOCONAZOLE
1467, p4zgxC_, 0.7928, 3.41, 0.163, 461, 381, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
1468, d4fdhG_, 0.7928, 3.47, 0.165, 461, 382, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
1469, d2vkuA_, 0.7927, 3.41, 0.165, 463, 381, 44 -DIHYDROXYBENZOPHENONE MIMICS STEROL SUBSTRATE IN THE BINDING SITE OF STEROL 14ALPHA-DEMETHYLASE (CYP51) IN THE X-RAY STRUCTURE OF THE COMPLEX
1470, p4zgxB_, 0.7926, 2.69, 0.292, 367, 353, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
1471, p2f9qD_, 0.7924, 3.56, 0.170, 464, 383, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2D6
1472, p4zgxK_, 0.7923, 3.39, 0.177, 455, 379, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
1473, d4fdhD_, 0.7923, 3.48, 0.168, 457, 381, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
1474, d4k9xA_, 0.7922, 3.53, 0.162, 461, 383, COMPLEX OF HUMAN CYP3A4 WITH A DESOXYRITONAVIR ANALOG
1475, d4fdhB_, 0.7922, 3.55, 0.148, 452, 384, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
1476, d1io9B_, 0.7920, 3.02, 0.279, 375, 362, THERMOPHILIC CYTOCHROME P450 (CYP119) FROM SULFOLOBUS SOLFATARICUS: HIGH RESOLUTION STRUCTURAL ORIGIN OF ITS THERMOSTABILITY AND FUNCTIONAL PROPERTIES
1477, p4zgxE_, 0.7917, 3.42, 0.165, 460, 381, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
1478, d4dvqH_, 0.7916, 2.67, 0.290, 367, 352, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
1479, d4dvqC_, 0.7916, 3.56, 0.172, 465, 383, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
1480, p4zgxJ_, 0.7915, 3.55, 0.170, 464, 383, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
1481, d4k9uA_, 0.7915, 3.48, 0.165, 464, 382, COMPLEX OF HUMAN CYP3A4 WITH A DESOXYRITONAVIR ANALOG
1482, d4dvqB_, 0.7913, 3.41, 0.189, 463, 380, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
1483, p4zgxA_, 0.7911, 3.44, 0.165, 465, 381, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
1484, p4zgxL_, 0.7907, 3.51, 0.154, 452, 382, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
1485, d4fdhC_, 0.7907, 3.47, 0.171, 462, 380, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
1486, p4zgxD_, 0.7906, 2.67, 0.293, 367, 352, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
1487, d4dvqJ_, 0.7905, 2.67, 0.293, 367, 352, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
1488, p4zgxH_, 0.7904, 3.34, 0.176, 413, 374, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
1489, d5hh3C1, 0.7903, 3.47, 0.171, 462, 380, OXYA FROM ACTINOPLANES TEICHOMYCETICUS
1490, d4fdhH_, 0.7902, 3.59, 0.170, 464, 383, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
1491, d4dvqD_, 0.7902, 3.34, 0.193, 459, 378, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
1492, d4fdhL_, 0.7901, 3.35, 0.195, 457, 379, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
1493, d4fdhK_, 0.7896, 3.54, 0.157, 452, 383, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
1494, d4dvqL_, 0.7896, 2.36, 0.300, 359, 347, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
1495, d4dvqI_, 0.7893, 3.45, 0.165, 464, 381, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
1496, d2j0dB1, 0.7893, 3.54, 0.157, 452, 383, CRYSTAL STRUCTURE OF HUMAN P450 3A4 IN COMPLEX WITH ERYTHROMYCIN
1497, d4fdhI_, 0.7891, 3.54, 0.157, 452, 383, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
1498, d3tjsA_, 0.7884, 2.36, 0.300, 359, 347, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN HUMAN CYTOCHROME P450 3A4 AND DESTHIAZOLYLMETHYLOXYCARBONYL RITONAVIR
1499, p4zgxF_, 0.7883, 3.31, 0.207, 448, 376, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
1500, d4dvqK_, 0.7882, 3.57, 0.148, 452, 384, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
1501, d5veuE_, 0.7881, 2.67, 0.290, 367, 352, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
1502, p4zgxI_, 0.7879, 3.27, 0.194, 451, 376, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
1503, p3danA_, 0.7878, 3.54, 0.157, 452, 383, CRYSTAL STRUCTURE OF ALLENE OXIDE SYNTHASE
1504, d3psxB_, 0.7873, 3.31, 0.162, 453, 377, CRYSTAL STRUCTURE OF THE KT2 MUTANT OF CYTOCHROME P450 BM3
1505, d4fdhJ_, 0.7868, 3.52, 0.165, 460, 381, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
1506, p3dbmA_, 0.7868, 3.58, 0.148, 452, 384, CRYSTAL STRUCTURE OF ALLENE OXIDE SYNTHASE
1507, p3damA_, 0.7862, 3.55, 0.157, 452, 383, CRYSTAL STRUCTURE OF ALLENE OXIDE SYNTHASE
1508, p3dsjB_, 0.7853, 3.32, 0.201, 458, 378, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE VARIANT (F137L) (AT-AOS(F137L) CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 13(S)-HOD AT 1.60 A RESOLUTION
1509, p2rcmB_, 0.7853, 3.55, 0.157, 452, 383, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE VARIANT (F137L) (AT-AOS(F137L) CYTOCHROME P450 74A) AT 1.73 A RESOLUTION
1510, p3dsiB_, 0.7851, 3.58, 0.148, 452, 384, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 13(S)-HOT AT 1.60 A RESOLUTION
1511, p3dskB_, 0.7849, 3.52, 0.165, 459, 381, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE VARIANT (F137L) (AT-AOS(F137L) CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 12R13S-VERNOLIC ACID AT 1.55 A RESOLUTION
1512, p2rclB_, 0.7846, 3.52, 0.160, 457, 381, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 12R13S-VERNOLIC ACID AT 2.4 A RESOLUTION
1513, p3cliB_, 0.7844, 3.35, 0.190, 459, 379, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) AT 1.80 A RESOLUTION
1514, d3psxA_, 0.7839, 3.28, 0.176, 458, 376, CRYSTAL STRUCTURE OF THE KT2 MUTANT OF CYTOCHROME P450 BM3
1515, p2rchB_, 0.7839, 3.33, 0.201, 457, 378, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 13(S)-HOD AT 1.85 A RESOLUTION
1516, d1w0eA_, 0.7839, 3.37, 0.193, 457, 379, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 3A4
1517, d1n97A_, 0.7824, 3.38, 0.195, 458, 379, CRYSTAL STUCTURE OF CYP175A1 FROM THERMUS THERMOPHILLUS STRAIN HB27
1518, d6bdhA_, 0.7814, 3.42, 0.195, 458, 380, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
1519, d1n97B_, 0.7786, 3.64, 0.145, 461, 385, CRYSTAL STUCTURE OF CYP175A1 FROM THERMUS THERMOPHILLUS STRAIN HB27
1520, d4tvfA_, 0.7740, 3.56, 0.159, 452, 383, OXYB FROM ACTINOPLANES TEICHOMYCETICUS
1521, p4r1zA_, 0.7733, 3.44, 0.175, 445, 377, ZEBRA FISH CYTOCHROME P450 17A1 WITH ABIRATERONE
1522, d2rfcC_, 0.7721, 3.36, 0.188, 458, 378, LIGAND BOUND (4-PHENYLIMIDAZOLE) CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1523, d2rfcA_, 0.7707, 3.22, 0.116, 465, 372, LIGAND BOUND (4-PHENYLIMIDAZOLE) CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1524, d2rfcD_, 0.7694, 3.58, 0.180, 452, 378, LIGAND BOUND (4-PHENYLIMIDAZOLE) CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1525, d2bz9B_, 0.7692, 3.38, 0.201, 455, 379, LIGAND-FREE STRUCTURE OF STEROL 14ALPHA-DEMETHYLASE FROM MYCOBACTERIUM TUBERCULOSIS IN P2(1) SPACE GROUP
1526, d1e9xA_, 0.7657, 3.38, 0.201, 455, 379, CYTOCHROME P450 14 ALPHA-STEROL DEMETHYLASE (CYP51) FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH 4-PHENYLIMIDAZOLE
1527, p4r1zB_, 0.7649, 3.71, 0.156, 464, 385, ZEBRA FISH CYTOCHROME P450 17A1 WITH ABIRATERONE
1528, d2w0bA_, 0.7622, 3.71, 0.156, 464, 385, CYP51 OF M. TUBERCULOSIS BOUND TO AN INHIBITOR 3-{[(4- METHYLPHENYL)SULFONYL]AMINO}PROPYL PYRIDIN-4-YLCARBAMATE
1529, d1wiyB_, 0.7621, 3.41, 0.114, 465, 376, CRYSTAL STRUCTURE ANALYSIS OF A 6-COORDINATED CYTOCHOROME P450 FROM THERMUS THERMOPHILUS HB8
1530, d3b6hB1, 0.7620, 3.69, 0.156, 463, 384, CRYSTAL STRUCTURE OF HUMAN PROSTACYCLIN SYNTHASE IN COMPLEX WITH INHIBITOR MINOXIDIL
1531, d2iagB1, 0.7619, 3.59, 0.148, 454, 378, CRYSTAL STRUCTURE OF HUMAN PROSTACYCLIN SYNTHASE
1532, d2bz9A_, 0.7611, 3.23, 0.173, 417, 371, LIGAND-FREE STRUCTURE OF STEROL 14ALPHA-DEMETHYLASE FROM MYCOBACTERIUM TUBERCULOSIS IN P2(1) SPACE GROUP
1533, d3b6hA1, 0.7602, 3.23, 0.173, 417, 371, CRYSTAL STRUCTURE OF HUMAN PROSTACYCLIN SYNTHASE IN COMPLEX WITH INHIBITOR MINOXIDIL
1534, d1ea1A_, 0.7600, 3.37, 0.196, 457, 378, CYTOCHROME P450 14 ALPHA-STEROL DEMETHYLASE (CYP51) FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH FLUCONAZOLE
1535, p6fshD1, 0.7587, 3.41, 0.114, 466, 376, CRYSTAL STRUCTURE OF HYBRID P450 OXYBTEI(BC/FGVAN) 
1536, d2iagA1, 0.7587, 3.71, 0.156, 463, 384, CRYSTAL STRUCTURE OF HUMAN PROSTACYCLIN SYNTHASE
1537, d1x8vA_, 0.7571, 3.52, 0.155, 464, 381, ESTRIOL-BOUND AND LIGAND-FREE STRUCTURES OF STEROL 14ALPHA- DEMETHYLASE (CYP51)
1538, d2rfbA_, 0.7560, 3.42, 0.114, 466, 376, CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1539, d2rfcB_, 0.7557, 3.22, 0.206, 455, 373, LIGAND BOUND (4-PHENYLIMIDAZOLE) CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1540, d1u13A_, 0.7548, 2.71, 0.300, 366, 350, CRYSTAL STRUCTURE ANALYSIS OF THE C37L/C151T/C442A-TRIPLE MUTANT OF CYP51 FROM MYCOBACTERIUM TUBERCULOSIS
1541, d3b98A_, 0.7538, 2.71, 0.300, 366, 350, CRYSTAL STRUCTURE OF ZEBRAFISH PROSTACYCLIN SYNTHASE (CYTOCHROME P450 8A1)
1542, p6fshA1, 0.7533, 3.37, 0.300, 381, 367, CRYSTAL STRUCTURE OF HYBRID P450 OXYBTEI(BC/FGVAN) 
1543, d3b99A_, 0.7525, 3.45, 0.114, 465, 376, CRYSTAL STRUCTURE OF ZEBRAFISH PROSTACYCLIN SYNTHASE (CYTOCHROME P450 8A1) IN COMPLEX WITH SUBSTRATE ANALOG U51605
1544, d1wiyA_, 0.7521, 3.46, 0.117, 465, 376, CRYSTAL STRUCTURE ANALYSIS OF A 6-COORDINATED CYTOCHOROME P450 FROM THERMUS THERMOPHILUS HB8
1545, d3g5nA1, 0.7519, 3.62, 0.148, 454, 379, TRIPLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
1546, d1h5zA_, 0.7519, 3.39, 0.206, 453, 378, CYTOCHROME P450 14 ALPHA-STEROL DEMETHYLASE (CYP51) FROM MYCOBACTERIUM TUBERCULOSIS IN FERRIC LOW-SPIN STATE
1547, d3g5nB1, 0.7512, 3.45, 0.114, 465, 376, TRIPLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
1548, p6fshB1, 0.7509, 3.62, 0.172, 444, 384, CRYSTAL STRUCTURE OF HYBRID P450 OXYBTEI(BC/FGVAN) 
1549, p6fshC1, 0.7503, 3.71, 0.145, 462, 385, CRYSTAL STRUCTURE OF HYBRID P450 OXYBTEI(BC/FGVAN) 
1550, d3g5nC1, 0.7503, 3.39, 0.204, 453, 378, TRIPLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
1551, d3g5nD1, 0.7498, 3.76, 0.156, 462, 385, TRIPLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
1552, d2rfbB_, 0.7479, 3.58, 0.154, 464, 382, CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1553, d3daxA1, 0.7474, 3.62, 0.154, 463, 382, CRYSTAL STRUCTURE OF HUMAN CYP7A1
1554, d3daxB1, 0.7472, 3.35, 0.213, 451, 376, CRYSTAL STRUCTURE OF HUMAN CYP7A1
1555, d2rfbC_, 0.7470, 3.31, 0.184, 406, 369, CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1556, d3v8dA1, 0.7467, 3.61, 0.148, 451, 378, CRYSTAL STRUCTURE OF HUMAN CYP7A1 IN COMPLEX WITH 7-KETOCHOLESTEROL
1557, d2w09A_, 0.7453, 3.57, 0.152, 463, 381, CYP51 OF M. TUBERCULOSIS BOUND TO AN INHIBITOR CIS-4- METHYL-N-[(1S)-3-(METHYLSULFANYL)-1-(PYRIDIN-4- YLCARBAMOYL)PROPYL]CYCLOHEXANECARBOXAMIDE
1558, d3v8dB1, 0.7440, 3.76, 0.156, 464, 385, CRYSTAL STRUCTURE OF HUMAN CYP7A1 IN COMPLEX WITH 7-KETOCHOLESTEROL
1559, d2w0aA_, 0.7436, 3.38, 0.207, 451, 377, CYP51 OF M. TUBERCULOSIS BOUND TO AN INHIBITOR N-[(1S)-2-METHYL-1-(PYRIDIN-4-YLCARBAMOYL)PROPYL] CYCLOHEXANECARBOXAMIDE
1560, d2cibA_, 0.7399, 3.60, 0.152, 465, 381, HIGH THROUGHPUT SCREENING AND X-RAY CRYSTALLOGRAPHY ASSISTED EVALUATION OF SMALL MOLECULE SCAFFOLDS FOR CYP51 INHIBITORS
1561, d3sn5A1, 0.7396, 3.72, 0.156, 463, 384, CRYSTAL STRUCTURE OF HUMAN CYP7A1 IN COMPLEX WITH CHOLEST-4-EN-3-ONE
1562, d3b98B_, 0.7396, 3.45, 0.189, 444, 375, CRYSTAL STRUCTURE OF ZEBRAFISH PROSTACYCLIN SYNTHASE (CYTOCHROME P450 8A1)
1563, d1po5A1, 0.7391, 3.59, 0.152, 465, 381, STRUCTURE OF MAMMALIAN CYTOCHROME P450 2B4
1564, d2ci0A_, 0.7382, 3.63, 0.148, 451, 378, HIGH THROUGHPUT SCREENING AND X-RAY CRYSTALLOGRAPHY ASSISTED EVALUATION OF SMALL MOLECULE SCAFFOLDS FOR CYP51 INHIBITORS
1565, d3sn5B_, 0.7363, 3.55, 0.161, 461, 380, CRYSTAL STRUCTURE OF HUMAN CYP7A1 IN COMPLEX WITH CHOLEST-4-EN-3-ONE
1566, p3r1bA1, 0.7265, 3.58, 0.152, 465, 381, OPEN CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1567, d3b99B_, 0.7234, 3.41, 0.198, 449, 374, CRYSTAL STRUCTURE OF ZEBRAFISH PROSTACYCLIN SYNTHASE (CYTOCHROME P450 8A1) IN COMPLEX WITH SUBSTRATE ANALOG U51605
1568, p2vz7A1, 0.7200, 3.57, 0.152, 465, 381, CRYSTAL STRUCTURE OF THE YC-17-BOUND PIKC D50N MUTANT
1569, p2vz7B1, 0.7145, 2.45, 0.297, 354, 344, CRYSTAL STRUCTURE OF THE YC-17-BOUND PIKC D50N MUTANT
1570, d2bdmA2, 0.7059, 3.63, 0.152, 459, 381, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND BIFONAZOLE
1571, d5bv5A_, 0.7049, 3.55, 0.155, 462, 380, STRUCTURE OF CYP119 WITH T213A AND C317H MUTATIONS
1572, p3be0A1, 0.6925, 3.65, 0.154, 462, 382, THE ROLE OF ASN 242 IN P450CIN
1573, d5bv5D_, 0.6907, 3.56, 0.155, 463, 380, STRUCTURE OF CYP119 WITH T213A AND C317H MUTATIONS
1574, p4tpoA1, 0.6897, 3.63, 0.202, 450, 377, HIGH-RESOLUTION STRUCTURE OF TXTE WITH BOUND TRYPTOPHAN SUBSTRATE
1575, p4l0eA2, 0.6877, 3.59, 0.152, 463, 381, STRUCTURE OF P450SKY (CYP163B3) A CYTOCHROME P450 FROM SKYLLAMYCIN BIOSYNTHESIS (HEME-COORDINATED EXPRESSION TAG)
1576, p5mnvD1, 0.6851, 3.62, 0.152, 465, 381, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
1577, p4l36B1, 0.6818, 3.66, 0.154, 462, 382, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 ENZYME TXTE
1578, p5u6tA1, 0.6786, 3.66, 0.154, 462, 382, THE CRYSTAL STRUCTURE OF 4-ETHOXYBENZOATE-BOUND CYP199A4 
1579, d5bv5C_, 0.6782, 3.61, 0.152, 465, 381, STRUCTURE OF CYP119 WITH T213A AND C317H MUTATIONS
1580, p4tpnA1, 0.6754, 3.67, 0.157, 462, 382, HIGH-RESOLUTION STRUCTURE OF TXTE IN THE ABSENCE OF SUBSTRATE
1581, p3wvsA1, 0.6725, 3.68, 0.154, 465, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450REVI
1582, p5mnvF1, 0.6721, 3.28, 0.302, 387, 364, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
1583, p6bldA1, 0.6718, 3.28, 0.302, 387, 364, MYCOBACTERIUM MARINUM CYTOCHROME P450 CYP268A2 IN COMPLEX WITH PSEUDOIONONE
1584, p3be0B1, 0.6704, 3.61, 0.155, 462, 381, THE ROLE OF ASN 242 IN P450CIN
1585, p4l77B1, 0.6689, 3.67, 0.154, 462, 382, P450CIN ACTIVE SITE WATER: IMPLICATIONS FOR SUBSTRATE BINDING AND SOLVENT ACCESSIBILITY
1586, p4l6gA1, 0.6687, 3.60, 0.155, 456, 380, CRYSTAL STRUCTURE OF P450CIN Y81F MUTANT CRYSTALLIZED IN 7 MM 18- CINEOLE
1587, p4fyzA1, 0.6687, 3.58, 0.153, 469, 380, CRYSTAL STRUCTURE OF NITROSYL CYTOCHROME P450CIN
1588, p3bdzB1, 0.6687, 3.58, 0.153, 469, 380, THE ROLE OF ASN 242 IN P450CIN
1589, p3bdzA1, 0.6686, 3.58, 0.156, 454, 379, THE ROLE OF ASN 242 IN P450CIN
1590, p4lhtA1, 0.6685, 3.68, 0.157, 462, 382, CRYSTAL STRUCTURE OF P450CIN Y81F MUTANT CRYSTALLIZED IN 3 MM 18- CINEOLE
1591, p4lhtB1, 0.6681, 3.48, 0.177, 441, 373, CRYSTAL STRUCTURE OF P450CIN Y81F MUTANT CRYSTALLIZED IN 3 MM 18- CINEOLE
1592, p4fyzB1, 0.6681, 3.69, 0.154, 462, 382, CRYSTAL STRUCTURE OF NITROSYL CYTOCHROME P450CIN
1593, p5mnvC1, 0.6672, 3.47, 0.210, 449, 376, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
1594, p4l6gB1, 0.6672, 3.59, 0.153, 464, 380, CRYSTAL STRUCTURE OF P450CIN Y81F MUTANT CRYSTALLIZED IN 7 MM 18- CINEOLE
1595, p4fmxB1, 0.6669, 3.69, 0.157, 460, 381, CRYSTAL STRUCTURE OF SUBSTRATE-BOUND P450CIN
1596, p1t2bB1, 0.6668, 3.23, 0.200, 441, 370, CRYSTAL STRUCTURE OF CYTOCHROME P450CIN COMPLEXED WITH ITS SUBSTRATE 18-CINEOLE
1597, p5yswA1, 0.6665, 3.71, 0.157, 458, 381, CRYSTAL STRUCTURE ANALYSIS OF RIF16 IN COMPLEX WITH R-L 
1598, p4fmxA1, 0.6665, 3.60, 0.106, 473, 376, CRYSTAL STRUCTURE OF SUBSTRATE-BOUND P450CIN
1599, p4l77A1, 0.6663, 3.60, 0.106, 473, 376, P450CIN ACTIVE SITE WATER: IMPLICATIONS FOR SUBSTRATE BINDING AND SOLVENT ACCESSIBILITY
1600, p3qi8A1, 0.6662, 3.18, 0.148, 414, 365, EVOLVED VARIANT OF CYTOCHROME P450 (BM3 CYP102A1)
1601, p1t2bA1, 0.6662, 3.60, 0.155, 462, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450CIN COMPLEXED WITH ITS SUBSTRATE 18-CINEOLE
1602, p5mnsE1, 0.6654, 3.61, 0.106, 467, 376, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN SODIUM FORMATE
1603, p4oqrA1, 0.6648, 3.62, 0.109, 467, 376, STRUCTURE OF A CYP105AS1 MUTANT IN COMPLEX WITH COMPACTIN
1604, p5mnsC1, 0.6618, 3.43, 0.105, 465, 371, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN SODIUM FORMATE
1605, p4fb2D1, 0.6617, 3.43, 0.105, 465, 371, CRYSTAL STRUCTURE OF SUBSTRATE-FREE P450CIN
1606, p5mnvE1, 0.6613, 3.43, 0.105, 465, 371, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
1607, p4fb2A1, 0.6607, 3.42, 0.105, 465, 371, CRYSTAL STRUCTURE OF SUBSTRATE-FREE P450CIN
1608, p4fb2B1, 0.6603, 3.43, 0.105, 465, 371, CRYSTAL STRUCTURE OF SUBSTRATE-FREE P450CIN
1609, p5mnsD1, 0.6593, 3.44, 0.105, 465, 371, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN SODIUM FORMATE
1610, p5omuA1, 0.6588, 3.24, 0.151, 412, 364, CRYSTAL STRUCTURE OF AMYCOLATOPSIS CYTOCHROME P450 GCOA IN COMPLEX WITH SYRINGOL 
1611, p5livB1, 0.6562, 3.45, 0.105, 465, 371, CRYSTAL STRUCTURE OF MYXOBACTERIAL CYP260A1
1612, p5xw2A1, 0.6559, 3.17, 0.202, 450, 367, CRYSTAL STRUCTURE OF THE HYDROXYLASE HMTN IN C 1 2 1 CRYSTAL FORM 
1613, p4fb2C1, 0.6559, 3.08, 0.194, 385, 361, CRYSTAL STRUCTURE OF SUBSTRATE-FREE P450CIN
1614, p2yjnB_, 0.6552, 3.08, 0.194, 385, 361, STRUCTURE OF THE GLYCOSYLTRANSFERASE ERYCIII FROM THE ERYTHROMYCIN BIOSYNTHETIC PATHWAY IN COMPLEX WITH ITS ACTIVATING PARTNER ERYCII
1615, p5ysmA1, 0.6549, 3.63, 0.211, 439, 374, CRYSTAL STRUCTURE ANALYSIS OF RIF16 
1616, p5livC1, 0.6446, 3.14, 0.200, 385, 360, CRYSTAL STRUCTURE OF MYXOBACTERIAL CYP260A1
1617, p6f8aB1, 0.6445, 2.47, 0.324, 352, 340, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276I) BOUND WITH HISTIDINE
1618, p6f8cA1, 0.6431, 2.96, 0.173, 417, 352, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276I) BOUND WITH PROGESTERONE
1619, p3nc7B1, 0.6425, 2.27, 0.268, 338, 336, CYP134A1 2-PHENYLIMIDAZOLE BOUND STRUCTURE
1620, p6f88A1, 0.6419, 2.31, 0.265, 338, 336, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276N) BOUND WITH PROGESTERONE
1621, p5ex9A2, 0.6416, 2.31, 0.262, 338, 336, STRUCTURE OF P450 STAF FROM GLYCOPEPTIDE ANTIBIOTIC A47934 BIOSYNTHESIS; GLYCEROL CRYO
1622, p5livA1, 0.6409, 3.44, 0.200, 432, 365, CRYSTAL STRUCTURE OF MYXOBACTERIAL CYP260A1
1623, p5xntA1, 0.6405, 3.94, 0.198, 449, 374, STRUCTURE OF CYP106A2 FROM BACILLUS SP. PAMC 23377
1624, p5tftB1, 0.6404, 3.94, 0.198, 449, 374, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
1625, p5ex8A2, 0.6404, 3.20, 0.169, 411, 354, STRUCTURE OF P450 STAF FROM GLYCOPEPTIDE ANTIBIOTIC A47934 BIOSYNTHESIS; ETHYLENE GLYCOL CRYO
1626, p6f8cB1, 0.6403, 3.99, 0.191, 440, 372, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276I) BOUND WITH PROGESTERONE
1627, p6f8aA1, 0.6391, 3.25, 0.198, 362, 354, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276I) BOUND WITH HISTIDINE
1628, p6f85B1, 0.6380, 3.96, 0.122, 469, 377, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276N) BOUND WITH HISTIDINE
1629, p3nc7A1, 0.6336, 3.93, 0.119, 466, 377, CYP134A1 2-PHENYLIMIDAZOLE BOUND STRUCTURE
1630, p3g93A1, 0.6246, 3.43, 0.197, 429, 361, SINGLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
1631, p3r1bC1, 0.6181, 4.12, 0.126, 468, 380, OPEN CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1632, p3g93C1, 0.6158, 4.04, 0.188, 447, 373, SINGLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
1633, p3g93D1, 0.6126, 2.73, 0.321, 343, 336, SINGLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
1634, p3r1bD1, 0.6018, 4.00, 0.122, 470, 377, OPEN CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1635, p3r1bB1, 0.5973, 4.00, 0.122, 470, 377, OPEN CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1636, p3g93B1, 0.5919, 3.76, 0.195, 429, 364, SINGLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
1637, p5bv5B1, 0.5804, 2.60, 0.255, 338, 333, STRUCTURE OF CYP119 WITH T213A AND C317H MUTATIONS
